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Scrapie, CJD and BSE are transmissible neurodegenerative disorders 
producing alterations in physicci 	chemical properties of the host protein 
PrP. In uninfected animals PrP is a membrane bound glycoprotein found in 
brain and other tissues. In disease PrP accumulates as protease resistant 
deposits in and around cells. This disease specific form of PrP (PrPSI  also 
differs from the normal form (PrP') by its greatly increased turnover time in 
cell culture and its inability to be released from scrapie infected cells by the 
action of PIPLC (Borchelt et al., 1990; Caughey and Raymond, 1991). The 
amount and distribution of PrP mRNA is identical in the brains of uninfected 
and infected mice suggesting that the accumulation of PrP in disease is due 
to post-transcriptional alterations in PrP synthesis. PrP undergoes three 
major post-translational changes, N-terminalcleavage, Winked glycosylation 
and the cleavage of a C-terminal peptide with the subsequent addition of a 
h1co_ phosphatidylinositol 
o- ?O% -  
(GPI-anchor), which is responsible for the 
attachment to the plasma membrane (Stahl et al., 1987). Most 
PrPSC appears to have an intact GPI-anchor although it cannot be released 
from tissue culture cells by the action of PIPLC whereas PrPC  is released 
into the medium (Stahl etal., 1990b). However, 15% of PrPSC  from hamster 
brain has been shown to be truncated at amino acid 228, these proteins 
having no GPI-anchor (Stahl et al., 1990a). The significance of these 
truncated proteins has not yet been elucidated. It is possible that the 
presence of a small amount of an abnormal, truncated protein could act as 
a seed for a conformational change that would result in the conversion of 
PrPC to PrP" (Prusiner, 1991). This project sets out to investigate the 
differences between the cellular processing of the wild type GPI-anchored 
protein and a mutant protein where addition of the GPI has been prevented. 
The mutant is investigated to show that the engineered mutation does 
indeed give rise to a GPI-less form and the size, glycosylation status, 
4 
immunoreactivity and cellularlocation of the two proteins are investigated 
firstly in a cell-free system and secondly in tissue culture cells. The question 
of whether PrPSC  can be produced when the GPI-anchor is absent will be 
addressed by subsequent studies of these mutations in transgenic mice. 
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CHAPTER ONE: 	 Introduction 
A group of transmissible neurological diseases collectively known as the 
transmissible degenerative encephalopathies (TDE's) has proved a difficult 
problem for molecular biologists due to the undefined nature and unusual 
properties of the infectious agent. The best documented example of this 
group is Scrapie in sheep, which has been recognised for over two hundred 
years, but for which the causitive organism has never been isolated. More 
recently the emergence of bovine spongifom encephalitis (BSE) (Wells et al., 
1987) has excited public concern, as has a spate of cases of Creutzfeldt-
Jacob disease (CJD), a human TIDE, in children treated with contaminated 
human growth hormone (Collinge et al., 1991). The nature of the infectious 
agent has proved controversial because of the failure to detect a disease 
specific nucleic acid and its resistance to procedures that normally destroy 
nucleic acids (Prusiner, 1982; Alper, 1985). Purification of the infectious 
fraction leads to the concentration of a disease specific, protease resistant 
form of a normal membrane protein PrP, and attempts to purify this protein 
from infected brains concentrates infectivity (Merz et al., 1981; Chesebro 
et al., 1985; Oesch et al., 1985; Locht et al., 1986) This has led some 
workers to postulate an infectious protein theory, whereby a disease specific 
protein is able to self-replicate in the absence of a disease specific nucleic 
acid (Prusiner, 1982). Opposed to this is the evidence that numerous, (at 
least 20), different strains of the scrapie agent exist (Bruce et al., 1991), 
which differ in their incubation period characteristics, pathology and clinical 
features, depending on the genotype of the host. These strains undergo 
mutation in a manner analogous to that seen for a nucleic acid containing 
agent. Also, genetic susceptibility seems to have a role to play in the 
disease, as illustrated by differences in incubation times in mice of different 
genetic backgrounds in experimental scrapie (Hunter et al., 1987) and as 
some forms of CJD and Gerstmann-Straussler syndrome (GSS) in humans 
arise in a heritable fashion (Goldfarb et at., 1992a, b). Thus any theory of 
infectivity has to be able to account for all these differing properties. 
In the past ten years much of the work in this field has concentrated on the 
analysis of the involvment in scrapie of the PrP protein (for review see 
(Hope and Manson, 1991). PrP is a membrane glycoprotein that exists in 
two forms: a normal cellular isoform PrPC,  a 33-35kD protein that is located 
at the cell surface and is completely protease sensitive, and PrPSC  which is 
partially protease resistant, giving rise to PrP 27-3OkD and accumulates 
intracellularly in the brains of scrapie infected animals. 	lntraneuronal 
vacuolation is the most common pathological lesion , with some strains 
giving rise to amyloid plaques made up of PrP protein. When infected brains 
are extracted with detergent PrP occurs as rod-shaped fibrils called scrapie 
associated fibrils (SAF). It has been shown that the primary structure of the 
PrP gene is the same in both infected and unifected brains, that the entire 
open reading frame (ORF) is contained on one exon and that usually only 
one species of mRNA is observed (Basler et al., 1986; Goldmann et at., 
1 990) Also, levels of mRNA expression do not differ between infected and 
uninfected brains as shown by in situ hybridization (Manson et al., 1992a). 
This rules out differences at the level of transcription or major RNA splicing 
as a mechanism to account for the differences between PrPC  and PrPSC. 
These physico-chemical differences are believed to result from some post-
transcriptional or post-translational change. 
lect JIe 
Both isoforms have been shown to have a 22 amino acid N-terminalsignaI 
peptide 	(Basler et al., 1986; Hope et at., 1986; Turk et al., 1988) 
Both have also been shown to have their two predicted N-linked 
glycosylation sites occupied by complex glycans (Caughey et al., 1989; 
Borchelt et al., 1990; Somerville and Ritchie, 1990) It has been shown by 
tunicamycin treatment (Taraboulos et al. 1 990) and also by site-directed 
OJ 
mutagenesis of the linkage sites (Rogers et al., 1 990) that this glycosylation 
is not necessary for the production of PrPSC  in scrapie infected neuroblastoma 
cells (ScN2a), so differential glycosylation cannot account for the differences 
between the two isoforms. 
The third post-translational modification of PrP is the cleavage of a C-
terminal peptide and the addition of a phosphatidylinositol-glycolipid (GPI) 
anchor. The objective of this project was to examine the role of the GPI-
anchor in the normal PrP protein and to investigate if the absence of this 
modification would lead to accumulation of the protein in a manner similar 
to that seen in the disease state. This was to be achieved by the production 
of site-directed mutations in I,PrP gene such that the signal sequence for 
ked 
GPI addition would be deleted 	the examination of these mutations in 
in vitro systems. Detailed experimental design is given in Chp.s 3, 4 and 5. 
To help understand the significance of this method of membrane attachment 
in relation to PrP a brief outline of current knowledge of GPI anchors is given 
below. 
GPI-membrane anchors 
Many membrane proteins are anchored to the cell surface by hydrophobic 
interactions of the protein with the lipid bilayer (Lingappa, 1991b). The 
possibility that some membrane associated proteins might be covalently 
linked to glycolipids was first raised by the release from cell membranes of 
proteins such as placental alkaline phosphatase (PLAP), 5'-nucleotidase and 
acetylcholinesterase (AChE), by the action of bacterial phosphoinositol-
specific phospholipase-C (PIPLC). Due to the abundance of this type of 
membrane attachment in the variant-surface glycoftre (VSG) of 
Trypanosoma brucef (up to 1x10 copies per cell), much of the initial 
determination of the chemical structure of GPI anchors was carried out using 
this protein (Fe 	t') Ever increasing numbers of eukaryotic proteins 
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(up to j50 are now known, ( rItc( 	 ina number of 
different cell types 	of disparate function and origin, have been found to 
utilize this mechanism of membrane anchorage. 
Structure and Biosynthesis. 
The GPI-anchoring units in these proteins share a common core structure 
consisting of an ethanolamine-phosphate, a glycan, 	consisting of 
three mannose (Man) residues, and a non-acetylated glucosamine attached 
to a phosphoinositol ring and 	 (see Fig.1 ). They are linked to 
the carboxy-terminus of the polypeptide via an amide bond. A substantial 
body of work has shown that the core structures of these GPI-moieties are 
preassembled in the rough endoplasmic reticulum (RER) (Cross, 1990; 
Amthauer et al., 1993) and are transferred en bloc to the nascent 
polypeptide within a couple of minutes of their luminal translocation (Cross, 
1990) 	 The addition of the GPI moiety is concomitant 
with the removal of a hydrophobic carboxy-terminus amino acid sequence, 
which may act to initially anchor the newly synthesized peptide to the 
membrane. The enzyme(s) responsible for this transamidation reaction have 
not yet been identified. As an increasing number of mammalian anchor 
structures are elucidated variations to the common core structure have been 
discovered. Many non-VSG GPIs, including PrP, contain a second 
ethano lamine phosphodiester linked to one of their Man residues and many 
GPIs are substituted with branching glycans which may be protein, tissue 
and species-specific (Cross, 1990), VSG GPIs undergo a fatty acid 
remodelling to myristate in the 	 ,, after their addition (Masterson 
, but, as yet, this has not been shown to be the case 
for mammalian anchors. 
The normal isoform of PrP (PrPC)  and the scrapie isoform (PrP) have both 
been shown to contain a GPI anchor (Stahl et al., 1987) by a combination 
of PIPLC release and chemical analysis of the C-terminus. A more extensive 
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analysis of the PrPSC  anchor has been performed (Stahl et al., 1991, 1992, 
1993), which has shown that there are six different glycoforms, which differ 
by the presence of additional hexose and sialic acid residues. Two of the 
glycoforms contain N-acetylneuraminic acid, which has not previously been 
reported as a component of any GPI (Stahl et al., 1992). Also, all the 
observed glycoforms contain two ethanolamine residues per moiety and 
contain stearic acid as part of their lipid anchor. Structural studies using 
mass spectrometry and Edman sequencing have shown no differences 
between the GPI anchors of PrPC  and  PrPSC  in their posttranslational chemical 
modification (Stahl et al., 1993). The anchor is attached at Ser 231 in the 
Syrian hamster PrP (Stahl et al., 1990a), but the attachment site for other 
species has not yet been determined. It has been observed that 15% of 
PrPSC extracted from hamster brains is truncated at amino acid 228 (Stahl et 
al., 1990a) and that these proteins do not contain a GPI anchor. The 
significance of this finding is not yet understood. 
Release by PIPLC 
Release from membranes by the action of PIPLC has often been used as an 
indication of GPI-anchorage. However, PIPLC resistance does not preclude 
the presence of a GPI, as some GPI-anchored proteins including human 
decay accelerating factor (DAF) and acetylcholine sterase (AChE) are 
resistant to cleavage, due to the presence of palmitic acid esterified to a 
position on the inositol ring(Ferguson and Williams,1988, Walter et al., 
1990, 	 I%' . '. This site has been identified for the procyclic 
acidic repetitive protein (PARP) of T.brucei (Ferguson, 1992), where it is 
esterified roughly equally to the 2- and 3- hydroxyls of the inositol. Many 
mammalian anchor precursor intermediates are acylated on their inositol 
moieties, but this acylation has been removed from the mature precursors, 
as judged by their sensitivity to PIPLC (Urkaze et a/. 1992). This 
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modification has not been observed on p1pC  and PrPsc GPI anchors (Stahl et 
al., 1992, 1993). It is not known if this is the only substitution that will 
prevent PIPLC cleavage. Experiments in tissue culture cells have shown that 
most PrPC  is released from the surface of neuroblastoma cells by the action 
of PIPLC, whereas p1psc  is not (Borchelt et al., 1990; Taraboulos et al., 
1990). If, however, the PrPSC  is first denatured before PIPLC treatment the 
GPI anchor is then released by the action of the enzyme. This result led to 
the postulation that the conformation or aggregation state of PrPSC,  or its 
position in the cell blocks the access of the enzyme to the C-terminus (Stahl 
et al., 1987). PrPSC  has been found to have an intracellular location by 
immuno-confocal lasar microscopy (Taraboulos et al., 1990). 
Cross Reactive Determinants (CRD) 
Treatment of many mammalian GPI-anchored proteins with PIPLC (but not 
PIPLD), produces a "cross reacting determinant" (CRD) that is found in anti-
VSG sera raised in rabbits (Ferguson and Williams, 1988). The reaction of 
anti-CRD sera is of lower affinity with other proteins than with VSG, but can 
be used as an additional indication of GPI presence. Further treatment of 
the PIPLC-treated protein with nitrous acid removes the inositol 1,2 cyclic 
phosphate and destroys reactivity indicating that this moelty may be the 
recognised epitope (Zi. 	( i• 
PrP released from the surface of tissue culture cells by PIPLC reacts with 
anti-VSG sera (Borchelt et al., 1990). 
Precursor biosynthesis pathway 
Much work has been done recently to elucidate the pathway of GPI 
precursor synthesis. A stepwise model of precursor synthesis has been 
E'k.-4 14Ct3) 
proposed (Tartakoff and Singh, 1992 A  These steps have been worked out 
by a combination of in vitro methods using trypanosome membranes and 
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radiolabelled sugar residues (Masterson et al., 1989; Menon et al., 1990; 
Tartakoff and Singh, 1992) and studies of a series of murine T-cell 
lymphoma mutants deficient in Thy-1 expression 
(Tartakoff and Singh, 1992). Inhibitors of precursor synthesis include 
mannosamine (Lisanti et at., 1991), which inhibits addition of the third Man 
*1OY 	cizcI e) 
residue, PMSF(phenyl ttw(Masterson  and Ferguson, 1991), which inhibits 
addition of ethanolamine phosphate, fluoroglucose (Cross, 1990), which 
inhibits Man addition and certain myristic acid analogues which 	npe! 
myristate addition in trypanosomes (Cross, 1990). Simply stated, the GPI 
moiety is assembled by the sequential glycosylation of phosphatidylinositol 
(P1), followed by the addition of phosphoethanolamine. Transfer of 
radiolabelled GPI precursor to VSG has been observed in a cell free system 
(Mayor et al. 1991). 
Disease associated precursor synthesis defects 
A general deficiency in GPI biosynthesis has been implicated in at least one 
S 
human disease, parox!4naI nocturnal hemoglobinuria (PNH) (Rosse, 1990). 
This is a rare disorder of bone marrow stem cells that is thought to develop 
through the clonal proliferation of an abnormal hematopoietic cell altered by 
somatic mutation. PNH-affected cells are characterized by an increased 
susceptibility to complement lysis. Three of the membrane proteins involved 
in the regulation of the complement cascade (DAF, HRF and CD59) are 
missing from the surface of blood cells in patients with PNH, and a common 
structural feature of these three is their GPI-anchorage (Plough et al., 1992). 
At least seven other GPI-anchored proteins have been shown to be absent 
from the cell surface in this disease . One of these , LFA-3,also exists in a 
transmembrane form, but only its GPI-linked form shows impaired 
expression. Normal levels of mRNA for the above proteins are present in the 
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cells, indicating that there is an underlying fault in the biosynthesis of the 
glycolipid precursor (Rosse, 1990; Plough et al., 1992). Recent work has 
shown that an early step in GPI precursor biosynthesis is deficient in B 
lymphocyte cell lines established from PNH patients (Takeda et al., 1993) 
and that this deficiency results from a somatic mutation in PIG-A, a gene 
that takes part in the synthesis of N-acetylglucosaminyl phosphatidylinositol 
(GlcNAc-PI), an early intermediary in the GPI precursor biosynthetic pathway 
(Miyata et al., 1993). 
Transfer of glycolipids to protein 
Sequence requirements 
GPI-anchor addition involves the coordinated removal of a carboxy-terminus 
amino acid sequence from the nascent chain, followed by the addition of the 
preformed anchor to the new carboxy-terminus. This substitution is a very 
early postranslational event (Bangs et al., 1985; Ferguson et al., 1986) and 
takes place in the endoplasmic reticulum (Cc 3 1r 	&j1qPI-addition is 
directed by a signal at the carboxy-terminus of the protein, but as no 
primary sequence homology between different GPI-anchored proteins has 
been identified the signal is thought to be of a general nature. 
Cell-free and tissue culture studies with PLAP, DAF, Fc1R111, Qa-2 and 
others have defined features which govern GPI-anchorage (Berger et al., 
1988; Waneck et al., 1988; Bailey et al., 1989; Kodukula et al., 1991a; 
Moran and Caras, 1991). These include a hydrophobic tail of a minimum 
length at the very C-terminal end of the primary amino acid sequence and, 
10-12 residues amino terminal to this sequence, the presence of a small non-
polar amino acid at the actual attachment site (Micanovic et al., 1990; 
Moran and Caras, 1991). Also, the absence of a recognisable possible 
cytoplasmic domain at the C-terminus seems to be a prerequsite of GPI 
addition (Englund, 1993). 
Hydrophobic domain 
It has been shown, (Berger et al., 1988), that for PLAP in COS cells a 
hydrophobic tail of at least 17 residues is necessary for the protein to 
become GPI-anchored. Truncation mutations which contained 13 or less 
hydrophobic residues failed to become anchored and were secreted into the 
medium (Berger et al., 1988). The exact amino acid content of the 
hydrophobic region is not important as proteins having different hydrophobic 
sequences substituted for their own are, nevertheless, GPI-anchored. 
Replacement of the hydrophobic region with a hydrophillic sequence, 
however, leads to the protein being secreted. The length of the hydrophobic 
sequence has recently been shown to have the same significance in cell-free 
system (Kodukula etal. 1992). 
The cleavage attachment site 
The nature of the amino acid residue at the attachment site has also been 
shown to be a specific requirement for GPI-addition (Micanovic et al., 1990). 
PLAP mutants containing what these authors designated category 1 amino 
acids (glycine, alanine, serine, cysteine or asparagine) at their attachment 
site were anchored normally at the plasma membrane and exhibited alkaline-
phosphatase activity, whilst those containing category 2 amino acids 
(glutamic acid, glutamine, proline, tryptophan, leucine, valine, phenylalanine, 
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reduced GPI-anchorage and little or no alkaline phosphatase activity 
associated with the cells. A general trend towards having a category one 
amino acid at positions one and two of the cleaved peptide has also been 
observed, with position w+2 (two amino acids amino-terminal from the 
attachment site, Fig.2) having a much more stringent requirement than 
position w+1 (Fig. 2). A similarity between N-terminal signal peptidase and 
the C-terminal transamidase with respect to the required amino acids at the 
cleavage site has been noted (Ferguson and Williams, 1988; Kodukula et al., 
1993). It has been suggested for signal peptidase that there is a requirement 
for particular amino acids to occupy positions -1 and -3, and that these 
amino acids represent sites of interaction with N-terminal signal peptidase 
(Von Heijne, 1990). Kodulkula et al. suggest that the positions wand w+ 2 
are sites of a similar interaction between the protein and the transamidase 
(Kodukula et al., 1993) It has been shown that the immunoglobulin heavy 
chain binding protein (BiP), a protein known as a molecular chaperone, binds 
to nascent PLAP and it is suggested that it acts to hold the protein in an 
appropriate conformation for interaction with the transamidase to take place 
(Amthauer et al., 1993). 
The general rules presented here have been tested by constructing synthetic 
GPI signals using unrelated sequence elements that do not normally function 
in GPI-anchoring and testing their efficacy in cell culture, and it appears that 
they do indeed act as GPI addition signals (Moran and Caras, 1991). 
Functions 
Our knowledge of the basic biochemical structure of the GPI anchor has 
increased greatly in the past few years, yet it is still difficult to assign a 
particular function to it, as the proteins attached in this way have diverse 
physiological functions, where, indeed, these functions are known at all 
(Cross, 1990). The fact that the cell should choose such a complex 
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mechanism of anchoring suggests that there may be good reasons, that may 
vary for different proteins, cell types and stages of development. A number 
of cell-cell adhesion molecules in the central nervous system (CNS) such as 
Thy-1, TAG-1, F3/F11, N-CAM and P-31 possess GPI anchors (Faivre-
Sarrailh and Rougon, 1993) and are selectively expressed in time and place. 
Often expression is restricted to a subset of neurons and can be ax Ily or 
dendritically specific. The function of the PrP protein is unknown, but it is 
known to possess a GPI anchor (Stahl et al., 1 987) and expression is known 
to vary between different cell types and stages of development (Manson et 
al., 1992b). 
Cellular location 
Most of the GPI anchored proteins thus far identified are located on the 
extracellular surface of the plasma membrane (Lisanti et al., i 990a). There 
are some exceptions to this rule which have an intracellular location, such 
as GP-2 in the zymogen granules of the exocrine pancreas (Fukuoka et al., 
1 992) but these all tend to face the lumen of an intracellular vesicle rather 
than the cytoplasm. Truncation mutations of GPI anchored proteins have 
been shown to be secreted in in vitro systems (Berger et al., 1988; Bailey 
et al., 1989; Amthauer et al., 1992), and conversely, a normally secreted 
protein can be relocated to the plasma membrane by the inclusion of a GPI 
addition signal (Moran and Caras, 1991). Thus a GPI-anchoring signal leads 
to the asymetrical distribution of the anchored protein. 
Apical sorting in polarized cells 
This seems to have particular importance in polarized cells, such as epithelial 
cells, where the presence of a GPI anchor has been implicated as a signal for 
sorting of proteins to the apical membrane (Lisanti et al., 1 989a; Brown and 
20 
Rose, 1992). In a number of different polarized cell lines such as Madin-
Darby canine kidney (MDCK) and Caco-2 cells GPI anchored proteins are 
selectively enriched in the apical membrane whilst depleted or absent in the 
basolateral membrane (Lisanti et al., 1990a, Garcia et al. 1993 ). The 
addition of a GPI signal sequence to the normally basolaterally sorted VSV 
G protein (Brown, 	et al., 1989) causes its relocation at the apical surface. 
It has been suggested that this apical sorting may result from the 
association of the apical protein to glycosing olipids in the trans-Golgi 
network (TGN) (Brown, 	and Rose, 1992). Experiments to support this 
hypothesis have shown that apically sorted proteins, such as influenza virus 
HA, are soluble in detergents such as TX100 and CHAPS when in the ER, 
but become insoluble on reaching the TGN (Simons and van Meer, 1988). 
Basolateral proteins, however, do not become insoluble. It has been 
proposed that this insolubility is due to the association of the proteins with 
glycospingholipids, which have also been shown to have detergent 
insolubility properties and that these mixed clusters might be packaged into 
apically directed vesicles (Simons and van Meer, 1988; Brown, 	and 
Rose, 1992; Hannan et al., 1993). In a similar fashion the GPI-anchored 
protein Thy-1 has been found to be sorted to the axonal membrane of rat 
hippocampal neurons and not to the dendritic membrane (Dotti et al., 1991), 
suggesting the possibility of a similar sorting mechanism to that in epithelial 
cells and the possible existence of tight junctions in neurons. However, 
other work implies that Thy-1 exhibits both axial and dendritic expression 
in other cell types (Morris et at., 1985; Xue et at., 1990), although it is 
possible that the dendritic form may exist in the transmembrane state. In 
general the distribution of GPI-anchored adhesion molecules in neurons is 
complex and seems to depend on the cell type, particular protein and 
differentiation state (Faivre-Sarrailh and Rougon, 1993). This regulation 
could be achieved by differences in the structure of the GPI-anchor or by 
regulation of microtubule-based transport vesicles by the modification of 
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cytoskeletal components during neuronal maturation. 
Exclusion from clathrin coated pits 
Many different membrane receptors that participate in receptor mediated 
endocytosis achieve internalization of their ligands via the formation of 
endosomes from clathrin coated pits (Brown 	et al., 1983). The 
clustering of receptors in these pits is promoted by their cytoplasmic tails 
(Brodsky, 1988). It has been shown that many GPI-anchored proteins, 
including Thy-1, 5'-nucleotidase and the folate receptor, are excluded from 
these pits. It is expected, therefore, that GPI-anchored proteins, having no 
cytoplasmic domain, undergo endocytosis via a clathrin-independant 
pathway. Recently it has been shown that transmembrane and GPI-
anchored forms of the same protein are endocytosed by different pathways 
(Keller et al., 1992; Schell et al., 1992). 	GPI-anchored CD4 was 
endocytosed via non-coated microinvaginations of the plasma membrane. 
These invaginations have now been named caveolae and GPI anchored 
proteins have been shown to be clustered in them (Anderson et al., 1992; 
Rothberg et al., 1992). Different proteins have shown different mechanisms 
of internalization, with 5'-nucleotidase (Van den Bosch et al., 1988) and 
DAF (Tausk et al., 1989) clearly becoming visible in internalized vesicles, 
whereas the folate receptor remains associated with caveolae at the plasma 
membrane, where it internalizes folate by a process named potocytosis 
(Anderson et al., 1992; Rothberg et al., 1992). Caveolae have a specialized 
lipid composition (Anderson et al., 1992), and although it has not been 
directly demonstrated to contain gylcospingholipids their similarity to apically 
sorted vesicles from the TGN has been further supported by the discovery 
Ccw't fl 
of a protein that is present in both, VlP21,(Dupree et al., 1993). Whether 
this or other proteins recycle from the plasma membrane to the TGN has not 
yet been shown. PrP has been shown by pulse-labelling experiments in 
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mouse neuroblastoma (N2A) cell lines to recycle from the cell surface 
(Caughey et al., 1991) and has also been found in caveolae (Anderson et 
al., 1992a). 
Lateral mobility 
One consequence of lipid anchoring is an inherent increase in mobility in the 
plane of the membrane. Diffusion coefficients in the order of 4x1 0 9 cm2/sec 
are observed for Thy-1 (Ishihara et al., 1987) alkaline phosphatase (Noda et 
al., 1987), DAF (Thomas, J. et al., 1987), and PH-20 (Phelps et al., 1988). 
These are lower than expected for freely diffusing lipid probes (0.5-1x10 9 ' 
but much higher than those for transmembrane glycoproteins (0.5-6x1O 10 
However, these proteins also contained a significant immobile fraction, 
suggesting some heterogeneity in structure or secondary interactions. Some 
GPI anchored proteins may need a high degree of mobility for their function 
(like AChE for deactivation of acetylcholine at the synapse), whilst others 
may require a high degree of immobility (like the trypanosomal VSG). 
Insertion of VSG into BHK cells did not increase its mobility, implying that 
it is not the tight packing of these molecules in the trypanasomal cell surface 
that retards it, but some other intermolecular interaction (Cross, 1990). PH-
20, a GPI-anchored guinea pig sperm protein, diffuses at varying rates at 
different stages of sperm maturation (Phelps et al., 1988). 
In general, although there is a wide variation in the diffusion properties of 
GPI-anchored proteins, their lipid anchorage gives them the ability to diffuse 
at a rate closer to that of lipids than that of integral membrane proteins. 
There is no documented evidence on the lateral mobility of PrP other than 
the existence of a "capping" effect that is seen with fluorescence labelled 
anti-PrP probes on the surface of N2a, PC12 and hamster primary brain 
cells (Stahl et al., 1987) 
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Release of proteins from the cell surface 
The GPI-anchor is the substrate for a number of different enzymes 
(proteases, glycosidases and phospholipases). The actions of these 
enzymes could possibly result in GPI-specific anchor degradation and 
consequent release of the attached protein from the membrane. Such an 
enzyme mediated release mechanism could be regulated or constitutive. 
Soluble forms of many of these proteins have been reported, both in vivo 
and from tissue culture cells (Low and Saltiel, 1988; Lisanti etal., 1990b; 
Tagliavini et al., 1992b). Some of these arise from differential splicing of 
mRNAs to produce non-GPI-anchored proteins, as shown for N-CAM, Qa-2 
and DAF (Lisanti et al., 1990b) whilst others are released as a result of 
certain stimuli. As the PrP open reading frame is all contained on one exon 
(Basler et al., 1986) there is no evidence to suggest that differential splicing 
gives rise to a soluble form. However, soluble forms of PrP are released 
from N2A cells (Caughey et al., 1988, 1989; Borchelt et al., 1993) and 
isolated from human cerebrospinal fluid (CSF) (Tagliavini et al., 1992b). PrP 
that is shed from tissue culture cells does not contain a CRD epitope 
(Prusiner, 1991) and it is believed that most if not all of the GPI-anchor is 
removed from these proteins (Borchelt et al., 1993). 
The observation that free GPI molecules are hydrolysed in response to 
insulin action led to the question if a similar reaction could be seen with GPI-
anchored proteins. Several such proteins were shown to be released from 
tissue culture cells in response to insulin, including 5'-nucleotidase (Klip et 
al., 1988) and alkaline phosphatase (Romero et al., 1988). A reduction in 
the number of PLC releasable proteins from the surface of insulin sensitive 
BC3H1 cells was observed when the cells were preincubated with insulin 
(Lisanti et al., 1989b). Only some of the GPI anchored proteins seemed to be 
affected, with levels of others remaining the same . This led to the 
speculation that hormone sensitive and insensitive structural pools of GPI 
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anchor exist. It is already known that structural modifications of the GPI, 
such as the esterification of palmitic acid to the inositol ring, can play a role 
in susceptibility to enzymatic degradation (Roberts et al., 1988, Ferguson 
1992). This is one mechanism whereby proteins could be differentially 
released by hormone action. Similarly, AChE is released from certain areas 
of the brain and adrenal chromaffin cells by a variety of stimuli (Greenfield, 
1984) and Qa-2 is released from concavalin-A stimulated T-cells (Soloski 
et al., 1986). Serum levels of carcinoembryonic antigen (CEA) are increased 
in disease, leading to the idea that loss of apical polarity and subequent 
basolateral expression, coupled with enzymatic degradation could account 
for this increase (Lisanti et al., 1990b). It is possible to check whether 
these soluble proteins have been released by the action of PIPLC by 
determining whether or not they react with the CRD of T. hruceI, as only GPI 
molecules so cleaved will contain the reactive determinant (Hooper and 
Bashir, 1991). 
Signal transduction 
A possible role for GPI-anchoring in the process of signal transduction has 
been postulated as a result of findings involving the activation of 
lymphocytes by treating them with antibodies against GPI-anchored proteins 
on their surfaces (Robinson et al., 1989; Cashman et al., 1990). PrP is 
found on the surface of lymphocytes and this surface abundance is 
increased by cell activation. Also polyclonal antibodies to PrP suppress 
mitogen induced activation (Cashman et al., 1990). These findings may 
implicate a role in signalling for PrP. Transgenic mice expressing either GPI-
anchored or transmembrane Qa-2 have been produced (Robinson et al., 
1 989) and it was shown that only T-cells from the former could be activated 
by Qa-2 specific antibodies, thus implying that the GPI-anchor is essential 
for activation. Antibody-mediated modulation of cell activation is also 
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observed for other GPI-anchored proteins such as TAP-1, Thy-1, Qa-2 RT-6, 
and DAF (quoted in Cashman 1990). The finding that some GPI-anchored 
proteins associate with protein tyrosine kinases (Stefanova et al., 1991; 
Thomas 	and Samelson, 1992), and the well documented involvement of 
free GPI in secondary messenger systems (Saltiel et al., 1986; Eardley and 
Koshland, 1991) increase the possibility that the GPI-anchor has some sort 
of signal transduction function. How the GPI-anchored proteins, which are 
located exclusively on the outer leaflet of the plasma membrane activate 
intracellular tyrosine kinases is not yet known but it has been postulated 
that transmembrane linker proteins mediate the interaction between the two 
(Brown 	, 1993). The possibility also exists that GPI-anchored proteins do 
not directly bind to transmembrane linker proteins, but that these 
transmembrane proteins are associated with specialized lipid clusters which 
GPI-anchored proteins also have an affinity for, and that this association is 
close enough for a kinase bound to the cytoplasmic domain of the 
transmembrane protein to interact with the GPI-anchored protein (Brown 
1993). Lipid structures have been coprecipitated with GPI-anchored 
protein/tryosine kinase complexes in a number of different cell lines (Brown, 
and Rose, 1992, Horejsi 1992, Lublin quoted in Brown 1993). 
The association of GPI-anchored proteins, including PrP, with caveolae 
(Anderson et al., 1992) leads to speculation whether they can become 
transiently internalized by the process of potocytosis. The role of such 
internalization in signaling is not known. 
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CHAPTER TWO: 	General Methods 
Chemicals 
All chemicals were of molecular biology grade and were obtained from BDH, 
Gibco-BRL, Sigma, and Boehringer-Mannheim and stored as per the 
manufacturers instructions. Restriction endonucleases and other enzymes 
were obtained from ( 	o-BRL, Boehringer-Mannheim and Promega. 
All water was double-distilled, except water used for tissue culture which 
was tissue culture grade from a Millipore Mill-QUF system 
Bacteria 
All bacteria used were laboratory attenuated strains of E. Coll and are listed 
in Table 1. 
Table 1. 
Strain Phenotype 
CMK 603 thr, leu, thi, supE, recBC, T,', T5R, 
(, m, laczAM15 lacY, F Iac' 
laczAM15 pro f  
Mut-L F, dam, 
GM242 F, dam3, recAl, Sin2, trrl, leuB6, 
proA2, his 4, metBi, lacYl, gaIK2, 
ara14, tsx33, thu, deoB6, supE44, 
rpsL260 (Strr) 
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Techniques of DNA manipulation 
Small scale DNA preparations 
Small scale DNA preparations were carried out by the alkaline lysis method 
of Birnholm and Dolby ,(Birnholm and Dolby, 1979) as described below. 
3m1 shaking overnight bacterial cultures were grown at 3711in L-broth 
(Gibco-BRL) supplemented with Ampicillin (Amp) to O.lpglml. 
imI of this was centrifuged in a minifuge at 13,000 rpm for 1mm. The 
supernatant was discarded and the pellet resuspended in in 0.1ml lysis 
solution (lysozyme 2mg/mI, 25mM Tris.Hcl pH 8.0, 10mM EDTA pH 8.0, 
50mM glucose) by vortexing. 
Samples were left at 0°C for 30mm. 
0.2ml alkaline SDS (sodium dodecylsuiphate) solution (NaOH 0.2N,SDS 
1%) was added. Samples were then mixed by inversion and left on ice for 
a further 5 mm. 
0.15ml of high salt solution (Na acetate pH5 3M, tRNA 300p/ml) was 
then added and samples left on ice for 30-60mm. 
The thick white precipitate that forms at this stage was removed by 
centrifugation for 5min and the supernatant removed to a fresh tube. 
DNA was precipitated by the addition of 1 ml of ethanol, leaving at -20°C 
for 30 min and centrifugation at 13,000 rpm for 2 mm. A further 
precipitation in 0.1ml 0.1M Na acetate pH 6, 0.2m1 ethanol at -20°C for 
5min was performed and DNA was recovered by centrifugation at 13,000 
rpm for 2mm, the supernatant discarded and the pellet dried and 
resuspended in SOpl of TE (appendix 1). 
Large scale DNA preparations 
Large scale DNA preparations were carried out by a modification of the 
alkaline lysis method of Birnholm and Dolby (Birnholm and Dolby, 1979), as 
described by Sambrook (Sambrook et al., 1989) 
The bacterial pellet from an overnight 500m1 culture was resuspended in 
1 8ml of solution 1 (50mM glucose, 25mM Tris.HCI pH 8.0, 10mM EDTA pH 
8.0). 
2ml of a freshly prepared solution of lysozyme (10mg/mi) in 
lOmMTris.HCI pH 8.0 was added, followed by 40m1 of freshly prepared 
solution 2 (0.2N NaOH, 1% SDS). The contents of the bottles were 
thoroughly mixed by inversion and stored at room temperature (RT) for 5-
10mm. 
20m1 of ice cold solution 3 (5M potassium acetate 60m1, glacial acetic 
acid 11 .5ml, H20 28.5mi) were added, the contents of the bottles mixed 
well and left on ice for 10mm. 
The bacterial lysate was centrifuged at 4000rpm for 1 5min at 4°C in a 
Beckman JS-21 centrifuge and the rotor allowed to stop without braking. 
The supernatant was carefully removed and filtered through four layers 
of cheesecloth into a 250ml bottle. 
A 0.6 volume of isopropanol was added, the contents mixed and allowed 
to stand at room temperature for 10 mm. 
The nucleic acids were recovered by centrifugation at 5000rpm for 1 5mm 
at RT. The supernatant was decanted and the pellet dried and then 
resuspended in 3ml of TE pH 8.0. 
This DNA was then purified by equilibrium centrifugation in CsCl-ethidium 
bromide gradients as follows. Caesium chloride (CsCl), was added to the 
DNA to a final concentration of 1 mg/ml, then 0.1 ml/ml of a stock solution 
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of 5mg/mi ethidium bromide solution and the remaining volume of the tubes 
filled with a 1mg/mi solution of CsCl. This solution was centrifuged either 
in a Beckman NVT65 vertical rotor at 57,000rpm for 1 6hours, or a Beckman 
70.lTi fixed angle rotor at 37,000rpm for 48hours in heat sealable 20m1 
Beckman polyaliomer tubes in a Beckman L8 ultracentrifuge. The closed 
circular plasmid DNA was visualised by UV illumination and separated from 
contaminating chromosomal DNA by side puncture of the tubes. 
Ethidium bromide was removed by extraction with TE-saturated butan-1-
ol and CsCI removed by dialysing against at least 5x1 litres of TE at 0°C, 
the final dialysis being left overnight. 
DNA concentration was determined by the optical density observed at 
a wavelength of 260nm in a quartz cuvette in a Beckman DU64 
spectrophotometer. 
Digestion of DNA with restriction endonucleases 
CsCI banded or mini-prep DNA was digested with 3 units of enzyme per jig 
in the presence of the appropiate restriction buffer at 37°C, in a reaction 
volume of 20-30111 for at least 1 and usually 3 hours. The enzyme Bcll was 
incubated at 50°C and Sma 1 at 30°C as these are the optimum 
temperatures for these enzymes. Double digests were performed in 
whichever buffer was optimal for the digest, with salt levels being adjusted 
before digestion with the second restriction endonuclease was carried out. 
Enzymes and buffers were obtained from Gibco-BRL and Boehringher-
Mannheim. 
Enzymes were inactivated either by heat treatment appropiate for the 
particular enzyme or by phenol/chloroform extraction and ethanol 
precipitation of the DNA. 
Phenol/Chloroform extraction and Ethanol precipitation 
Where necessary phenol/chloroform extraction was carried out by adding an 
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equal volume of TE-equilibrated phenol to the sample, vortexing it for 2-5 
min in a minifuge and removing the upper aqueous layer to a fresh tube, 
followed by a similar extraction with chloroform. Ethanol precipitation was 
carried out by the addition of one tenth volume of either 3M sodium acetate 
pH 5 or SM pot assium acetate to the sample along with three volumes of 
100% ethanol. The tubes were mixed and stored at -20°C from 1 hour to 
overnight. DNA was recovered by centrifugation in a minifuge for 15mm, 
and the pellets washed with 70% ethanol and dried briefly before 
resuspension in either TE (Appendix 1) or H20 as required. 
Agarose electrophoresis 
Agarose gels were prepared using high grade agarose from Gibco-BRL 
Usually, 0.8% gels were used, with 1-3% gels being used when smaller 
fragments were being examined. TAE buffer (appendix 1) was used to make 
the gels and as a running buffer. Gels were run at varying voltages 
according to their size, but generally from 50-100 volts for two to three 
hours or at 25 volts overnight, on a Bio-Rad horizontal gel apparatus. Low 
melting point agarose was also supplied by Gibco-BRL and gels were 
prepared in a similar manner and run overnight at 25 volts. 3pl of agarose 
gel loading buffer (appendix 1) was added to each sample before loading and 
11ug of an Hindlil digest of lambda used as size markers. 
Gels were stained for 15 min in a lpg/ml solution of ethidium bromide and 
destained for 30min in double distilled water before photographing on a 
Polaroid MP-4 Land Camera 
Recovery of DNA fragments from gels 
A number of different techniques were used to recover fragments of DNA 
from gels. For random priming of cDNA (see below) fragments were 
isolated by carefully cutting the appropriate band out of a low melting point 
gel with a sterile scalpel blade and then weighing the piece of gel and 
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incubating it in 3m1/g of H20 at 100°C for seven minutes. The obtained 
solution was stored at -20°C until required (Wieslander, 1989). For cloning 
and the recovery of PCR products two methods were used. Fragments were 
separated on agarose gels as above. 
These fragments were then cut out and centrifuged at 1 3,000rpm for 1 
c* 
mm. through a piece of blotting paper in an eppendorf Tht bottom ,had 
been pierced with a needle, allowing the expressed buffer to be collected in 
another eppendorf (Weichenhan, 1991). 	It was not necessary to 
phenol/chloroform the DNA which could be recovered by ethanol 
precipitation. 
A piece of DEAE membrane (Schleicher & Schull, NA45 0.45pm ) was 
placed in front and behind 	the appropriate fragment and the 
electrophoresis was continued until the band had run onto the membrane 
(Dretzen et al., 1981). DNA was eluted from the membrane by heating it 
to 65°C for 15 min in elution buffer (10mM Tris, 1mM EDTA, 2.5M NaCl 
pH 8). This was then extracted once in phenol , once in chloroform and 
then ethanol precipitated as described above. 
Ligations 
In general fragments that were to be used in ligations were ethanol 
precipitated after extraction from gels before inclusion in the ligation 
reaction. 




T4 DNA ligase buffer x5, 
T4 DNA Ligase (lu/pl), 
xpg, 
3x molar excess over 
lpl, 
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H20 to a final volume of 20pl. 
Incubate overnight at 9°C 
Making competent cells 
Bacteria were made competent for the transformation of plasmid DNA by 
two methods, one of which was designed to prepare a stock of frozen 
competent cells and one to prepare highly competent cells. 
Calcium chloride method: 
This was based on the method of Cohen (Cohen et al., 1972). Starting with 
L 
a fresh plate of bacteria a 3ml overnightwas grown up. This was used to 
inoculate approximately 1 00m of L-broth in a sterile 250ml conical flask. 
The culture was incubated at 37°C with gentle shaking and the optical 
density measured at various times by comparing it to that of uninfected L-
broth at 560nm in a Beckman DU64 spectrophotometer until it reached an 
OD of 0.25. At this stage the cells should be replicating exponentially 
When the required cell density was achieved further growth was inhibited 
by placing the cells on ice for ten minutes. 
The cells were collected by centrifugation at 4000g for 10min and 
resuspended in 1/2 x volume of ice-cold, sterile 0.11VI calcium chloride 
(CaCl2). They were then mixed gently and left on ice for 15 mm. The 
centrifugation step was repeated and the cells resuspended in 1/25 the 
original volume of 0.1 m CaCl2. They were mixed gently and left on ice for 
four to twelve hours before use. 
Freezing method: 
CLJ 
This was carried , n much the same manner as the previous method, except 
that buffers containing cryoprotect rants were substituted for CaCl2' 
After the first centrifugation cells were resuspended in 1/3 volume of RF1 
(appendix 1) and after the second centrifugation in 1 /12.5 of RF2 (appendix 
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1). 
This was followed by a 15 min incubation on ice, after which the cells were 
aliquoted into freezing vials and flash frozen in liquid nitrogen. Frozen 
competent cells were stored at -70°C and used within three months of 
manufacture. 
Transformation of bacteria with plasmid DNA 
DNA or ligation mixes were diluted or divided into the desired quantities and 
aliquoted into sterile 13m1 round-bottomed Falcon tubes (Becton and 
Dickinson). 200pl of competent cells were then added and mixed gently. 
The mixture was left on ice for 30 min and then heat shocked in a 42°C 
water bath for 45 sec. The tubes were returned to ice for 2 mm . 800p1 of 
L-broth was added to each tube and they were placed at 37°C for 45-60 
min to allow the cells to express their Amp resistance gene. The cells were 
plated onto L-Agar plates containing ampicillin or other appropriate plates by 
spreading with a sterile spreader and incubated overnight at 37°C. 
Transfer of DNA to nitrocellulose and nylon filters 
Agarose gels were run, stained and photographed as described above. A 
number of different methods were used during the course of these 
experiments. 
1) Dry blotting 
Gels were soaked for 2 x 15 min in 0.25M HCI, 
rinsed in distilled water, 
soaked for 2 x 15 min in 0.5N NaOH, 1.5 M NaCl, 
soaked for 2 x 30 min in 1M NH4Ac, 0.02 N NaOH ,pH 8. 
While this is being done a gel sized piece of nitrocellulose (Schleicher & 




Southern BOot Set=up Procedure 
WEIGHT 
third buffer, along with four gel-sized pieces of Whatmann 3mm paper. The 
gel was then sandwiched as shown in Figure 3 except that the buffer was 
omitted, with a suitable weight being placed on top of the glass plate and 
the whole blot being covered with cling-film and left overnight at RT. When 
the filter was removed from the blot it was washed in 2 x SSCP for 2 mm 
and air dried before baking at 80°C (nitrocellulose), or crosslinking with UV 
light (Hybond membranes) to fix the DNA to the filters. 
Southern blots 
Southern blots were performed using a buffer resevoir (Southern, 1 975) and 
Genescreen (Du Pont) or Hybond membrane exactly as described for 
Northern blots (see below). 
Colony blotting 
This was carried out by the methods of Wallace (Wallace et al., 1980) and 
Suggs (Suggs et al., 1981). Colonies or plaques were picked off plates and 
streaked onto squared, numbered nylon filters (Hybond) on the surfaces of 
appropriate plates. These were allowed to grow up overnight at 37°C. 
Corresponding master plates were also streaked out at the same time. The 
filters were treated as follows: 
3 sheets of Whatmann 3mm paper were soaked in denaturation solution 
(0.5M NaOH, 1.5M NaCl). The filters were placed face up on this for 5 mm. 
The colonies lysed. 
Using flat edged forceps the filters were transferred to the surface of 
Neutralizing buffer-soaked paper (1M Tris.HCI pH 7.5,) and left for 5 mm. 
The filters were transferred to 2x SSCP (appendix 1) soaked paper and 
left for 5 mm. 
The filters were then transferred to dry filter paper and allowed to air dry 
for> 1 hour. 
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5) They were wrapped in Saran wrap, and placed face down on UV 
illuminator for 2 min to fix the DNA. 
Random priming of cDNA fragments 
This was performed essentially as described by (Sambrook et al.,1989). 
Suitable restrictions were performed to obtain the required fragment 
containing an appropriate amount of DNA and these fragments were 
separated on low-melting point agarose (Gibco-BRL) at 25 volts. The 
fragment of interest was cut out with a scalpel and treated as follows: 
3m1 of H20 per g of agarose was added. 
The tubes were boiled in a water bath for 7 min and left at 37°C for 10 
min to 1 hour. 
4)The following were mixed: 
DNA (20-50ng) 	 35.5/il 
OLB buffer (appendix 1) 	 10 p1 
32p dCTP (Amersham lOpC/pl) 	5 p1 
Klenow fragment (5u/pl) 	 1 p1 
This mixture was incubated at RT for at least 4 hours and preferably 
overnight. 
200/il of 50pg/ml herring sperm (HS) DNA was added. 
One phenol extraction was performed. 
Probes were ethanol precipitated and air dried, and resuspend in lOOpI 
TE. The probes could be stored at -20°C at this stage. 
ipI of each probe was taken and counted in a scintillation counter 
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Labelling of oligonucleotides 
This was performed as described by Sambrook (Sambrook et at., 1989). 
Oligos were diluted to 20-40ng in a 4p1 volume. 
The labelling reaction was prepared as follows: 
Oligo 	 4 p1 
lOx Polynu4otide kinase buffer 	2.5p1 
32PdATP 	 30pC 
Polynucleotide Kinase 	 1 p1 
H20 	 to 	25p1 
and incubated at 37°C for 1 hour. 
200p1 herring sperm (HS) DNA (50pg/ml) and 4001i1 Ethanol were added, 
and the probe precipitated at -20°C, recovered by centrifugation and air 
dried. 
5) The probe was resuspended in lOOpI of TE. 
Southern hybridization with labelled fragments 
Filters were pre-hybridized overnight in sealed plastic bags or in hybridization 
tubes and hybridized over the following night as follows. 
Pre hybridization buffer: 
20x SSPE 	 2.5m1 
Formamide(BDH 40%w/v) 	 5 ml 
50x Denharts solution (appendix 1) 	0.9m1 
BSA (100 mg/ml) 	 O.lml 
Denatured HS DNA (lOOpg/ml) 	O.lml 
10%SDS 	 0.1ml 
H20 	 to 10 ml 
HS DNA was denatured by boiling for 10 min before adding to the 
prehybridization mix. 
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Incubations were overnight at 42°C. 
For hybridization the probe was added to this buffer and incubations carried 
out overnight at 42°C. 
After hybridization was complete the probes were collected and stored for 
decay and background radiocativity washed off with sequential washes as 
below. The filters were monitored with a Geiger counter between washes. 
 2x SSPE, 0.1% SDS 15 mm, 37°C. 
 2X SSPE, 0.1% SDS 15 mm, 55°C. 
 2X SSPE, 0.1% SDS 15 mm, 65°C. 
 1X SSPE, 0.1% SDS 15 mm, 65°C. 
 0.5 X SSPE, 0.1% SDS 15 min,65°C. 
The filters were sealed in plastic, covered with X-OMAT (Kodak) X-ray paper 
stored, at -70°C and developed after an appropriate length of time. 
Southern hybridization with oligonucleotides 
Filters were sealed into plastic bags or hybridization tubes and pre-hybridized 
overnight at 37°C. 
Pre-hybridization buffer: 
20XSSCP 	 15ml 
10% SDS 	 0.5ml 
50X Denharts 	 1 .Oml 
HS DNA (5mg/mi) 	1.0ml 
H20 	 to 50ml 
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Techniques of RNA manipulation 
Total RNA isolation from tissue culture cells 
For all RNA manipulations gloves were worn at all times, glassware was 
baked at 200°C for 4 hours , tips autoclaved and water treated with DEPC,( 
appendix 1). Total RNA was isolated from tissue culture cells using RNAzoI 
B (Biogenesis Ltd.), a single-step preparation method, as per the 
manufacturers instructions. 
Each 35mm dish of cells was washed in phosphate buffered saline (PBS, 
Gibco-BRL tissue culture grade) and then overlaid with 1 ml of RNAz0I B. 
The cells start to lyse immediately and RNA was solubilized by passing the 
lysate up and down through a pipette. 
Samples were transferred to Eppendorf tubes and lOOpl of chloroform 
added to each. The tubes were shaken vigorously and stored at 4°C for 5 
mm. 
The aqueous and phenol-based phases were separated by centrifugation 
at 13,000rpm for 15 min and the aqueous phase removed to a fresh 
e p pen do rf. 
An equal volume of isopropanol was added and the samples stored at 
4°C for 15 min or longer. 
RNA was recovered by centrifugation at 1 3,000rpm for 15 mm, followed 
by a 70% ethanol wash. 
Samples were briefly air dried and resuspended in an appropriate volume 
of H20. 
Agarose gels for RNA 
Small aliquots of RNA were run on 0.8% agarose gels in exactly the same 
manner as DNA samples in order to visualise ribosomal bands and thus 
indicate the quality of the RNA preparation. 
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Formaldehyde gels for RNA 
RNA was separated on formaldehyde gels as described by Sambrook et al. 
1989 which were made as follows: 
1.95g of agarose was dissolved in 1 O9ml of H20 (for a 1 % gel in a 
150ml cast). 
The agarose was cooled to 60°C and 15 ml lOx MOPS (Sigma) added. 
26m1 formaldehyde solution (BDH) was added and the gel poured 
immediately (N.B. in a fume hood). 
Samples were prepared as follows: 
An equal volume of formamide sample buffer (appendix 1) was added to 
the RNA sample. 
This was heated to 60°C for 5 min and snap cooled on ice. 
0.25 volume of Ficoll-dye-EDTA (FDE)(appendix 1) was added, and the 
sample mixed and loaded onto the gel immediately. 
Gels were run overnight at 25 volts. 
Northern blotting 
Northern blots of formaldehyde gels were done as follows , as described by 
Seed (Seed, 1982), with the substitution of nylon membrane for 
nitrocellulose. 
The gel was washed in 2x 500m1 of H20 for 15 min each to remove the 
formaldehyde. 
The gel was then washed for 2x 10min in lOx SSC (appendix 1). 
A piece of Genescreen (Du Pont) was cut to the exact dimensions of the 
gel, and this soaked first in H20, then in 1 O SSC. 
Step 3 was also done with 4 sheets of Whatmann 3mm paper. 
The gel was sandwiched as shown in Fig.1 and lOx SSC used as the 
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reservoir buffer. 
6) After blotting overnight the filter was allowed to air dry for at least 1 hour 
and then baked at 80°C for 2 hours. 
Northern hybridization with labelled fragments 
Filters were pre-hybridized overnight at 65°C in a Hybaid-maxi hybridization 
oven. 
Pre-hybridization buffer: 
Dextran-sulphate 	 2.5g 
20x SSC 	 7.5m1 
H20 	 to 20 ml 
The buffer was vortexed hard to dissolve dextran sulphate and incubated at 
65°C to get rid of bubbles. 
i)N 
0.25m1 of sonicated single-stranded salmon sperm ,(SSSSS1  Stratagene) was 
added, which had been heated to 100°C for 5 mm. 
For hybridization, the pre-hybridization buffer was removed from the 
hybridization tube, the denatured probe added and the 20m1 buffer replaced 
in the tube. Filters were hybridized overnight at 65°C, and washing steps 
performed as above for southern hybridizations with the exception that SSC 
was used instead of SSPE. 
Developing of autoradiographs 
All autorads were developed for 1 min with AGFA Gi 50 developer and fixed 
for 1 min in AGFA G350 fixer at room temperature (RT), washed and air 
dried. 
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Techniques of manipulating phage and phagnids 
Plating of phages 
All manipulations with phage and phagemids were carried out as described 
by Sambrook et al., 1989 Phage were plated out into bacteria that contained 
an F episome and thus were competent for the production of single 
stranded phage DNA. Routinely, E. Co/i strain CMK (see Table 1) were used. 
Double-stranded phage DNA (see below) was transformed into competent 
cells by the same method as plasmids, except that no incubation at 37°C 
was required, but 200p1 of a bacterial overnightand 3 ml of melted top agar 
(appendix 1) was added and the mixture quickly mixed and plated onto 
minimal plates (appendix 1). This gives rise to plaques or holes in the 
bacterial lawn that result from the production of single-stranded phage that 
replicate and lyse their host cells. The dilution that gave the best separation 
could then be used for picking single plaques. 
Alternatively, if a stock of single stranded phage was available it was 
possible to streak this solution , onto the surface of a minimal plate, and 
then to pour onto this 3ml of top agar (appendix 1) to which 0.5ml of an 
appropiate bacterial culture had been added, pouring from the more dilute 
side of the streak to the more concentrated side. Plaques appeared after 8-
10 hours of incubation at 37°C. 
Small scale preparation of double stranded M13 DNA 
A single plaque was picked with a sterile toothpick from a plate prepared 
as above into 3m1 of an appropriate bacterial culture that had been grown 
to OD 0.3. 
This was then grown up with vigo rous shaking at 37°C for a further 4.5 
hours. 
1 ml aliquots were centrifuged at room temperature (RT) for 5 min and the 
supernatant removed and either kept at 4°C for use in single-stranded 
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preparations (see below) or titrated and kept at 4°C for use as a stock of 
single stranded phage. 
4) The pellet was used to prepare the RF (replicative form ie. double 
stranded) form of the phage by the same method used for plasmid mini-
preparations (Birnholm and Dolby, 1979) and above. 
Large scale preparation of double stranded M13 DNA 
A dilution of the phage was plated out as described above. Also a 3 ml 
(wjt b j 
overnightof an appropriate bacteria was grown up. 
This overnight,was used to inoculate 20 ml of L-broth and this was 
grown to OD 0.3. 
Plaques were picked with a sterile toothpick and placed in 3ml aliquots 
of this culture. This was incubated with shaking for 6 hours at 37°C and 
then stored overnight at 4°C. 
On this day a large overnightof appropriate bacteria (approx. 20ml) was 
set up. 
(_ k 
This overnight1was diluted 1/40 with fresh L-broth to a volume of 500ml 
in sterile conical flasks and grown to OD 0.3. imI of the six hour culture 
was inoculated into each 250ml flask and incubated at 37°C with shaking 
for 4.5 hours. 
6)This culture was then taken off and prepared as a normal plasmid 
preparation. This method produces the "RF" form of the phage, which 
behaves exactly as an ordinary double-stranded plasmid. 
Propagation of the helper phage M131K07 
The helper phage M13KO7 was propagated by plating out serial dilutions 
and then single plaques were picked into media containing kanamycin 
(701jg/ml). The resultant supernatant was collected and stored at 4°C. 
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Preparation of single stranded M13 DNA 
An overnightof an appropriate bacterkwas diluted with fresh L-broth 
and grown to an OD of 0.3 at 560nm wavelength. 
This was divided into 3ml aliquots and a single plaque picked into each. 
The tubes were incubated with vigorous shaking at 37°C for 4.5 hours 
exactly as for the mini-RF prep. 
0.8m1 of the supernatant was carefully removed and placed in a fresh 
t(,6 ' 
eppendorfwhere it could be stored at 4°C overnight if necessary. A second 
centrifugation of 5 min was usually performed to ensure that all of the 
bacterial pellet had been removed. 
200pl of 20% polyethyleneglycol (PEG 6000,BDH) was added and the 
mixture allowed to stand at RT for 30 mm. 
It was then centrifuged in a microfuge for 5 min.  
The supernatant was taken off , with a second brief A  being used to 
ensure that all the PEG 6000 was removed. The pellet was resuspended in 
lOOpl of TE (appendix 1). 
SOpI of phenol was added and the mixture vortexed for 10 mm, then 
allowed to stand at RT for 10 mm, after which the 10 min vortex was 
repeated. 
After a 1 min p, in a microfuge the aqueous layer was removed to a 
fresh tube and the single stranded DNA precipitated by the addition of 10p1 
of 3M sodium acetate pH 5 and 250p1 of ethanol, followed by storage at - 
70°C for 5 min and centrifuging in a microfuge for 10 mm. The pellet was 
washed once with 1 m of ethanol and then air dried. 
The DNA was resuspended in 50pI of TE and stored at -20°C. 
Single stranded DNA was visualized by the addition of lpl of 2% SDS 
to 5pl or lOpl aliquots and then running on 0.8% agarose gels as used for 
double stranded DNA. 
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Production of single stranded DNA from phagmids 
This was carried out according to the methods of Vieira and Messing, 1987.   
A fresh bacterial colony containing the phagmid was suspended in 3m1 
of L-broth containing Amp in a 1 5m1 sterile tube. 
The helper phage M13K07 was added to a final concentration of 2x107 
pfu/ml (plaque forming units), and the culture incubated with shaking at 
37°C for 1.5 hours. 
Kanamycin was then added to a final concentration of 70pg/ml and the 
incubation at 37°C allowed to continue overnight. 
1 ml aliquots of this culture were centrifuged and the single stranded prep. 
performed as for ordinary phages. 
Analysing insert orientations in M13 
If different Ml 3 DNAs contain identical DNA sequences inserted in opposite 
orientations they are able to hybridize to each other, forming a DNA 
structure with a higher molecular weight than either of the parental DNAs 
(Howarth et al., 1981). This larger molecule can be recognised by agarose 
gel electrophoresis. 
The phage were grown up in a suitable bacteria as described above for 
6.5 hours. 
imI aliquots were taken and centrifuged for 5 mm. 
20pl of the supernatant was taken and to this ipi of 1 % SDS and 3p1 of 
agarose loading buffer (appendix 1) were added 
This was incubated at 65°C for 1 hour. 
Samples were loaded onto gels and run as for normal agarose gels. 
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Analysis of DNA 
Sequencing 
All sequencing was done using the method of Sanger, 1977 and the United 
States Biochemical (USB) Sequenase version 2.0 kit and using single 
stranded templates prepared either from Ml 3 or from phagmids as described 
above. The buffers for the sequencing reaction were all supplied by USB. 
Gels were run on a Life Technologies sequencing tank, model SA. 
Preparation of glass plates for pouring of polyacrylamide gels: 
Plates were washed in H20 and methanol and dried. In earlier experiments 
gels were dried directly onto the glass plates , whilst in later experiments the 
gels were removed from the plates and dried onto 3mm Whatmann paper. 
In the first case one plate was coated with two layers of a solution of Bind-
silane (Pharmacia) (appendix 1), a silica based substance which causes the 
gel to adhere to the glass plate, whilst the other plate was treated with 
Repel-silane (Pharmacia), which causes the plate to repel the gel and 
facilitates separation of the plates without damage to the gel. These 
operations were carried out in a fume hood, the plates allowed to dry and 
were then wiped over once with a damp tissue. For gels that were to be 
transfered to paper the Bind-silane step was omitted . 1 mm spacers and a 
sharks-tooth comb were used and the edges of the plates sealed with PVC 
tape. 
Polyacrylamide gels: 
7% or 8% gels were prepared from a 40% stock solution as described in 
appendix 1, poured into the assembled plates taking care to avoid the 
formation of bubbles and allowed to polymerize for at least 1 but usually 2-3 
hours at RT. Excess polyacrylamide was removed from the comb bed and 
the gel warmed by running it for 30-40 min at 2000V before loading the 
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samples. TBE (appendix 1) was used as a running buffer and gels normally 
run at 2000V. Gels were run for 1.5-3 hours depending on how close or far 
from the primer the required sequence lay. 
Sequencing reaction: 
One tenth of a single stranded (ss) DNA preparation, as described above, in 
a volume of 5p1 was used in each sequencing reaction . Sequencing 
oligonucleotides were at least 12 and usually 15 or more nucleotides long 
and were commercially produced on an Applied Biosystems Oligonucleotide 
Synthesizer (Oswell DNA Services, Dept. of Chemistry, Edinburgh 
University). The components of the annealing step are listed below. 
SS DNA 	 5p1 
Primer 	 lpl (2pmole) 
5 x sequencing buffer 	 2pl 
H20 	 2p1 
Reactions were heated to 65°C in a hot block for 3 min and then removed 
from the heat and cooled slowly to less than 35°C. After this the tubes 
were stored on ice and used within 4 hours. 
While the annealing reaction was cooling each of the four 
dideoxynucleotidetriphosphates (ddNTPs), A, C, G, and T were aliquotted 
at 2.5p1 in colour coded tubes. The labelling mix was diluted 1:10 in sterile 
H20 and the Sequenase enzyme diluted 1:8 in the buffer provided. The 
labelling reaction was assembled as described below. 
template/primer 	 1 OpI 
0.1 M dithiothreitol (DTT) 	 ljil 
diluted labelling mix 	 2111 
35  S dATP (Amersham) 	 0.5pl 
diluted Sequenase 	 21il 
When sequence very close to the primer was required ipi of the manganese 
buffer supplied by the manufacturer was also included at this stage. The 
above components were mixed and incubated at RT for 2 min exactly. 
Immediately the 2 min incubation was finished 3.5pl aliquots of the reaction 
were added to each of the four previously prepared ddNTP tubes, mixed and 
incubated at 37°C for a further 5 min. (ddNTPs were stored as aliquots at - 
20°C and thawed and warmed to 37°C for at least 1 min prior to use.) 
This termination reaction was stopped by the addition of 4pl of loading 
buffer (USB) to each tube, mixing and storing on ice until use. 
Before loading the samples were heated to 85°C for 5 mm. 
Drying the gels: 
After the gel had run for the required length of time the plates were removed 
from the electrophoresis apparatus and carefully levered apart. The gel, still 
attached to one plate, was then washed gently in 10% acetic acid for 20 
min to remove the urea. In the experiments where Bind-silane was used the 
gel was then dried directly onto the plate by baking it in an 80°C oven for 
20 mm. When Bind-silane was not used the gel was carefully transferred 
to 3mm Whatmann paper and dried on a vacuum slab gel drier (Hoeffer 
Scientific) for 30 min at 80°C. Dried gels were exposed to Kodak X-OMAT 
film overnight at RT. 
ManiDulation of Droteins 
SDS-page electrophoresis 
Proteins generated using in vitro translation (Chp. 4) or isolated from tissue 
culture cells (Chp.5) were examined for size heterogeneity by SDS 
polyacrylamide gel electrophoresis (SDS-page) (Laemmli, 1970). A Bio-Rad 
"Protean" mini-gel system was used throughout. Plates were routinely 
cleaned in chromic acid to ensure removal of any contaminating proteins, 
and then rinsed thoroughly in H20 and finally washed with methanol. 15% 
slab gels, with 7 or 8% stacking gels were generally used and the 
ingredients for their formulation are given below: 
15% Separating gel 	7% Stacking gel 
H20 	 2.7m1 	 2m1 
30% acrylamide 	5.55m1 	 600pl 
Gel buffer 	 2.85m1 	 888p1 
10%APS 	 168u1 	 56p1 
Temed 	 7.5p1 	 lOpl 
These were mixed and poured immediately. 
APS = ammonium persuiphate 
The 30% acrylamide solution was prepared by adding: 
Acrylamide 	 30g 
Bisacrylamide 	 0.8g, 	H20 to lOOmI. 
Buffer compositions are listed in Appendix 1. 
Before loading samples were diluted 1:5 in final sample buffer (FSB, 
appendix 1) and heated to 90°C to denature the proteins. A Tris-glycine 
running buffer was used (appendix 1) and gels run at 200 volts for 45-50 
min or until the dye-front had run off the gel. 
Gel drying 
Gels bearing radiolabelled proteins were dried onto 3mm Whatmann paper 
on a vacuum slab gel drier (Hoffmann Scientific) for 2 hours and exposed to 
X-OMAT X-ray film (Kodak) at RT for varying periods of time. 
Some of these gels were first fixed and treated with the fluorographic 
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reagent Amplify (Amersham) according to the manufacturers instructions, 
and consequently exposed at -70°C instead of RT. 
1mm u nob lotting 
Gels that did not bear radiolabelled proteins were transferred to nitrocellulose 
paper and probed with anti PrP primary and gold conjugated secondary 
antibodies as described below. 
Transfer 
2x6 pieces of 3mm Whatmann paper and 1 piece of nitrocellulose were 
cut to the exact size of the gel and briefly soaked in semi-dry blotting buffer 
(appendix 1). 
These were loaded onto a semi-dry transfer cell (Bio-Rad) in this order: 
6x Whatmann paper 
Nitrocellulose 
Gel 
6x Whatmann paper 
taking care to exclude all air bubbles. 
A current of 2mA /cm2 was passed through the cell for 1 hour. 
The cell was unloaded and the filter allowed to dry. 
Blotting 
All steps were performed at RT. 
Filters were washed in blocking solution with shaking for 2 hours +. 
Blocking solution: 	Bovine Serum Albumin (BSA) 0.5g 
Natural Goat Serum (NGS) 	0.5ml 
PBST (appendix 1) 	to 25m1 
The blocking solution was poured off and primary (1 °) antibody solution 
(Farquhar etal. 1989) added. 
1° antibody solution: Antibody 1133 (1/1000) 	25pl 
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U. 
PBST 	 to 25m1. 
This was allowed to wash at RT with shaking for at least 2 hours or 
overnight. 
Filters were washed 4 x 5 min with PBST. 
20 antibody solution was added and allowed to wash with shaking for 
at least 2 hours. 
21  antibody solution: Antibody (Biocell) 	 1 001J 
Gelatin (Cambio) 	 250p1 
NGS 	 100u1 
PBST 	 to 25m1. 
Filters were washed 2 x 5 min with PBST and 2 x 15 sec with H20- 
Silver enhancement of the 21  antibody was performed according to the 
manufacturers instructions (Biocell). 7m1 initiator and 7m1 enhancer were 
mixed and the filter washed in this for 30-40 mm. This step was repeated 
after a brief water wash if necessary. 
8) The gel was washed in 2 X 50m1 H20 for 30 min dried and 
photographed. 
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CHAPTER THREE Site-directed Mutagenesis 
Introduction 
As described in Chp.1, for various different GPI-anchored proteins the 
removal of the C-terminal signal sequence prevents attachment of the GPI 
and the proteins are completely translocated across the membrane (Berger 
et al., 1988; Bailey et at., 1989). Experiments with PLAP and DAF have 
found that a minimum of thirteen hydrophobic amino acids left at the C-
terminus were necessary for GPI attachment (Berger et al., 1988; Caras and 
Weddell, 1989). Therefore mutated PrP genes were designed which 
contained early stop mutations which should give rise to truncated proteins 
in which varying numbers of the C-terminal hydrophobic amino acids were 
removed (Fig. 4). Whether these mutations also prevented GPI-addition to 
the PrP protein was investigated in in vitro systems. 
Oligonucleoticie-mediated site-directed mutagenesis 
Oligonucleotide-mediated site-directed mutagenesis was chosen as the 
method to make these mutations because it can be used to introduce 
specific alterations in the DNA to the level of one base pair and thus alter 
individual codons in the DNA coding sequence (Sambrook et al., 1989). 
Two variations of the method were used, where in each case the mutated 
oligo is used as a template to amplify the DNA using different mechanisms 
to achieve this amplification. The first of these is the double primer method, 
which is an adaptation of the original method of Hutchinson et al. 
(Hutchinson et al., 1978) which uses amplification in filamentous phage. 
The second involves the use of mutagenic oligonucleotides (oligos) and the 
polymerase chain reaction (PCR). (Saiki et al., 1985; Mullis and Faloona, 
1987) to amplify the mutated DNA. 
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TabIel:Oligonucleotides used in SDM 
Oligo.no. 	Sequence 
968 GCA CAA GAA CTG GGG CAG GAG AAA CAG 
162 CTC CTC CCC TCC TG A*TC ATC CTC CTC ATC 
063 TTA CGA CGG GAG ATA G*GA TCC AGC AGC ACC 
902 AAT GCT GCC CTC TAT C*CT AGG TCG TCG TGG 
873 CAT G*AA  TCC TGC AGA TCA GTC ATC ATG GCG A 
874 GCA CCC TAC_TCC CTC CGG AAG AGA T*CT CGA 
Bases in bold represent insertions into the normal PrP sequence. 
In oligo 873 the start codon is underlined, and the position of the EcoRl site 
marked with an asterix. 
In oligo 874 the normal PrP stop codon is underlined and the position of the 
Xbal site marked with an asterix. 
Oligos 063 and 902 are from the same position on opposite strands of DNA 
for the PCR site-directed mutagenesis and the asterix represents the position 
of the engineered BamHl restriction site. 




PREDICTED C-TERMINUS AMINO ACID SEQUENCE FOR 
PrP PROTEIN PRODUCED FROM WILD-TYPE &ND MUTANT DNA 
f -t-tt H- - 
221 SQAYYDGRRSSTVLFSSPP VILLISFLIF LIVG 	pSKPr251 
+ 
221 	SQAYYDGRRSTVLFSSPP V 	 pSKPr241 
221 	SQAYYDGR 	 pSKPr228 
+ = hydrophobic amino acid 	= putative GPI attachment point 
= GPI attachment signal sequence 
Design of oligonucleotides 
Careful design of the mutagenic oligonuleotides can greatly increase the 
frequency of positive mutants obtained. Firstly the oligo must be made from 
the strand complementary to that produced by the single stranded (ss) 
phage. It must be sufficiently long to anneal, preferably 25 or more 
nucleotides in length and be free from palindromic sequences. Also the oligo 
should be tested for homology to non specific sequences in the vector to 
avoid spurious priming. The substitution or insertion should be placed as 
close as possible to the centre of the oligo leaving the flanking arms 
perfectly matched. 
Two such oligos were designed, incorporating these features, which 
introduced early stop codons into the PrP gene sequence (Table.1). An 
additional feature that these oligos incorporated was that they introduced 
a unique restriction site into the DNA which could subsequently be used to 
identify phage carrying the mutation (Fig.5). The first mutation (stop 241) 
introduces two mismatches, inserts a Bcll site and should result in the 
removal of eleven hydrophobic amino acids. The second (stop 228) 
introduces two mismatches, inserts a BamHl site and should remove all 
seventeen hydrophobic amino acids. This should also remove the putative 
site of attachment (Ser 231) for the GPI anchor. In this case the mutated 
protein should be truncated at the same position as the 15% of PrPSc 
identified by Stahl et al (Stahl et al., 1990a). 
Flanking oligos for use in the 2° PCR reaction, (oligos 873 and 874), were 
at least 30mers, containing 21 and 22 bases of homology with either end 
of the PrP ORF, and 9 non-homologous bases which contained a unique 
restriction site at their ends (Table. 1). The 5' oligo, (873), was designed to 
conserve the sequence immediately 5' to the start codon as this contains 
the consensus sequence for the correct initiation of translation (Kozac, 
1983) (Fig.6). 
The sequences of the mutant oligonucleotides are listed in Table 1. 
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C-terminus of PrP 
stop 228 	 stop 241 
+++ 	++ + +++ ++++ ++++ 
SQAYYDG RS SSTVLFSSPP V LLISFLIF LIVG 
Barn Hi 	 BcI 1 
+ hydrophobic amino acid 
Figure 5. 




PrP Translation start 
I 	 I 
'TAJACCCACAT C CAATTC TCCACAATCACTCATCATCCCCAAC 
Kozac sequence 
T7 transcription start 
"Double primer" method 
This involves the use of filamentous phage vector. The fragment to be 
altered is cloned into M13 or one of its modified derivitives (M13mp18/19, 
Gibco-BRL) and single-stranded DNA templates are then prepared to which 
an oligonucleotide containing the desired mutation can be annealed. The 5' 
end of the oligonucleotide is phosphorylated to prevent its displacement by 
the 5'-3' exonuclease activity of the Kienow fragment and a second, non-
phosphorylated universal primer, is also annealed to the template. The 
Klenow fragment of DNA polymerase 1 and T4 ligase are then used to 
complete the double stranded DNA molecule. This is then transfected into 
a repair negative (Dam-) strain of E. Coil. (to avoid correction of the mutation 
by the bacterium's repair mechanisms), where the mutated strand is used 
as a template for the production of ss phage particles containing the 
mutation. The strain of E.CoIi used is called Mut-L (Chp.2, Table 1). The 
resulting plaques are then screened for the presence of the mutation using 
the mutated oligonucleotide as a probe in a differential hybridization 
experiment. Once a potential mutant has been selected it must first be 
sequenced in its entirety to ensure that no spurious mutations have been 
inserted, whereupon it may,reinserted into its original position in the gene 
of interest. The experimental procedure is outlined below. 
1) A 3.61(b fragment of the PrP gene from the NZW strain of mouse 
(Westaway et al., 1987) was cloned into the Xbal site in the multicloning 
region of the vector M13mp18 (BRL) and the subsequent clone called 
Mpl 8NX3.6. 
The recombinant phage was grown in an E. Coil strain that contains an F 
epitope, (M13 infect via the sex pili), E.Co/1NM522 and CMK were used 
(Chp.2). 
High quality ss DNA was prepared from the above as described in Chp.2. 
The mutagenic oligo was synthesized by Oswell DNA Services at 
Edinburgh Univerisity on an Applied Biosystems synthesis machine and 
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HPLC purified. 
The mutagenic oligo was phosphorylated with T4 polynucleotide kinase: 
Mutagenic oligo 200pmole 
1OxT4 kinase buffer 2p1 
10mMATP li/I 
T4 kinase 4units 
H20 to 	201i1 
Incubate 37°C, 1 hour. 
Heat to 68°C, 10 min to,-if  enzyme. 
Mutagenic and 	universal primers were annealed to ss recombinant 
template: 
universal primer (17mer) 10pmole 
ss template O.Spmole 
phosphorylated mutant oligo 10pmole 
10xPE1 buffer (see below) 1/il 
H20 	 to lOpI 
Mix. 
Heat to 20°C >Tm, (Tm=4[G+C]--2[A+T]), in this case 62°C, 5 mm. 
Tm = dissociation temperature 
Allow to cool slowly to AT. 
Whilst this was cooling PE3 mixture was prepared: 
10XPE2 buffer (see below) 	 ipI 
dNTPs 2mM 	 11111 
10mMATP 	 ipI 
T4 ligase 	 5units 
Klenow fragment 	 2.5 units 
H20 to 10,ul 
This was stored on ice until needed. 
lOpl of PE3 was added to reaction mixture (step 5) and incubated at 
AR 
16°C, 6-15 hours. 
8) Serial dilutions of the reaction mix were made and transfected into Dam-
E. coli 
1OxPE1 buffer 	 1OxPE2 buffer 
Tris.HCI pH7.5 200mM 	 Tris.HCI pH7.5 	200mM 
MgCl2 	100mM 	 MgCl 2 	 100mM 
NaCl 	50mM 	 DTT 	 100mM 
DTT 	10mM 
Screening plaques for positive mutants by differential hybridization. 
At an appropriate dilution the reaction mix from above gave rise to well 
spread out plaques that could be picked without cross-contamination. To 
screen these plaques for the presence of the mutation the method of 
differential hybridization was used, where the mutant oligonucleotide was 
used as a probe. Small synthetic oligonucleotides which are hybridized to 
a piece of complementary DNA will dissociate over a sharp range as the 
temperature increases (Wallace et al., 1980; Suggs et al., 1981). The 
dissociation temperature Td (°C) of a perfectly matched duplex between a 
synthetic oligonucleotide up to 20 bases long and single stranded template 
can be calculated from the equation: 
Td = [2x number of A,T base pairs] + [4x number of G,C base pairs]. 
The Td for the mismatched duplex will be less than that for the perfectly 
matched duplex. When the filter is washed at close to the calculated Td the 
probe should selectively dissociate from the wild type DNA. The 
temperature of the wash had to be raised a few degrees higher than the 
calculated Td for oligonucleotides greater than 20 bases. 
Colonies that appeared positive from hybridization were picked and grown 
up for DNA extraction and the DNA was analysed using the enzyme for 
which the unique site had been engineered. 
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Results of "double priming" experiments 
Stop 241 mutation: 
Differential hybridization gave rise to two potential mutants and these were 
tested for the presence of the mutation by both restriction with Bcll and 
sequencing of the mutation site. Bcll will only recognise DNA that is 
unmethylated, and thus it was necessary to first transfect the phage into a 
methylase negative strain of E.CoIi (GM242 Chp.2, Table 1) and prepare 
plasmid DNA from these bacteria. When this was done one of these clones 
appeared to contain the mutation and the other did not. This result was 
confirmed by sequencing the region of the mutation for both clones (Fig.7) 
and the ORF of the one containing the correct mutation was subsequently 
sequenced in its entirety. No spurious mutations were located. As the NZW 
PrP mouse gene has no suitable sites for cloning flanking its ORF it was 
necessary to use the polymerase chain reaction (PCR) to add restriction sites 
to the 5' and 3' ends before cloning into an expression vector was possible. 
This process is described in detail in the next section. 
Stop 228 mutation: 
Although the second mutation, stop 228, repeatedly gave rise to what 
looked like positive mutants in different experiments, on subsequent 
digestion with BamHl they did not contain the unique restriction site that 
the mutation incorporates. This was confirmed by sequencing the site of 
the mutation in these possible mutants (Chp.2), which all proved to 
ressemble the wild-type. As repeated efforts using this strategy did not 
produce the stop 228 mutant a different strategy involving PCR was 
undertaken. 
Oligonucleotide-mediated site-directed mutagenesis by PCR 
PCR (Saiki et al., 1985; Mullis and Faloona, 1987) is a process whereby two 
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Figure 7a. The presence of specific mutations is confirmed 
by sequence data. 
Wild-type (pSVPr251) 	Bcll mutant (pSVPr241) 









Unmutated sequence: 	C CCC TCC TGT CAT CCT CCT CAT C 
Mutated Sequence: 	C CCC TCC ATG ATC ATC CTC CTC A 
1.1 
Figure 7b. 	The presence of specific mutations is confirmed 
by sequence data. 
BamHl mutant (pSVPr228) 
A C G T 
Mutation 
Unmutated sequence 	A CGA CGG GAG AAG ATC CAG CAG 
Mutated sequence: 	A CGA CGG GAG ATA GGA TCC AGC 
synthetic oligos are used as primers to amplify a sequence of interest. The 
primers anneal at either end of the sequence of interest, one to each strand, 
and multiple rounds of 3' extension by DNA polymerase, denaturation and 
reannealing is used to achieve amplification. It is possible to incorporate 
changes into the primers that will then be amplified giving rise to a mutated 
fragment of DNA. The limitation of this strategy has been that such 
mutations can only be placed at the ends of the amplified fragment, as this 
is where the primers are. This problem has now been overcome by the use 
of more than one round of PCR involving two different sets of oligos in a 
process termed overlap extension (Higuchi et al., 1988; Ho et al., 1989; 
Horton et al., 1989). 
Oligos containing the desired mutation are synthesised to opposite strands 
of the target DNA (Fig.8), and two separate PCR reactions are performed, 
the double stranded product of each having the desired mutation at one end. 
These two products are then used as the template for a further round of 
PCR, using two unmutated flanking oligos as primers (873, 874, Table 1). 
On denaturation and reannealing the mutated ends will bind as they are 
complementary and extension will continue until a full length fragment is 
created between the two flanking primers. Thus the mutation can be placed 
in the centre of a clonable fragment of DNA which can then be reinserted 
into the gene of interest. 
In the mouse PrP gene the restriction sites at the 5' and 3' ends of the ORF 
are unsuitable for cloning and it is difficult to isolate a fragment of the gene 
that contains just the ORF (Locht et al., 1986). For this reason it was 
decided to use the secondary PCR reaction to introduce useful restriction 
sites at the 5' and 3' ends of the ORF to facilitate its insertion into an 
expression vector .This was done by adding these sites onto the ends of 
otherwise homologous primers flanking the ORF (Table 1). Thus the final 
PCR product consists of an 850bp PrP fragment containing the 228 stop 
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= 3' non—coding region 	 873 =EcoRl 
= pUC18 	 874 =Xbal 
______ 	= intron 	 oligos are numbered in order of production 
end which can be cloned directly into an expression vector. The oligos were 
designed to leave intact the nine bases 5' of the start site as these encode 
the consensus sequence (Kozac 1 983) for efficient initiation of translation 
(Fig.6). The fragment was sequenced to ensure that no spurious mutations 
were introduced by the PCR reaction. 
Experimental procedure 
Primary PCR was performed on Mp18NX3.6 which had been linearized with 
Sail, phenol/chloroform extracted and ethanol precipitated and resuspended 
















Taq . polyme rase (Cetus) 
	
0. 5p1 
Components were added in the order listed, mixed, spun briefly and overlaid 
with a couple of drops of mineral oil to prevent evaporation. Controls 
included a reaction with no DNA and a reaction with no enzyme. The 
cycling parameters used were: 
Denaturation 	 94°C, 2mm. 
Annealing 	 60°C, 2mm. 
Extension 	 71 °C, 3mm. 
30 cycles of amplification were performed and a Techne thermocycler was 
used throughout. 
Products were examined by agarose gel electrophoresis (Chp.2). 
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Results of PCR mutagenesis experiments 
The primary (1 0)  round of PCR gave rise to two products which 
corresponded to the predicted sizes (Fig.9). Oligo 968 was used in this 
1 'round in preference to oligo 874 as the distance between the site of the 
mutation and the end of the ORF is too small to yield a retrievable fragment 
in this instance (Fig.8). Thus the expected sizes were 2.21(b for the 
968/063 reaction and 700bp for the 902/873 reaction (oligo 902 is exactly 
complementary to oligo 063) (Fig.9). The 2.2Kb reaction did not work every 
time, giving either the correct sized band or no band at all. This may be due 
to a number of causes, including limitation of components or a difference in 
the ideal parameters for a fragment of this length. However, each fragment 
was isolated from agarose gels and together used as the template for the 
secondary (20 ) PCR reaction. For this reaction oligos 873 and 874, which 
respectively added the EcoRl site to the 5' end and the Xbal site to the 3' 
end of the ORF, were used, giving rise to an 850bp fragment. This 
fragment should contain a unique BamHl site near to its 3' end if the 
mutation has been incorporated. A number of fragments were obtained 
which did not contain this site and which resembled the wild type. This was 
explained by examining the isolated fragments used as template in the 2 0 
reaction. One of these was found to contain some plasmid contamination 
ie. traces of the unmutated plasmid template used for the 1 0  reaction which 
was being used as a template instead of the mutated fragment. Subsequent 
re-isolation of the mutated fragment meant that the 20 reaction proceeded 
as planned and a fragment containing the 228 stop mutation and BamHl 
site was obtained. 
PCR addition of restriction sites 
As described above PCR was used to add unique restriction sites to the ends 
of the 20 PCR product of the mutagenesis experiment. Exactly the same 
process and the same oligos (873 and 874) were used to add restriction 
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sites to the ends of the ORF of the 241 mutation obtained from the double 
primer method and also to the wild type PrP ORF, so that this could be used 
as a comparative control. All PCR fragments were hybridized with a probe 
containing the coding region of PrP to verify their authenticity according to 
the methods described in Chp.2. 
Figure 9. 	Agarose gel electrophoresis of 1 ° and 21  PCR 
fragments. 
Lanes 	 A B C DE F 
Two rounds of PCR were performed to introduce the BamHl mutation 
into the PrP ORF and at the same time engineer suitable 
restriction sites for cloning onto the ends of the fragment. 
The first round(11 ) produced two fragments, one of 2Kb and one 
of 700bp, each having the mutation at one end. The second round 
used these fragments as a template to produce one 850bp fragment 
with the mutation at its centre and EcoRl and Xbal sites at its 
5' and 3' ends respectively. 21 PCR 850bp fragment (Lane A), 10 
PCR 700bp fragment (LaneB), 10 PCR 2KB fragment (Lane C), 	10 
PCR 2KB fragment (Lane D,E-before gel isolation), AHind ill size 
markers. 
Cloning of PCR fragments into expression vector 
In vitro transcription involves combining all the necessary components for 
correct RNA processing. This is usually under the control of a very strong 
promoter, often a bacteriophage promoter, ie.T7, SP6. These are 
particularly useful as bacteriophage RNA polymerase is extremely specific 
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for its own promoter sequence and thus will give no detectable transcription 
from other prokaryotic or eukaryotic promoters; it is extremely strand 
specific and does not tend to initiate or terminate at nicks in double stranded 
DNA template molecules (Kreig and Melton, 1987). A splice site and 
polyadenylation site must be provided in the vector for correct processing 
of mammalian RNA. In vitro transcripts of protein coding sequences can 
act as functional mRNAs with a stability and translational activity equivalent 
to that of natural mRNAs (Kreig and Melton, 1987). Thus in vitro 
transcription can be used to examine the mRNAs produced by the mutated 
PrP genes and compare them to the mRNA of the unmutated gene 
transcribed in the same system. 
The expression vector that was chosen is a member of the pSV family called 
pSVK3 (Mongkolsuk, 1988). This vector is a phagemid, having an origin of 
replication for Fl and can therefore be used to produce ss as well as ds 
DNA. It contains the T7 promoter upstream of a comprehensive multiple 
cloning site (MCS), the SV40 early polyadenylation site and the SV40 small 
T antigen splice sites. For transient expression it has the SV40 early 
promoter. Thus once the DNA of interest is cloned into the multiple cloning 
site a single vector can be used for in vitro transcription/translation 
experiments, transient expression and sequencing. 
Two PCR fragments containing the correct mutations and one containing the 
wild-type with convenient EcoRl/Xbal restriction sites at their ends were 
produced as described above. These were cloned into the MCS of pSVK3 
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	 Figure 10. 
Verification and sequencing of PCR products 
Both mutations underwent a round of PCR to facilitate cloning as described 
above. Therefore it was necessary to sequence the entire open reading 
frame of both to check for spurious mutations. As this was now contained 
in a phagmid it was possible to make ss DNA and perform the sequencing 
according to established methods (Chp.2). Both mutant clones contained 
the intended codon changes in their C-termini (Fig.7). pSVPr241 contained 
no other changes in its ORF. Similarly, the wild-type clone contained no 
mutations in its ORF. However, on sequencing, an additional mutation was 
found in pSVPr228. 
This was a G to A change at base pair 510, which leads to a Arginine to 
Lysine change at codon 135. As both of these are basic amino acids and 
an initial transcription/translation experiment detected no difference at the 
protein level between this and the product of the other mutant (see Chp.4), 
due to constrr 	of time it was decided to continue using this clone 
instead of repeating the mutagenesis and cloning stages. 
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CHAPTER 4: 	Cell-Free Transcription and Translation of mutants 
Introduction 
We owe much of what we know about the topogenesis of membrane bound 
and secretory proteins to the use of cell-free and whole-cell systems to 
study simple model polypeptides (Lingappa, 1991a). Such systems provide 
a much simplified environment in which to observe the fate of polypeptides 
of a specific sequence. 
The Rabbit Reticulocyte Lysate System 
Rabbit reticulolysate (RRL) is prepared from New Zealand white rabbits 
injected with phenylhydrazine (Pelham and Jackson, 1976). The 
reticulocytes are purified to remove contaminating cells and then lysed. The 
lysate is treated with micrococcal nuclease to destroy endogenous mRNA 
and reduce background translation to a minimum. The lysate contains the 
cellular components necessary for protein synthesis: tRNA, rRNA, amino 
acids and initiation, elongation and termination factors. Further optimization 
of the system has been achieved by the addition of i) hemin to prevent 
inhibition of initiation, ii) phosphocreatine kinase and phosphocreatine as an 
energy generating system, iii) potassium acetate and magnesium acetate 
at levels recommended for the translation of most mRNAs and iv) a mixture 
of tRNAs to expand the range of mRNAs that can be translated. 
Processing events such as signal peptide cleavage, core glycosylation and 
GPI addition can be examined by adding canine microsomal membranes 
(DPMs) to a standard translation reaction. 
The RRL system has been used previously to produce recombinant PiP (Hay 
et al., 1987a, b), and has more recently been shown to possess all the 
necessary biosynthetic machinery for GPI addition (Fasel et al., 1989). This 
system enabled us to characterise the mutant protein in the absence of any 
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endogenous background protein. 	As discussed previously, truncation 
mutants of normally GPI-anchored proteins, in which the COOH-terminal 
signal peptide has been deleted are predicted to be secreted, and this has 
been shown for several proteins (Berger et al., 1988; Bailey et al., 1989). 
The two truncation mutations of the PrP gene, which have the GPI addition 
signal sequence deleted, as well as the full-length wild type gene have been 
cloned into an expression vector. 	This vector, pSVK3, contains the 
bacteriophage T7 promoter directly behind a multiple cloning site, and by 
the in vitro addition of T7 RNA polymerase, ribonucleotides and a capping 
analogue can be used to produce mature mRNA . This mRNA can then be 
used in the rabbit reticulolysate (RRL) system, in the presence of DPMs, to 
produce fully processed proteins in vitro. 
In vitro transcription:- 
Preparation of DNA templates: 
CsCl banded DNA (see chp.2) was used to produce linear template DNA by 
digesting 1 Ojig overnight in the presence of excess Xhol restriction enzyme 
(40 units). This enzyme produces a 5' overhang as recommended for run-
off RNA transcription. Aliquots of the reaction were run on agarose gels to 
ensure that restriction had gone to completion. The remainder of the 
reaction was phenol/chloroform extracted and ethanol precipitated, followed 
by two washes with 70% ethanol. The DNA was resuspended in RNAse 
- 	free water (DEPC treatment, appendix 1) at a concentration of lpg/ml. 
Transcription reaction: 
In vitro transcription was carried out using T7 RNA polymerase as 
outlined below. Reaction constituents were added in the order listed 
below to prevent the possible precipitation of DNA by the spermidine in 
the buffer. 
T7 RNA polymerase buffer xl (BRL and Promega), 
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10mM DTT, 
50u RNAsin (Promega), 
0.5mM ATP, CTP, UTP, 0.05mM GTP, 
0.5 mM m7G 5'ppp 5'1 (Pharmacia), 
5pg linarized DNA, 
40u T7 polymerase. 
The mixture was incubated for two hours at 40°C 
After 30 min lpl of 8mM GTP was added. 
After 1 hour an additional lpl of T7 RNA polymerase was added. 
After the incubation was complete 1 -5ul of the reaction volume was run on 
an agarose gel to check for RNA production, whilst the rest of the reaction 
was extracted once with phenol/chloroform and chloroform respectively, and 
then ethanol precipitated and washed with 70% ethanol as before. 
The RNA was resuspended in 5-1 OpI of RNAse free water, depending on the 
amount produced and stored at -70°C. 
lpl of this was used per translation reaction. The DNA template was not 
removed as its presence had no effect on the translation reaction. 
For the production of uncapped RNA the cap analogue was omitted from the 
reaction and GTP included at 0.5mM at the outset of the reaction. 
In vitro Translation 
In vitro translation was performed using a Promega RRL kit as per the 
manufacturer's instructions. The standard reaction was normally 
supplemented with DPMs to facilitate the co-translational processing of the 
proteins produced. 35S methionine was used to label the newly synthesized 
proteins and thus enable small quantities of product to be visualized by 
fluorography. A standard reaction contained: 
17.51i1 RRL, 
0.5p1 1mM amino acids (minus methionine), 
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2pl 35S methionine (1200Ci/mmole) at lOmCi/ml, 
2.2pl RNAse free H20 
1.8 p1 DPMs, 
lpl RNA substrate in H201  
to a total volume of 25pl, and was incubated at 30°C for 90mm. 
RNA substrate was heated to 65°C for 10 min and cooled immediately on 
ice prior to addition to prevent the formation of secondary structures. 
5pl aliquots of the translation reaction were added to 20pl of final sample 
buffer (FSB) and 5-1Opl of this run on 15% polyacrylamide slab gels on a 
Bio-Rad mini-gel apparatus as described in Chp.2. 
Reactions performed without DPMs were done in essentially the same 
manner except the volume of all reagents was doubled. 
Negative control reactions were performed by adding H20 in an equal 
volume instead of the RNA substrate. 
Coupled in vitro Transcription and Translation 
Whilst this work was in progress coupled in vitro Transcription and 
Translation systems became commercially available (Promega). These 
systems greatly simplify the process of in vitro protein synthesis as they do 
away with the necessity of performing separate transcription and translation 
reactions and greatly reduce the number of steps and the amount of 
handling necessary, with a consequent reduction in the chance of RNA 
degradation taking place. 
The saving in time is also considerable as it is no longer necessary to 
produce linear DNA templates as supercoiled plasmid DNA can be used 
directly as a template. This system is also reported to produce significantly 
more protein in a 1-2 hour reaction than the conventional one (Promega 
technical bulletin). For these reasons some of the later experiments used 
the Promega TnT coupled system in preference to the conventional one. 











TnT reaction buffer 
TnT T7 RNA polymerase 
Amino acids ( minus methionine), 1 m 




H20 to 25p1. 
Incubate at 30°C for 90 mm. 
SOS-page electrophoresis 
All in vitro synthesised proteins were examined by SDS-PAGE 
electrophoresis on a Bio-Rad mini-gel system, dried and exposed to X-ray 
film as described in the General Methods section (Chp.2). 
Protease protection assays 
5p1 aliquots of the translation reaction were incubated with lpl of the 
protease proteinase K (1 mg/ml), in the presence or absence of a 1 % solution 
of the detergent Triton X-1 00, to a final volume of 1 Opl, at 0°C for 1 hour. 
Prior to use, the Proteinase K was diluted from a -20°C stock of 20mg/mi 
and warmed to 37°C for 15 mm. The reaction was stopped by the addition 
of PMSF to a final concentration of 2mM. 20pl of FSB was added and lOpi 
of this sample subjected to SDS-page electrophoresis. 
Immunoprecipitation 
Proteins were immunoprecipitated from the translation reaction mix by the 
use of a polyclonai anti-mouse SAF antibody, 1133, raised in rabbits (Farquhar 
et al., 1989). lOpi of translation reaction was diluted in 400pi of lysis 
buffer (10mM TrisHCI pH7.4, 100mM NaCl, 10mM EDTA, 0.5% Sodium 
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Deoxycholate, 0.5% Nonidet P-40, 1mM NEM, 1mM phenylmethane 
sulphonyl flouride (PMSF)). 
Two volumes (800pl) of TBST (see appendix 1) and antibody 1B3 to a 
dilution of 1/1000 (1.2p1) were added. This mixture was incubated at 4°C 
with rocking for three hours or overnight. lOOpl of 10% w/v Protein A-
Sepharose solution (made up in TBST) was then added and the incubation 
continued at room temperature for a further hour, also with gentle shaking. 
The Sepharose beads were collected by spinning for 20 sec in a microfuge 
and the excess liquid carefully drawn off using a syringe attached to a 23g 
or smaller needle. This minimised the loss of beads during the washing 
step. Five washes of lOOpl of TBST were performed with the beads being 
recollected each time by brief centrifugation in a microfuge. This was 
sufficient to remove any residual unbound protein. After the final wash the 
bound proteins were released from the beads by washing in 81i1 of 
(0.5%SDS, 50mM NaCI) and incubating at 90°C for 10 mm. As much of 
the sample as possible (lOpl) was then, on addition of loading buffer, loaded 
directly onto a SIDS-polyacrylamide gel and dried and examined as previously 
described. 
Deglycosylation procedures. 
To examine if the higher molecular weight bands observed in the in vitro 
synthesised proteins were the result of glycosylation at the predicted N-
linked glycosylation sites the proteins were treated with an enzyme, PNGase 
F, which cleaves off Winked glycans from the peptide backbone. This was 
done by first immunoprecipitating the proteins as described above, with the 
exception that a different elution buffer was used that contained a reduced 
amount of SIDS (0.2% SIDS, 25mM NaCI) and this remaining SIDS was 
captured into micelles by the further addition of 100mM NaPO4 and 10% 
NP40 to a final volume of 50p I. This sample was split into two aliquots of 
251il to one of which 54ul of enzyme (1 unit) was added and to the other 5pl 
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of water and both samples were incubated overnight at 37°C. This 
procedure protected the enzyme from the denaturing effects of the SIDS by 
complexing it into micelles with the NP40. Ovalbumin was used as a control 
for assaying enzyme activity. 
Sodium carbonate extraction 
Various procedures were used to try to determine if it was possible to 
release the in vitro synthesised proteins from membranes by the actions of 
sodium carbonate extraction and/or sonication and membrane sedimentation. 
Sodium carbonate extracts peripherally attached or secreted proteins, which 
should then be found in the supernatant fraction, but leaves integral 
membrane proteins attached to the membrane. 
Carbonate extraction (Perara and Lingappa, 1985): 
Translation reactions (25pl) were split into two aliquots and diluted to 2.5 
ml with either ice cold 0.1 M Na2CO3 pH 11.5 or an isotonic solution (0.25M 
sucrose, 5mM MgCl2, 1mM DTT, 50mM triethanolamine pH 7.4, 0.1 M 
KCI). Samples were then incubated at 0°C for 30 min and then centrifuged 
at 50,000 rpm for 1 hour at 2°C and the supernatants removed. Pellets 
were resuspended in 1 % Triton buffer as above, and then both pellet and 
supernatant of the carbonate extracted sample had their pH adjusted with 
10% acetic acid. The supernatants were then methanol precipitated as 
before. 
Sonication and pH: 
Translation reactions (25pl) were made up to 1 ml with Tris.HCI, either pH 
8 or 10, and subjected to 3x10 sec bursts of sonication with a Kontes 
micro-sonic cell disrupter, and left on ice for 30 mm. Samples were then 
centrifuged in a Beckman benchtop ultracentrifuge (TL100) at 50,000 rpm 
for 1 hour at 2°C. Supernatants were taken off and precipitated at -20°C 
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with four volumes of methanol, whilst pellets (the membrane fraction) were 
resuspended in a 100mM Tris.HCI pH.8, 1% Triton X-100 solution, before 
both were run on SDS-PAGE. 
TX1 14-extraction and PIPLC treatment 
Differential solubilization in detergents can be used to separate proteins 
which have an overall hydrophobicity from hydrophillic proteins. Detergents 
with low critical micellar concentrations (ie. Triton X-1 00, Triton X-i 14 and 
Nonidet P-40 ) have been shown to be relatively ineffective at solubilizing 
substantial amounts of GPI-anchored proteins, whilst detergents with high 
critical micellar concentrations (ie.CHAPS) solubilized substantial amounts 
of GPI-anchored proteins (Hooper and Turner, 1988). The action of bacterial 
phosphoinositol-phospholipase-C (PIPLC) cleaves the GPI anchor from the 
protein, thus greatly reducing its overall hydrophobicity. These two results 
can be combined to separate and identify GPI anchored moieties from those 
which do not contain a GPI-anchor and those that contain membrane 
spanning regions (Hooper and Bashir, 1991). Thus, a protein that partitions 
into the detergent phase on TX-1 14 extraction and subsequently shifts into 
the aqueous phase on PIPLC digestion can be identified as a GPI-anchored 
protein. 
TX-1 14 extraction was performed by a modified version of the method of 
(Bordier, 1981) . For extraction without PIPLC treatment, 
two translation reactions were pooled (501l) and diluted up to 2001A in 
(0.11M Tris.HCI pH 7.4, 0.5M NaCI , 10mM EDTA) and briefly sonicated. 
Membranes were sedimented by centrifugation at 100,000g for 1 hour at 
2°C and the supernatant taken off and discarded. The pellet was 
resuspended in 200p1 of extraction buffer (10mM Tris.HCI pH 7.4, 150mM 
NaCl, 1% TX-11 14) and sonicated for 20 sec, before being left on ice for 30 
mm. The samples were centrifuged for 10 min at 2,000rpm in a bench top 
Beckman GS-6R centrifuge at 0°C and the supernatants collected and 
centrifuged further at 55,000 rpm for 1 hour at 2°C in a Beckman benchtop 
ultracentrifuge T1100.3 rotor. The pellets from this centrifugation were 
stored at 4°C to be examined in later experiments, whilst the supernatants 
were subjected to phase separation at 30°C. This was achieved by 
carefully layering the supernatant on to 300pl of 6% sucrose buffer (10mM 
Tris.HCI pH 7.4, 6% sucrose, 1 50mM NaCl, 0.06% TX-1 14) and immersing 
this in a 30°C waterbath for 10 mm. This temperature is above the cloud 
point of TX-1 14 and causes a microscopic phase separation to occur. 
Macroscopic separation is achieved by centrifugation in a microfuge for 5 
mm. A detergent layer, a sucrose layer and an aqueous layer separate out. 
The two 	were pooled and this and the detergent layer both were 
methanol precipitated and run on SDS-PAGE. 
TX-1 14 extraction after PIPLC digestion required small modifications of the 
technique. 50pl of translation reaction was diluted and membranes pelleted 
as before but a different extraction buffer (0.05 M Tris.HCI pH 7.4, 
iOMmM EDTA, 0.1% TX-114) containing a lower concentration of 
detergent was used to resuspend the membranes. The sample was split in 
half and 20pl of Bacillus thuringiens/s PIPLC (0.014 u/I, ICN-Flow) added to 
one half , whilst 20p1 of H20 was added to the other. The samples were 
then incubated with slow shaking at 37°C for 3 hours and then cooled to 
0°C. The TX-1 14 concentration was then made up to 1% by the addition 
of a stock solution (11%) and the extraction carried out as before. All TX-
114 used in these experiments was first precondensed according to the 
method of Bordier (Bordier, 1981). 
Non-denaturing gel electrophoresis 
GPI-anchored proteins and their amp,phi lic counterparts are often 
indistiguishable on SIDS-page despite predicted size differences, which is 
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probably a result of the anionic detergent binding to the lipid moiety 
providing a negative charge density more than enough to compensate for 
the size contribution of the lipid. However, some have been distinguished 
by their size heterogeneity on non-denaturing gels (Palfree and Hammerling, 
1986; Hammelburger et al., 1987; Toutant et al., 1989), using such 
detergents as Triton X-100, Sodium deoxycholate and octyiglucoside. 
These detergents should bind to the hydrophobic membrane-associated 
region of the protein and contribute only to the size of the solubilized 
molecule and not to its charge. 
TX-100 gels: 
15% polyacrylamide slab gels were prepared using a Tris-triton buffer 
(0.375M Tris.HCI pH 8.8, 1% TX-100) and a Tris-glycine upper resevoir 
buffer (0.025M Tris.HCI pH 8.8, 0.192M glycine) and Tris lower resevoir 
buffer (0.025M Tris.HCI pH 8.3). Samples were diluted 1:1 in loading 
buffer (40mM Tris.HCI pH 9.5, 30% glycerol, .002% bromophenol blue) and 
preheated to 37°C for 15 min prior to running at 150 volts for 45 mm. No 
stacking gel was used. 
Sodium deoxycholate gels: 
These were prepared essentially as above except 0.25% sodium 
deoxycholate was substituted for the TX-100. 
Results 
Size heterogeneity in in vitro translated PrP: 
Both the wild type and mutant PrP give rise to a single band of approx. 
26kD on SIDS-page (Fig. 11). No corresponding band is seen in the RNA 
negative control. The diffuse band at approx. 14-2OkD seen in all reactions 
including the control corresponds to a globin molecule from the RRL 
(Promega ). Faint bands of higher molecular weight at regular intervals up 
Figure 11. 	Translation of wild-type and mutant mRNA 
(capped and uncapped) in RRL. 
Capping 	 + + + + 	- - - - 
DPMs - - - - -- ++ 
Lane 	 A B C D 	B F G H 
kD 	 - 
35- 
29— 	 to _26 
One fifth of a translation reaction from 1 Ong of mRNA with and without capping 
reagent and DPMs as indicated. Brome Mosaic Virus (Lane A), pSVPr251 (Lane B), 
pSVPr241 (Lane C), no RNA control (Lane D), pSVPr241 (Lane F), 
Figure 12. Translation of wild-type and mutant 
mRNA (capped and uncapped) in the 
presence and absence of DPMs. 
Capping 	 - - - + 
DPMs + + - + 




One fifth of a translation reaction from lOng of mRNA 
with and witout capping reagent and DPMs as indicated. 
pSVPr241 (mutant) (Lane A),pSVPr251 (wild-type) (Lane 
B),pSVPr25]. (Lane C),pSVPr241 (Lane D).DPM= dog 
pancreas membranes. 
to the top of the gel were consistently observed when DPMs were omitted 
and also when uncapped RNA was used as a transcription substrate (Fig. 11, 
Fig. 12). These bands were also observed when the TNT system was used 
without membranes (Fig. 13) and were not observed in the RNA negative 
control lane (Fig.11,Lane D). Similar bands were observed when a fusion 
protein containing the ninety amino- terminal amino acids of PrP fused to a 
luciferase reporter gene (Promega) was expressed in the RRL system but 
not when the luciferase reporter alone was expressed (M.Firoozan, 
pers.commun.) Discussions with the manufacturers suggested that these 
could possibly be an artefact of the system when used with PrP. 
Alternatively, they could suggest that the protein, when overexpressed 
outside its natural 
Figure 13. Translation of wild-type 	
enviroment, is incorrectly 
and mutant constructs in coupled folded or does not interact 
transcription/translation (TnT) system 	with the proper chaperones 
in the absence of DPMs 
and is allowed to aggregate. 
Lane. 	A 	B 	 When DPMs were included 
kD 	 wild type and mutant 
constructs gave rise to 
differing multiple band 
26— 	 patterns (Fig. 14). 	The 
wild type protein typically 
One 	fifth 	of 	a 
transcription/translation reaction 	had two major bands which 
from lpg of wild-type and mutant 
DNA. pSVPr251 (Lane A), pSVPr241 	corresponded to the 
(Lane B. 
unprocessed 26kD form 
seen in the absence of DPMs and a band of approx. 33-35kD, which may 
exist as a doublet as two bands could be resolved on some gels. Similarly, 
in some reactions a second band is seen below the 26kD band. The larger 
bands are believed to correspond to the processed and N-glycosylated forms 
of the protein, with the doublet consisting of N-terminally cleaved , GPI- 
HIM 
Figure 14 	Translation products of wild-type 
and mutant in the presence of 
DPMs. 
Lane 	A B 	C D 
MR 
Translation products produced with the 
uncoupled (Lanes A and B) and coupled (Lanes C 
and D) in vitro transcription/translation 
systems. pSVPr251 (Lanes A and C), pSVPr241 





2kD 	___ 	___ 	
28kD 32kD 
 
26kD.., 	26kD  
Cobin_, 	 Clobin_, 
.- 28kD 
Line diagram of Fig. A,B 	Line diagram of Pig 	C,D 
anchored proteins, with either one or two of the predicted N-glycosylation 
sites filled. The 26kD band probably represents the unprocessed form of 
the protein and the slightly smaller band possibly represents the N-terminally 
cleaved but as yet unglycosylated protein (Fig. 14, Lanes A and C). 
In the mutant a different pattern was observed (Fig. 14, Lanes B and D). 
The unprocessed protein may be fractionally larger than that observed in the 
wild type but the difference is so small that it is difficult to resolve. Three 
other bands are observed, the largest of which corresponds to the 
processed, glycosylated form seen in the wild type. The negative charge of 
the lipid moiety in the GPI-anchored protein compensates for its larger size 
on SIDS gels and consequently we would expect to be unable to differentiate 
between the fully glycosylated protein and the GPI-less protein by size using 
this system. Of the two other bands the smaller (24kD) may correspond to 
the N-terminally cleaved, unglycosylated form which is only sometimes 
observed in the wild type . The identity of the fourth band of intermediate 
size has not yet been conclusively assigned . Fig. 1 5 is a very over exposed 
gel which clearly shows the major protein species. 
Figure 15. 	Overexpression of translation products 
of wild-type and mutant. 
Lane 	A B C D One fifth of a translation 
- 	 reaction was run on a 15%cjL 
and exposed for eight 
weeks. psvpr251 (Lanes 
A and B). pSVPr241 
(Lanes C and D). 
30 - 
1.6 - 
Further manipulations of these proteins were designed to show whether 
these predictions were correct or not. 
Protease protection assays: 
This experiment was designed to decipher which of the observed bands 
were translocated across the membrane, and consequently, would be 
protected from the action of exogenously added proteases and would have 
undergone co-translational processing, such as N-terminal signal cleavage. 
The disruption of the membrane by the addition of detergent should abolish 
this protection. The results showed that in the wild type the 26kD band 
disappears with PK treatment, whilst the 33-35kD bands are protected (Fig. 
16). A similar result is observed when the treated proteins are 
immunoprecipitated with the PrP polyclonal antibody 1133 (Fig. 17). This 
correlates with the idea that the 26 kD band represents the unprocessed 
translation product which has not passed through the membrane and has 
not had its N-terminal and C-terminal signal sequences cleaved. In the 
mutant (Fig18, LanesD,E,F, Fig.19,Lanes D-I) the second largest band 
disappears, which suggests that this is the corresponding unprocessed 
translation product, whilst the smaller molecular weight band which is 
protected could be an N-terminally cleaved band which has crossed the 
membrane, but has not been glycosylated. All the higher molecular weight 
bands are protected, which implies that they are all located on the interior 
of the membrane vesicle and have thus passed through the membrane and 
have undergone co-translational processing. The size (33-35kD) of the 
largest band in both mutant and wild type correlates to what we would 
Figure 1 6. 	Proteinase K treatment of wild-type protein. 
PK 	—++ + + ++ + + 
DIET ——+ - + - + - + 
Lane 	A B C D E F G H I 
One fifth of each translation reaction was incubated with lpl 
of Proteinase K (1mg/mi) at 0°C for 1 hour in the presence of 
1% Triton X-100 	as indicated. PK = proteinase K, DET = 
detergent. Untreated (Lane A). PK treatment only (Lanes 
B,D,F,H). PK plus detergent treatment (Lanes C,E,G,I). 
Figure 17. Immunoprecipitation of Proteinase K treated wild-type 
protein. 
Immunoptn. — + + + + + + 
PK 	 - - - + + + + 
DIET - - - - + - + 





Immunoprecipitation of wild-type protein with the poly-clonal 
anti-PrP antibody 133 after PK treatment in the presence or 
absence of detergent. Unprecipitated, untreated protein (Lane A), 
Untreated immunoprecipitated protein (Lanes B and C), PK treated 
protein in the absence of detergent (Lanes D and F), PK treated 
protein in the presence of 1% TX-100 (Lanes E and G). 
Figure 18. 	Proteinase K treatment of wild-type and mutant 
protein. 
PK 	 - + + - + + - 
DIET - - + - - + - 
Lane 	A B CD E 	G 
&OW&i  mml 
Translation products from the constructs pSVPr251 (wild-type) and 
pSVPr241 (mutant) were treated with Proteinase K, in the presence 
and absence of detergent as described in Fig.6 and the text. 
PK=proteinase K, DET= 1% TX-100. pSVPr251 (Lanes A,B,C),pSVPr241 
(Lanes D,E,F), no RNA control (Lane G). 
Figure 19. 	Proteinase K treatment of two different 
mutants. 
PK 	 - + + - + + - + + 
DIET - - + - - + - - + 
Lane 	A B C D E F G H I 
-- 	-- 
Proteinase K treatment was carried out as described in 
previous figures and the text. pSVPr251 (Lanes A,B,C), 
pSVPr241 (Lanes D,E,F), pSVPr228 (Lanes G,H,I). + PK 
treatment (Lanes B,C,E,F,H,I). + 1% TX-100 (Lanes C,F,I) 
PK= proteinase K, DET= 1% TX-100. 
expect for the glycosylated protein. The smaller molecular weight (28kD) 
band which is only seen in the mutant was thought at this stage to be a 
possible glycosylation intermediate. 
In the wild type PK treatment gave rise to a protease resistant band of 
approx. lOKd which appears to be a degradation product (Figs. 16 and 17) 
and which does not appear to be present in the mutant (Fig. 18,19,20). 
With this exception addition of detergent abolished the resistance to 
degradation of all species, thus this mutation does not give rise to the 
production of protease resistant PrP in this system. 
Immunoprecipitation: 
Following immunoprecipitation of the wild type protein with the polyclonal 
antibody 1133, it was found that all the bands previously observed on SDS-
PAGE were recognised by this antibody (Fig. 1 7,20,21). The 1 OkD protease 
degradation product picked up in the PK experiments was also recognised 
by this antibody (Fig.17,20,21). When the mutant protein was 
immunoprecipitated a pattern of five bands was observed. The largest of 
these appears to correlate with the largest band observed without 
immunoprecipitation. The other four bands may be two sets of doublets, 
implying that one of the four bands previously observed does not 
immunoprecipitate with this antibody. Further evidence for this theory 
comes from PNGase experiments (see below and Fig.22), where, after 
immunoprecipitation, the undigested mutant protein has a pattern of only 
three bands, two of which, on better resolution could have been doublets. 
The identity of exactly which of the four original bands is not being 
immunoprecipitated has been difficult to assess. 
Deglycosylation procedures: 
This experiment was designed to investigate whether the large molecular 
weight species observed were indeed the result of carbohydrate addition at 
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WILD TYPE 	MUTANT 
DIET 	 + 	 + 
PIK + + + + 
3lkD - 	 - 
26kD-  
15kD__.  
Line diagram of immunoprecipitated Proteinase K 
treated wild—type and mutant proteins. (see Fig.20) 
Figure 20. Immunoprecipitation of Proteinase K treated wild-type and 
mutant proteins. 
PK 	 - + + - + + 
DET - - + - - + 
Lane 	 A B C D E F 
I 
After each Proteinase K treatment the reaction was stopped with 2mM PMSF 
and each sample immunoprecipitatted overnight with 1B3, a polyclonal 
anti-PrP antibody, before collection on Sepharose A beads and elution 
with 0.5% sds,50mM NaC1.PK= Proteinase K, DET= 1% TX-100. 
pSVPr251 (Lanes A,B,C), pSVPr241 (Lanes D,E,F). + PK treatment (Lanes 
B,C,E,F), + TX-100 (Lanes C,F) 
Figure 21. 	Immunoprecipitated versus non- 
immunoprecipitated wild-type and 
mutant proteins. 
Lane 	 A B C D 
One 	fifth of a non- immunoprecipitated sample 
(5pl) was diluted in sample buffer and run (Lanes 
A and C) while one half of a translation reaction 
(lOpl) was immunoprecipitated as described in the 
text (Lanes B and D). pSVPr251 (Lanes A and B), 
pSVPr228 (Lanes C and D). 
Figure 22. 	Deglycosylation of wild-type and 
mutant proteins by PNGase F. 
PNGaseF 	- + - + 	- + 
Lane 	 A B C D E F 
Proteins were first immunoprecipitated as 
described and then treated with 1 unit of 
PNGase F at 37°C overnight. pSVPr251 (Lanes A, 
B,E,F), pSVPr241 (Lanes C and D). PNGase F 
(Lanes B,D,F) 
the predicted Winked glycosylation sites. The enzyme used, PNGase F, 
specifically removes Winked oligosaccharides by hydrolyzing the GlcNAc-
Asn bond which attaches the carbohydrate to the protein. If the proteins 
are glycosylated then enzyme treatment should result in a ce- te& 
Suitable reaction conditions for the action of this enzyme required that the 
protein was first immunoprecipitated. As noted above only three of the 
four bands in the mutant protein are immunoprecipitated by 1133. PNGase 
treatment of both mutant and wild type led to ovc-. 	(Fig.22). In 
each case it was only the highest molecular weight band that was removed 
by action of the enzyme, implying that this is the only glycosylated species 
Increasing the duration of incubation with the enzyme did not lead to the 
disappearance of the other bands. This leaves the origin of the intermediate 
band (28kD) in the mutant unidentified as it is probably not a glycosylation 
intermediate. As expected the running of the unprocessed band was not 
affected by this treatment. Purified ovalbumin exhibited cc(eto v' 
after PNGase treatment, thus showing that the enzyme functions under the 
described conditions. 
Sodium carbonate extraction: 
Sodium carbonate extraction is known to strip peripherally associated 
proteins from the membrane, but to leave integral membrane proteins in the 
membrane fraction (Perara and Lingappa, 1985). It was not known before 
this experiment exactly how a GPI-anchored protein would behave in this 
system, but it was thought that it would remain associated with membrane 
fraction. In the first experiment the wild type protein remained in the 
membrane fraction in both cases when treated with either an isotonic buffer 
or the carbonate buffer, as did the 241 mutant ,whereas the 228 mutant 
was associated with the membrane fraction in isotonic buffer and displayed 
a shift of approx. 50% into the supernatant fraction on carbonate 
extraction (Fig.23). This would imply that the wild type is not stripped by 
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this treatment but this result is put into doubt by the association of the 
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One translation reaction was split in half and each half extracted 
with either an isotonic buffer or a Sodium Carbonate buffer pH 11.5 
at 0°C for 30 min and then centrifuged at 50,000rpm for 1 hour. 
Pellets were resuspended in 1% Triton and sample buffer and 
supernatants precipitated with methanol. 
A= pSVPr251, B= pSVPr241, C= pSVPr228, P= pellet fraction, S= 
supernatant fraction. 
mutant with the membranes in the isotonic buffer . We would not expect a 
secreted protein to associate with the membrane fraction . It was thought 
that the microsomal vesicles might be remaining intact, thus trapping the 
mutant protein in their lumen and causing to come down in the membrane 
fraction. Also, in this experiment a fresh translation reaction of mutant 228 
was used, whereas the wild-type and mutant 241 translation reactions had 
been stored at -70°C before use and this may have affected their 
extractability in the carbonate buffer (Fig.23). Therefore a different 
experimental design was attempted. It is known that the stripping action of 
the carbonate buffer is largely a function of its alkali pH so an experiment 
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involving buffers of different pH coupled with sonication to ensure total 
Figure 24. 	Extraction of wild-type and mutant proteins 
with alkaline buffer and sonication. 
WT 	MUT 
pH8 	pHlO rH8 	pH 10 
PS PS PS PS 
j0 
The product of one translation reaction (25pl) was diluted to lml 
in either a buffer of pH8 or pUlO, and then sonicated with 3xlOsec 
bursts. Samples were then centrifuged for 1 hour at 50,000rpm at 
2°C and pellet and supernatant fractions collected and run on a 
gel.WT= pSVPr251 (wild-type) ,MUT= pSVPr241 (mutant) 
disruption of the microsomal vesicles was attempted. In this experiment the 
wild type protein was found in the membrane fraction at pH 8 but shifted 
totally to the supernatant at pH 10 (Fig.24), whereas the mutant protein 
was found mostly in the supernatant at pH 8 and totally so at pH 10 
(Fig.24). A subsequent experiment coupling sonication with the original 
isotonic and carbonate buffers led to a totally conflicting result, where both 
wild type and mutant were found in the membrane fraction in isotonic buffer 
and where only the wild type showed a shift to the supernatant on 
carbonate extraction (Fig.25). These results are confusing but imply that 
the wild type is stripped from the membrane by this treatment and thus does 
not exhibit the properties of an integral membrane protein. The situation 
with the mutant is less clear, as it behaves much like a secreted protein in 
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the second experiment but more like an integral membrane protein in the 
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This experiment combined the carbonate buffer extraction with sonication. 
A= pSVPr251, B=pSVPr241, C= pSVPr228. P= pellet, S= supernatant. 
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third set. One possible explanation is that the mutant protein isA  but is 
clumped into aggregates under some conditions causing it to sediment with 
the membrane fraction. The GPI-anchored proteins GP-2 and THP have 
been shown to self-associate in an ion-dependent and pH-induced fashion 
in vitro after PIPLC cleavage (Fukuoka et al., 1992). 
TX1 14 extraction and PIPLC treatment 
PrP is a GPI-anchored protein which is susceptible to PIPLC treatment (Stahl 
et al., 1987). GPI-anchored proteins are known to separate into the 
detergent phase when extracted with the detergent TX1 14 (Bordier, 1981). 
On treatment with PIPLC they lose their hydrophobic glycolipid anchor and 
as a result will partition into the aqueous phase on TX1 14 extraction. Our 
results show that the wild type is found almost exclusively in the detergent 
phase, but on PIPLC treatment shows a considerable shift into the aqueous 
Figure 26. Treatment of wild-type and mutant proteins with 
PIPLC and subsequent extraction in TX1 14. 
WI 	- 241 	 228 
PIPLC 	 - + — + — + — + 	 — — ++ 
DO P. ADD J - \A DADA 
Lanes 	 A B C D E F G H 	 IJK L 
- 
Two translation reactions were pooled and the membrane fraction 
sedimented as described in the text. These were extracted with a 
buffer containing 1% TX114, or 0.1% TX114 when PIPLC treatment was 
carried out. Samples were incubated with 0.014units of PIPLC for 3 
hours at 37°C and the extraction buffer was then made up to 1% TX114 
and the extraction continued as described in the text. WT= pSVPr251, 
241=pSVPr241, 228= pSVPr228. pSVPr251 (Lanes A-D), pSVPr241 (Lanes 
E-H), PsvpR228 (Lanes I-L) 
phase (Fig.26). This is consistent with its containing a GPI-anchor, with the 
residue in the detergent being protein from which the enzyme has not 
removed the glycolipid anchor. In contrast the bulk of the mutant is found 
in the aqueous phase and PIPLC treatment does not alter the pattern of its 
phase partitioning (Fig.26). This is consistent with the protein not having 
a GPI anchor. Interestingly, one of the four mutant bands seems to be 
poorly extracted into the aqueous phase. This is the second smallest band 
and the one that was previously postulated to be the unprocessed 
translation product. The corresponding band in the wild type also seems to 
partition poorly into the aqueous phase. 
Non-denaturing gel electrophoresis: 
Some workers have been able to use non-denaturing gels to differentiate 
between the GPI-anchored and hydrophilic forms of a protein, (Palfree and 
Hammerling, 1986; Hammelburgeret al., 1987; Toutant et al., 1989). We 
tried to do so using a number of different gel formulations, which ranged 
from a basic Tris.-glycine gel to ones containing TX100 or sodium 
deoxycholate. However, these attempts were inconclusive as in each case 
most of the protein was trapped in the wells and it was difficult to say what 
those bands that were observed represented (Fig.27). It looks as if the 
highest molecular species, which should represent the fully processed 
protein, is migrating at the same rate in both wild type and mutant, which 
suggests that this method cannot be used to differentiate between them. 
Attempts to run PrP extracted from the brains of scrapie infected mice on 
similar gels were also unsucessful (J.Hope, pers. commun.). 
Figure 27. Non-denaturing gel electrophoresis of wild-type and 
mutant proteins. 
Tris-glycine 	Deoxycholate 	TX-100 
Lane 	 A B 	 A B 	 A B 
U" 
N 
Different types of detergent were used in an attempt to 
differentiate between the GPI-anchored and the hydrophillic 
forms of the protein on polyacrylamide gels. A= pSVPr251 (wild-
type), B= pSVPr241 (mutant). 
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Conclusions 
Examination of our PrP mutants in the RRL cell free system has shown that 
they differ from the wild type. They exhibit an extra band of 28kD which 
is translocated across the membrane but does not appear to be a 
glycosylation intermediate. All bands of the wild type protein were 
immunoprecipitatable with the anti-PrP polyclonal 1133 . It is possible that 
one of the bands in the mutant is not. The availability of peptide specific 
antibodies, such as N- and C- terminal specific antibodies, would have been 
very useful in assigning definite origins to each of the observed protein 
species. 
We have shown that the mutant proteins behave as expected for a 
hydrophillic form of the protein lacking a GPI-anchor as they are found in the 
aqueous phase of TX1 14 extractions and this phase distribution is not 
affected by the action of PIPLC, in contrast to the wild type which is found 
in the detergent phase and shifts to the aqueous on PIPLC treatment. Thus 
we conclude that similar to previously examined GPI-anchored proteins, 
inserting truncation mutations into the open reading frame of the PrP gene 
causes the loss of a C-terminal signal sequence for GPI-addition . Both the 
mutants that were examined, pSKPr241 and pSKPr228, which are truncated 
by thirteen and twentysix amino acids respectively, gave rise to the same 
pattern of protein species. Thus we conclude that the removal of ten of the 
seventeen hydrophobic C-terminal amino acids is sufficient to prevent the 
addition of a GPI-anchor. The removal of a further thirteen amino acids 
including the predicted attachment site of the GPI (Ser 231), does not give 
rise to any observable difference in the pattern of protein species observed. 
It was not possible to establish the presence or absence of a GPI-moiety 
on the recombinant proteins by separation on non-denaturing gels. 
In the absence of DPMs a regular series of higher molecular weight bands 
was observed (Figs. 12, 13, 14, 15) ranging in size from 35kD up to 
1 50,000kD. 
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These bands are also seen to a lesser extent when DPMs are included, but 
uncapped RNA is used in the translation reaction (Fig.12,13,14). It is 
possible that these bands are an artefact of the overproduction of the 
protein when there is a limiting amount of membranes present and thus 
only a proportion of the nascent protein can be processed. The unprocessed, 
unglycosylated protein may have a greater tendency to aggregate. There is 
some evidence for this from experiments in which site-directed mutagenesis 
has been used to produce non-glycosylated PrP in scrapie infected cells 
(Taraboulos et al., 1990). These researchers found that PrPSC,  the 
aggregated, protease resistant form of the protein, is produced more quickly 
in cells expressing the non-glycosylated form of the protein than in those 
containing the wild-type. 
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HAPTER FIVE: 	Tissue culture analysis of mutants 
Introduction 
Tissue culture cells provide a much more realistic representation of the 
actual conditions that prevail in the whole organism than cell-free studies, 
without involving the time and high costs of animal work. Proteins 
expressed in tissue culture can be expected to be post-translationally 
modified in a similar manner to native proteins. It was predicted from the 
cell free work (Chp.4), that the wild-type PrP, having a GPI-anchor would be 
associated almost exclusively with the cells, whilst the mutant protein, 
having no GPI-anchor, would be secreted into the tissue culture medium. It 
was hoped that these constructs, under the influence of the viral SV40 
promoter would overproduce the proteins which would then be easily 
detectable in amounts that could be used for further biochemical 
examination. It is necessary to be able to distinguish between the 
recombinant protein and any endogenous protein that may be present in the 
cell type utilised. In this case the use of a cell line of neural origin like 
neuroblastoma cells was ruled out as our recombinant wild-type PrP should 
directly ressemble the endogenous protein. Therefore a cell line was chosen, 
CV1 cells (monkey kidney cells) that had previously been shown to express 
recombinant PrP and which did not express endogenous PrP by ELISA 
assays (Rogers et al., 1990). 
General methods 
Cells 
CV1 cells, (an adherent monkey kidney cell line) and mouse neuroblastoma 
cells (N2as) were obtained from ION-Flow. 
Media. 
Initially, following the recommendations of the suppliers Minimum Essential 
Eagles medium (MEEM) supplemented with 10% fetal calf serum (FCS) and 
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certain nutrients as outlined below , was used as a growth medium. 
Subsequently, this was changed to Dulbeccos Modification of Eagles 
medium (DMEM) as this appears to be a better medium for efficeint 
transfection (pers.comm. K.Chapman). 
MEEM was obtained from Flow-ICN as a lOx concentrate and diluted with 
tissue-culture grade H20 as outlined below. 
MEEM 
lox Medium 	 50m1 
100% Fetal calf serum 	 SOml 
lOOx L-Glutamate 	 5m1 
lOOx Non-essential amino acids 	 5m1 
7.5% Sodium bicarbonate 	 16.5m1 
H20 	 374.5ml 
DMEM was obtained from Gibco-BRL as a lx solution which was 
supplemented as outlined below. 
DMEM 
ix Medium 	 500m1 
100% Fetal calf serum 	 SOml 
lOOx non-essential amino acids 	 5m1 
All media was supplemented with 1 % pen/strep 
Maintenance of cells 
Cells were grown to confluence and were initially divided 1/10 , but this 
ratio was reduced to 1/4 in later experiments in order to reduce stress on 
the cells during the transfection process. Cells were released from the 
surface of the flask by the action of a solution of trypsin (TVP) as outlined 
below. 
IN 










1 ml of TVP was added per each 25c M2  of flask and this then incubated at 
37°C for 3 mm. At this stage the cells rounded up and detached from the 
bottom of the flask. The TVP was diluted out by the addition of at least an 
equal volume of medium and clumps of cells broken up by repeated pipetting 
up and down. Fresh medium was added and the cells incubated at 37°C 
and in 6% CO2 in a Heraeus 6000 incubator. 
Freezing cells 
Frozen stocks of cells were prepared by detaching the cells from the flask 
as described above and collecting them by centrifigation at 3,000rpm for 
3mm. The cells were then resuspended in lOmI (per 75c M2  flask) of 
freezing mix (see below) and the centrifugation step repeated. The cells 
were then res spended in 5m1 of the freezing mix and aliquoted into 0.5m1 
aliquots in Nunc screw top freezing vials. These were transferred into a 
polystyrene container and kept overnight at -70°C before transfer to liquid 
nitrogen where they could be stored indefinitely. 
For thawing, vials were removed from liquid nitrogen and quickly thawed at 
37°C. They were diluted in 5m1 of medium and immediately collected by 
centrifugation, before being reususpended in lOmI of media and plated out 
in a 25cm2 flask. This step had the result of removing the DMSO (Sigma) 
in the freezing mix, which is toxic to the cells when unfrozen. 
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Freezing mix 
MEEM 	 6m1 
DMSO 	 2m1 
FCS 	 2m1 
DNA for transfection 
The DNA used for transfection was double banded on caesium chloride 
gradients (see Chp.2) and used in its supercoiled state, as nicked DNA and 
the presence of residual RNA and chromosomal DNA decreases transfection 
efficiency. Cells were transfected with lOpg DNA including the test DNA 
(lpg) and a control DNA (lpg) that is known to transfect efficiently . The 
control was chosen to have an activity which is easily monitored, in this 
case the chioramphenicol acetyl transferase (CAT) gene under the control 
of the Rous Sarcoma Virus (RSV) promoter. Thus the transfection efficiency 
was measured by the levels of CAT activity expressed by the cells. The 
amount of DNA was increased to lOpg using the vector pGEM. 
As well as the pSV series of constructs two further constructs were used 
in later transient assay experiments. These contained the wild-type ORF and 
an ORF with a truncation mutation at codon 231 (IAH2 and IAH4a 
respectively) under the control of the human cytamegalovirus and had been 
shown to produce recombinant protein in tissue culture (A.Bennett pers. 
comm.) DNA stocks of these constructs were prepared as described above 
for the pSV series. 
CAT assays 
Chloramphenicol acetyl transferase (CAT) is an enzyme that transfers an 
acetyl (or butyl) 	group from acetyl (or butryl) coenzyme-A onto 
chloramphenicol. In the CAT assay expression of the gene was measured 
by the ability of extracts from cells into which the CAT gene had been 
transfected to transfer this acetyl group onto a radiolabelled chioramphenicol 
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molecule. Molecules with the extra group attached partitioned into the 
xylene phase when extracted in this solvent. The amount of CAT activity 
present was measured by measuring the radioactivity present in this phase 
compared to that obtained from extracts from cells into which no CAT DNA 
had been transfected. 
The procedure followed for a 35mm dish is outlined below. 
The supernatant was removed from the cells and the cells scraped off 
into 1 m of ice cold PBS. 
Cells were collected by centrifugation and washed in a further 1 ml of PBS 
and the centrifugation step was repeated. 
Cells were lysed in 50pl of lysis buffer (10mM TrisHCl. pH 8, 2mM 
MgCl2 , 0.5% Nonidet P-40) , heated for 7 min at 60°C and centrifuged at 
13,000rpm for 10 mm. 
Mix A was prepared:- 
TrisHCl pH 8 	 1 001J 
14C Chloramphenicol 	 200pl 
2.5mM But,ryl CoA 	 2001.i1 
H20 	 500111 
43pl of mix A was added to the 50p1 of cell lysate and left at 37°C for 
5 hours. 
2001jl of xylene was added and the tube vortexed for 5 mm. 
180pl of the xylene (top) layer was removed to a fresh tube and lOOpI 
of TE added to it. This was vortexed briefly and then centrifuged for 3 mm. 
The top layer was taken off to a fresh tube and a further lOOpI of TE 
added to it, after which the centrifugation was repeated. 
The top layer was taken off and 2m1 of scintillation fluid added to it. 
This was counted in a scintillation counter. 
The heating step destroyed other enzyme activities and a negative control 
(untransfected or mock transfected cells) was always included in the assay 
for comparative purposes. Mock transfected cells were treated with the 
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transfection reagent but no DNA was added 
Transfection 
Many different protocols are now available for the transfer of exogenous 
DNA into the interior of mammalian cells (Sambrook et al., 1989). There are 
many different variables in the efficiency of these protocols, including 
different cell type, the stage of growth of the cell, the medium, and the 
state of the DNA used for the transfection. As great difficulty was 
experienced in sucessfully transfecting these cells a number of different 
protocols were attempted before a method that worked consistently was 
found. 
Lipofection. 
This is a method where a chemical analogue of the lipid bilayer is used to 
form micelles containing the DNA to be transfected, which are subsequently 
fused with the cell membrane, thus releasing the DNA into the cells. It has 
been shown to be 5-100x more efficient than Calcium Phosphate 
transfection depending on cell type (Feigner et al., 1987) and therefore was 
attempted first. Lipofection reagent is commercially available (Gibco-BRL, 
Lipofectin) and was used according to the manufacturers instructions, as 
described below for 35mm dishes. 
Cells were seeded and grown to 40-60% confluency. 
10jig of DNA was mixed with 1 m of serum-free medium (SFM). (Mix A) 
lOpl of Lipofectin reagent was mixed with lOOpl of SFM.(Mix B) 
Mixes A and B were combined and left at RT for 10-15 mm. 
Cells were washed x2 in SFM. 
800p1 SFM was added to each tube ,mixed gently and added to the cells. 
These were incubated at 37°C for 3-5 hours or longer. 
1 m of medium containing 20% FCS was added. 
The incubation was continued for 48-72 hours and the cells assayed. 
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Prolonged exposure of the cells to Lipofection reagent in SFM caused cell 
death, so a balance between optimised transfection efficiency and maximum 
permissible cell death had to be achieved, usually by trial and error. 
Optimum conditions for CV1 cells allowed for 5 hours of incubation in the 
reagent. 
Lipofection results 
Lipofection was carried out as described above, and the cells were observed 
during the process. A certain amount of cell death occurred during the 
serum-free phase, presumably the result of disruption of the plasma 
membranes of some cells. However, after the 48-72 hour incubation period 
the cells had recovered and grown to full confluency. CAT assays 
performed on early Lipofection experiments gave very high levels of CAT 
activity- 50-1 00x that of an untransfected or mock transfected cell 
(Tablel). These transfected cells were used to try and isolate the 
recombinant proteins (see below). After the initial couple of experiments it 
was not possible to isolate PrP from cells or supernatants of cells 
transfected with either the wild-type or mutant construct. Various different 
techniques were utilized, including TX1 14-extraction, direct methanol 
precipitation of cell supernatants with methanol, concentration of 
supernatants in Amicon concentrators, and pulse-chase labelling of proteins 
with 35S-labelled metionine (see results below). It became clear that the 
protein was not being expressed in these cells, which prompted a 
reexamination of the CAT assay results for these transfections. It was 
noticed that there was a rapid drop off in the efficiency of transfection after 
the initial few experiments (Table 1), until the levels of CAT activity were 
only 3-10x that of the untransfected cells. Many variations in the basic 
protocol were tried to improve this efficiency. New reagents and new media 
made no improvement. Increasing the amount of Lipofectin from 10p1 
through to 50pl, and increasing or decreasing the amount of time that the 
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reagent was left on the cells did not help. New cells were brought out of 
freezing and also obtained from another laboratory and new stocks of DNA 
UM 
Table 1 :Lipofection results 
Exp.no. DNA Counts Times x 
background 
Method/amount 
1 none 160 1 Lipofection 
1 rsvCAT 5721 35.7 Lipofection 
2 none 83 1 Lipofection 
2 pSVPr251 (wt) 5896 71 Lipofection 
2 pSVPr241 5627 67 Lipofection 
3 none 249 1 Lipofection 
3 pSVPr251 2152 8.7 Lipofection 
3 pSVPr241 1830 7.3 Lipofection 
4 none 133 1 Lipofection 
4 pSVPr251 115 <1 Lipofection 
4 pSVPr241 349 2.6 Lipofection 
5 rsvCAT 3509 ? Lipofection 
5 pSVPr251 2431 ? Lipofection 
5 pSVPr241 3660 ? Lipofection 
6 none 991 1 Lipofection 
6 rsvCAT 2590 2.6 Lipofection 
6 pSVPr251 1573 1.5 Lipofection 
6 pSVPr241 2317 2.3 Lipofection 
6 pSVPr228 2686 2.7 Lipofection 
im 
Exp.no. DNA Counts Times x 
background 
Method/amount 
7 none 88.4 1 Lipofection 
7 rsvCAT 142.7 1.61 Lipofection 
7 pSVPr241 88.8 1 Lipofection 
8 none 295.77 1 Lipofection 
8 rsvCAT 1812 6.14 Lipofection 
8 pSVPr251 2110 7.1 Lipofection 
8 pSVPr241 2578 8.7 Lipofection 
9 none 182 1 Lipofection 
9 rsvCAT 763 4.1 Lipofection 
9 pSVPr251 227 1.2 Lipofection 
9 pSVPr241 546 3 Lipofection 
10 none 93 1 Lipofection 
10 rsvCAT lOpg 576 6 Lipofection 201u1 
10 rsvCAT lOpg 5800 62 Lipofection 25p1 
10 rsvCAT lOpg 913 9.8 Lipofection 3OpI 
10 rsvCAT lOpg 5169 55 Lipofection 351i1 
10 rsvCAT lOpg 9216 99 Lipofection 40pI 
11 none 149 1 Lipofection 
11 rsvCAT 13290 89 Lipofection 
11 pSVPr251 8366 56 Lipofection 
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Exp.no. DNA Counts Times x 
background 
Method/amount 
16 pSVPr251 647 1.5 Lipofection 
16 pSVPr241 930 2.1 Lipofection 
prepared. Using new cells led to an initial increase in efficiency, but this 
rapidly dropped off as before, and high levels of transfection efficiency could 
not be achieved consistently. As the only time that PrP had been isolated 
from the transfected cells was one of the initial experiments where the 
levels of CAT activity in the transfected cells was 67-70x that observed in 
the untransfected cells , it was concluded that a high level of transfection 
efficiency was necessary for expression at detectable levels with these 
constructs. As this method was unable to consistently produce high levels 
of transfection efficiency other methods were tried. 
Electroporation 
Electroporation is a method of introducing foreign DNA into cells by placing 
the cells and DNA in a specialized cuvette in a suitable buffer and then 
briefly passing a large electric current through them. This causes temporary 
pores to open in the plasma membranes of the cells and the DNA enters via 
these channels. The optimum conditions for electroporation vary greatly 
from cell-type to cell-type so it is helpful to have some previous knowledge 
of conditions that have been sucessfully utilised in the cell-type of interest. 
In these experiments conditions used for CV1 cells by other workers (Chu 
et al., 1987, Doncheva et al., 1991) were used as a starting point. A Bio-
Rad Gene-Pulser plus capacitance extender were used throughout. 
The variables involved in such an experiment include i) media in which the 
electroporation takes place, ii) voltage, iii) capacitance, iv) whether the cells 
are stored on ice before and/or after the pulse, v) the amount of DNA, vi) 
the % confluency of the cells when harvested and vii) the number of cells 
per cuvette. All different combinations of these variables were used 
according to the general protocol described below. 
Cells were grown to near confluency and harvested. 
Cells were resuspended in the medium of choice and counted. 
Cells were resuspended at a density of 5x106 cells in 4001iI of chosen 
buffer. 
4)1 Opg (total) DNA was added to each cuvette (precooled on ice) and to this 
the 400p1 of cells was added. All were stored on ice for 2 mm. 
The electroporator was set to 250 volts and 960p Fd capacitance. 
The cuvette was placed in the electroporator and both buttons pressed 
until the digital display showed "high". 
Samples were stored on ice for 10 mm, then plated out into 60mm dish 
with an appropiate amount of medium and incubated for 48 hours. 
Electroporation results 
Although this method has been used to transfect CV1 cells (Chu et al., 
1987) we were unable to duplicate these results. Every combination of 
parameters that was tried (Table 2) led to 80-100% cell death and therefore 
this approach was abandoned. The exact reasons why this technique was 
so lethal to the cells was not ascertained, but it may be possible that the 
culture condititons that were used were not optimum for cell survival using 
electroporation . As described below, new cell stocks grown in DMEM ,split 
1/4 instead of 1/10 and who had fresh media applied a couple of hours 
before transfection were sucessfully transfected by the Calcium Phosphate 
method, so it is possible that these changes would have influenced 
transfection efficiency with electroporation also. 
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Table 2:Electroporation results 
EXP.No No. 
Cells 






1 1.4X106 SFM 250 960 14.7  5min 5x 
2 3X106 SFM 250 960 12.5  5mm 10% 
3 3x106 SFM 250 960 12.5 5mm 10% 
4 3x106 SFM 250 960 12.5  5mm 10% 
5 3x106 SFM 250 960 12.5  5mm 10% 
6 1.4x106 SFM 300 960 11.9  5min all died 
7 1.5x10°  PBS 300 960 11.6  5min all died 
8 1.5x106 HEPES 250 960 11.8 5min all died 
9 2.5x10°  SFM 250 960 13.1 5min all died 










11 2.5x106 HEPES 250 960 12.0  5min all died 
12 2x106 SFM 250 960 14.2 5min all died 
13 1x106 SFM 250 960 13.9 5min all died 
14 2.5x106 SFM 200 960 21 1 Omin 5min all died 
15 2.5x106 SFM 250 500 11.3 1 Omin 5min all died 
16 2.5x106 SFM 300 960 15.1 1 Omin 5min all died 
17 2.1x106 PBS 
0.3m1 
250 960 14.7 1 Omin 20min all died 
18 2.1x106 PBS 250 960 11.8 10min 20min all died 
19 2.1x106 SFM 250 960 12.9 1 Omin 20min all died 










10 2.5x106 PBS 250 960 17.9 5min all died 
11 2.5x106 HEPES 250 960 12.0 5min all died 
12 2x106 SFM 250 960 14.2 5min all died 
13 1x106 SFM 250 960 13.9 5min all died 
14 2.5x106 SFM 200 960 21 1 Omin 5min all died 
15 2.5x106 SFM 250 500 11.3 1 Omin 5min all died 
16 2.5x106 SFM 300 960 15.1 1 Omin 5min all died 
17 2.1x106 PBS 
0.3m1 
250 960 14.7 1 Omin 20min all died 










19 2.1x106 SFM 250 960 12.9 1 Omin 20min all died 
20 2.1x106 SFM 200 960 13.2 1 Omin 20min all died 
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Calcium Phosphate Precipitation 
Due to the failure of the above two protocols to produce consistent results 
a third transfection method, that of Calcium Phosphate Precipitation was 
tried. A fresh supply of cells were obtained from another laboratory who 
were using this method, reagents purchased from Promega throughout and 
used according to the manufacturers instructions (Promega technical manual 
1 990) as outlined below. 
1)3x105 cells were plated out per 60mm dish and grow to 60-70% 
confluence. 
2)The spent media was replaced with fresh media 2-3 hours before 
transfection. 
Two tubes were prepared for each transfection as follows: 
i)2x HEPES-buffered saline (HBS) 	 300p1 
ii)DNA 	 lOpg 
2M CaCl2 	 3711 
H20 to 300p1 
(ii) was added to (i) dropwise whilst mixing thoroughly at RT. 
This was left at RT for 30 mm. 
Samples were vortexed briefly then added dropwise to the plates and 
returned to the 37°C incubator for 4 hours. 
The media containing the CaCl2  was removed and washed xl with 
ordinary media. Fresh media was added and incubated for a further 48-72 
hours. 
For this cell type it was not necessary to perform a glycerol shock after the 
four hour incubation and it was important to remove all the CaCl2 mixture 
at this point, as leaving it on for longer proved to be very toxic to the cells. 
Calcuim Phosphate Precipitation results 
Once the optimum conditions for these cells had been worked out this 
method was able to give reproducible results (Table 3, selected results). 
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With the constructs pSVPr251, pSVPr241 and pSVPr228 transfectants 
consistently had CAT activities 50-1 50x greater than those of untransfected 
or mock transfected cells. Levels of CAT activity for cells cotransfected 
with the constructs IAH2 and IAH4a (Fig.28) were, however, much lower, 
in the region of 2-10x background. This was found to be a consistent 
result, despite the fact that DNA stocks of all the constructs were prepared 
in exactly the same manner. This method obviously did put stress on the 
cells, as seen if the Calcium Phosphate mixture was left on the cells for too 
long, but they were able to recover completely in a short space of time once 
this mixture had been removed. The high levels of CAT activity in 
transfected cells (Table 3) showed that high levels of transfection efficiency 
were being obtained. 
Figure 28. 	OAH2/4a 
pBR 	Amp / SV40 	
/ 	
GS 	 hCMV 	PrP ORF 
pBR= pBR328 vector sequence 
AMP= ampicillin resistance gene 
SV40=SV40 early promoter 
GS= glutamine synthetase gene 
hCMV= human cytomegalovirus promoter—enhancer 
polyA = SV40 polyadenylation signal 
PrP ORF =PrP wild type or mutated open reading frame 
polyA I 
Table 3: Calcium Phosphate results 
Exp.no. DNA Counts X 
background 
Method 
1 none 162 1 Calcium PO4 
1 rsvCAT 13034 80 Calcium PO4 
1 pSVPr251 12198 75 Calcium PO4 
1 pSVPr241 4851 30 Calcium PO4 
1 lAH4a 719 4 Calcium PO4 
1 14H2 0 all died 0 Calcium PO4 
2 none 91.6 1 Calcium PO4 
2 rsvCAT 11884 129.5 Calcium PO4 
2 pSVPr251 8593 93 Calcium PO4 
2 pSVPr241 17086 186 Calcium PO4 
2 IAH2 168 1.8 Calcium PO4 
2 lAH4a 679 7 Calcium PO4 
3 none say 100 1 Calcium PO4 
3 pSVPr251 20,469 204 Calcium PO4 
3 pSVPr241 18,395 183 Calcium PO4 
3 IAH2 671 6.7 Calcium PO4 
4 none 222 1 Calcium PO4 
4 pSVPr251 23,452 105.6 Calcium PO4 
4 pSVPr241 14,582 65 Calcium PO4 
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Exp.no. DNA Counts X 
background 
Method 
4 IAH2 372 1.6 Calcium PO4 
4 lAH4a 1484 6.6 Calcium PO4 
5 none 429 1 Calcium PO4 
5 pSVPr251 60163 140 Calcium PO4 
5 pSVPr241 60935 142 Calcium PO4 
5 IAH2 2399 5.5 Calcium PO4 
5 lAH4a 9715 22 Calcium PO4 
Isolation and analysis of protein from transfected cells and cell supernatants 
A number of different strategies were utilized to isolate recombinant proteins 
from the cells and supernatants of transfected cells. 
TX1 14 extraction 
This was performed essentially as described in the previous chapter for cell-
free translated proteins with adjustments of volume as described below: 
From cells: 
Cells were harvested and washed x2 in PBS. 
Cells were resuspend in 1 .5m1 of extraction buffer (see chp.4) 
Samples were sonicated for 30 sec. and left on ice for 30 mm., 
centrifuged 10 mm, 2000rpm ,at 0°C 
5)Supernatants were centrifuged at 65,000 rpm in a Beckman TI-100.2 
rotor for 1 hour at 2°C. 
6)The supernatants were overlaid onto 1 .8m1 of 6% sucrose buffer (see 
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chp.4). (N.B.the pellet from this step was stored and used in the float 
experiment described below) 
This was incubated at 30°C for 10 mm. and the phases separated by 
centrifugation. 
Both detergent and aqueous phases were methanol precipitated. 
From cell supernatants: 
For extraction from cell supernatants the extraction buffer was made up to 
2.8x normal strength and with a starting volume of 3ml of supernatant the 
procedure was carried out in the same manner as above, adjusting the 
volumes appropiately. 
When TX1 14- extracted proteins were to be treated with the enzyme PIPLC 
the amount of detergent in the extraction buffer was reduced and the 
incubation carried out as described in chp.4. 
TXII4 results 
In an initial experiment with TX1 14-extraction immuonoreactive protein 
was seen in the detergent phase of cells transfected with the wild-type DNA 
but not in the aqueous phase (Fig.29). An equivalent protein was not seen 
in cells transfected with the mutant DNA (Fig.29). No proteins were seen in 
either supernatant fraction of this experiment (Fig.29), but this may have 
been due to the difficulty in resuspending the large pellet obtained from a 
starting volume of 3ml. It was thought that it would be necessary to use 
as much of the supernatant as possible in order to detect the recombinant 
protein. 
To establish whether the TX-1 14 extraction could extract PrP from cells 
under our experimental conditions the extraction of PrP from N2a cells was 
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Figure 29. 	Anti-PrP immunoblot of TX1 14 extracted proteins 
from transfected CV1 cells and supernatants. 
SUPS 	CELLS 
MUT WT —yE MUT WT —yE 




Lanes 	 ... 
One 35mm dish of cells was washed and harvested and resuspended in 1.5m1 
of TX114 extraction buffer and supernatants (1.5m1) were extracted with 
2.8x extraction buffer and both samples centrifuged as described in the 
text. The supernatants of this centrifugation were overlaid onto 6% 
sucrose buffer and phase separation achieved by immersion in a 30°C water 
bath. Both the detergent (D) and the aqueous (A) phases were methanol 
precipitated. SUPS= supernatants, MUT= pSVPr241 (Lanes A,B,G,H), WT= 
pSVPr251 (Lanes B,C, I,J), -VE= mock-transfected cells (Lanes E,F, K,L). 
Figure 30. 	Anti-PrP immunoblot of 
TX1 14 extracted protein 





TX114 extraction was performed on a 35mm 
dish of N2a cells as described in the 
text. D= detergent phase, A= aqueous 
phase. The gel was blotted with the 
polyclonal antibody 1B3; blotting with 
another polyclonal anti-PrP antibody 1A8 
gave a similar result (data not shown). 
attempted. PrP is an endogenous protein in these cells and would be 
expected to be present at a lower level than a recombinant protein under the 
control of a viral promoter. A major immunoreactive band of 33kD was 
observed (Fig.30) mostly in the detergent phase as would be expected for 
wild-type PrP which implies that the TX1 14 extraction and blotting methods 
are sufficient for the detection of small amounts of the protein. A second 
round of extraction may have removed the remaining protein from the 
aqueous phase. Because of the problem of detecting recombinant protein 
in supernatants, different methods were tried (see below). As described in 
the transfection results, this failure to detect the recombinant protein led to 
a thorough examination of the transfection efficiency and no further protein 
extractions were attempted until a satisfactory system had been established. 
When TX1 14-extraction continued to give negative results after a good level 
of transfection efficiency had been established with the Calcium Phosphate 
Precipitation method it was undertaken to investigate the state of the 
RNA. Also the constructs IAH2 and IAH4a (Fig.28) which were known 
to express the recombinant proteins, were used to test if any of our protein 
extraction procedures were not working. We also acquired a stably 
transfected CHO cell line (CHOL761h) (Bebbington 1991) (by permission 
A.Bennett IAH, Compton) which stably expresses the same construct as 
IAH2, that is a truncation mutation at codon 231. This was used to 
compare the protein products with those of the transiently transfected CV1 - 
cells. 
Examination of the "float" fraction 
In a number of cases it has been found that a proportion of a particular 
glycoprotein, often a large proportion of the total, is insoluble in TX1 14. 
This fraction of the protein can be extracted from the pellet in step 6) in the 
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Figure 31. 	Immunoblot of whole cell extracts 




Cells from a 35mm dish were harvested and washed 
in PBS before lysis with 1% TX-100 and 
resuspension in FSB. 1AH4a (Lane A), IAH2 (Lane 
B), pSVPr241 (Lane C), pSVPr251 (Lane B), mock 
transfected control (Lane E). 
Figure 32. 	Methanol precipitation of supernatants 
from transfected cells 
Lanes 	A B C D E 	A B C C fl E 
43- 	 43- 
25Opl aliquots of supernatant were precipitated with 4x methanol 
at -20°C, pelleted, dried and resuspended in running buffer. IAH4a 
(Lane A), IAH2 (Lane B), pSVPr24I. (Lane C), pSVPr251 (Lane D), 
mock-transfected control (Lane 	. 
1 2J 
phase of the supernatant can be explained by the fact that only one TX-11 14 
extraction was performed on this fraction. Many workers have found that 
multiple rounds of extraction are necessary to extract all the hydrophillic 
protein into the aqueous phase. The protein found in the supernatant shows 
a pattern of two doublets one of 24-26kDa and the other of 30-33kDa 
(Fig.34), and is present in much greater amounts than the protein found in 
the transiently transfected cells (Fig.35, compare Lanes D & A) 
Other methods of protein isolation from supernatants of the pSV series of 
constructs 
Firstly, incubating the cells in serum free media for the 48-72 hours post-
transfection was tried as a means of reducing the amount of serum protns 
present in the media. However, this approach was unsucessful as the CAT 
assays were completely negative and nothing was seen on immunoblots 
indicating that the return to serum positive media after transfection with 
Lipofectin is an essential step fo sucessful transfection. 	A Centricon 
concentrator was used according to the manufacturers instructions to 
reduce the volume of the supernatant and run this directly on a gel, but no 
proteins were detected from any of these samples (not shown). 
Radiolabelling proteins with 35S methionine 
For pulse-chase radiolabelling of nascent proteins with 35S methionine 35mm 
dishes of cells were transfected as usual and grown for 48-72 hours and 
then treated as follows. This experiment was carried out using the pSV 
series of constructs. 
1) The supernatant was removed and the cells washed xl in complete media 
minus- methionine (Gibco-BRL). 
0.25m1 of complete media minus methionine was added and incubated 
at 37°C for 1 hour. 
1 20pCi of 35S-methionine (DuPont) was added and dishes incubated for 
2 hours. 
This supernatant was harvested and stored for immunoprecipitation. 
The cells x3 were washed in PBS, 2m1 of standard media added and the 
dishes incubated for a further 1 hour. 
This supernatant was harvested and immunoprecipitated 
The cells were lysed and immunoprecipitated as described in Chp.2. 
Samples were loaded onto 15% polyacrylamide slab gels, run, dried and 
exposed as described in Chp.2 
Results of 35S labelling 
Labelling newly translated proteins with 35S-methionine and 
immunoprecipitation is a method whereby small amounts of a particular 
protein can be detected. This was carried out as described above and no 
detectable differences could be seen between either the wild-type and 
mutant or between either of these and the negative control cells (Fig.3). 
This was true for both cell and supernatant fractions (Fig3). This result 
implied that the recombinant proteins were not being expressed at all and 
at this point repetition of the TX1 14 experiment was attempted 
unsucessfully and reexamination of transfection efficiency undertaken (as 
above). 
Blotting with anti-CRD serum 
PrP contains a CRD epitope when it has been cleaved with PIPLC and in its 
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Figure 33 Methanol precipitation of supernatants 
from the stably transfected cell line 
CHOL761 h. 
	
Lanes 	A 	B C D 
Aliquots of cell supernatant of increasing volume 
were precipitated with methanol, pelleted, dried 
and resuspended in running buffer. The gel was 
immurioblotted with antibody 1A8. Lane A 50pl, Lane 
B lOOpl, Lane C 200il, Lane D 250pl. 
Figure 34. 	Immunoblot of TX1 14-extracted protein from 
CHOL761h cells and supernatant. 
Sup 	 Cells 




Cells were extracted with TX114 as described previously, 
supernatants were first methanol precipitated and then 
resuspended in TX114 extraction buffer, and subsequently 
treated as other samples. A= aqueous, D= detergent. 
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Figure 35. 	Comparison of methanol precipitated 
protein from cell supernatants of different 
transfectants. 
Lanes 	A B C D 
kD 
—43 -t 
150pl aliquots of supernatants from cells transiently 
trarisfected with the IAH constructs were compared to 
those taken from the supernatant of the stable cell 
line CHOL761h. Each was methanol precipitated and 
immunoblotted with the antibody lA8. IAH4a (Lane A), 
IAH2 (LaneB,C), CHOL761h (Lane D). 
Figure 36. 	Radiolabelling of proteins with 31S_  methionine 
and immunoprecipitation with the polyclonal antibody 
163. 
Lanes 	 A B C D E F G H I 
j
kD 
I 	 —43 
It I 
35mm dishes of cells were first washed with, and then incubated in, 
media minus methionine, after which 35S-labelled methionine was 
added to each dish (120pC) and the dishes incubated at 37°C for one 
hour. At this time the supernatant was removed and stored on ice 
(1 hour sup) and replaced with standard media and incubated for a 
further two hours. Then this supernatant (3 hour sup) was removed 
and immunoprecipitated along with the one hour supernatant and the 
cells themselves. pSVPr241 (Lanes A,B,C), pSVPr251 (Lanes D,E,F), 
mock transfected control (Lanes G,H,I) 3 hour supernatant (Lanes 
A,D,G), 1. hour supernatant (Lanes B,E,H), cells (Lanes C, F I). 
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GPI anchored form should react with anti-CRD antibodies after such 
cleavage. A soluble or non GPI-anchored form should not react with such an 
antibody after PIPLC treatment. A whole-rabbit serum raised against an 
intact soluble form of a T.brucei VSG was obtained as a gift from 
M.Ferguson, along with some purified sVSG1 17 to act as a positive control. 
The antibody was used at a dilution of 1/1000 and visualized by a gold-
labelled anti-rabbit 2 anti-body (Bio-cell) in the manner described in chp.2. 
Anti-CRD immunoblot results 
A titration experiment with our 2 antibody system showed that up to 250ng 
of sVSG1 17 protein per sample was necessary in order to get a positive 
signal (Fig.37) Negative results were obtained with all the transiently 
transfected constructs of PrP, both wild-type and mutant . This was possibly 
because the amounts of protein present in the samples were not very high 
before PIPLC treatment and thus the CRD epitope was undetectable in this 
system. 
Figure 37. 	Immunoblotting of PIPLC treated 
sVSG117 with anti-CRD antibody. 
Lanes 	 A B C D E 	kD 
- 
The protein was first digested with PIPLC and then 
serial dilutions of sVSG117 were made and these 
blotted with a 1/1000 dilution of anti-CRD antibody. 
The proteins were visualized by a gold-labelled 
anti-rabbit secondary antibody (Bio-cell). Lane A 
SOOjig, Lane B 250pg, Lane C lOOpg, Lane D 50pg. 
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Total RNA extraction and Northern blots 
Total RNA was extracted from cells by use of the reagent RNAzol, and blots 
and hybridizations carried out as described in chp.2. 
Figure 38. 	Northern hybridization of total RNA from transiently 
transfected CV1 cells. 
Lanes 	 A B C 	D B F 	G H 
kB 
0-0-5 
Total RNA was prepared from transfected cells using RNAzo1, a one step 
preparative method, and separated on formaldehyde gels, before blotting 
onto Genescreen membrane. These were then hybridized with a double 
stranded probe prepared from PrP ORF cDNA. All samples on this gel were 
transfected and harvested at the same time with all the same reagents. 
Mock-transfected control(Lane A),pSVPr251 35mm dish (LaneB), pSVPr241 
35mm dish (Lane C), pSVPr251 60mm dish (Lanes D,E), pSVPr241 60mm dish 
(Lane F), IAH2 (Lane G), IAH4a (LaneH). 
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Northern hybridization results 
RNA was extracted from CV1 cells transiently transfected with pSVPr251, 
pSVPr241, pSVPr228, IAH2 and IAH4a, blotted and hybridized with a 
probe made from the PrP ORF as described in Chp.2. Stringent washing 
steps at 65°C gave the pattern observed in Fig.38. RNA from the two IAH 
constructs existed as a single band of the predicted size (900bp) whilst 
RNA from the other constructs appeared on the autorad as a band and large 
smear. As all the transfections were carried out on the same batch of cells 
at the same time, and all RNA preparation and handling was done with the 
same reagents at the same time it is highly unlikley that the RNA from one 
set of constructs should be degraded by contaminating RNAses and the 
other not . Also, visualization of ribosomal RNA for each sample on 
agarose gels before blotting (Fig.39) showed similar patterns for all the 
samples, with no obvious degradation in the pSV construct RNA. Therefore, 
it was concluded that the RNA from the pSV constructs was being degraded 
in the cells whilst the IAH RNA was not. 
Cotransfection of RNA polymerase 
Figure 39. 	Agarose electrophoresis of aliquots of 
total RNA prepared from transfected CV1 cells. 
Lanes 
	
A B CD E F G H 
One tenth volume of total RNA samples prepared from either 35mm or 
60mm dishes was run on a 1% agarose gel and stained with ethidium 
bromide.pSVPr241 60mm (Lane A), pSVPr251 60mm (Lane B), IAH4a 35mm 
(Lane C), IAH2 35Mmm(Lane D), pSVPr241 35mm (Lane E),pSVPr251 35mm 
(Lane F), mock-transfected control 35mm (Lane G), X HinDill size 
markers (Lane H). 
From the results of the Northern analysis (Fig.38) it was concluded that the 
RNA expressed from the SV40 promoter of the pSV series of constructs 
was being degraded in the cells. As these constructs also contain a T7 
promoter, from which the recombinant PrP genes were successfully 
expressed in the cell-free system (see Chp.4), it was decided to attempt a 
new technique that has been developed recently whereby T7 RNA 
polymerase is cotransfected with the construct (Gao and Huang 1 993) and 
can drive expression of a foreign gene controlled by the T7 promoter. These 
workers found that expression of a reporter gene was transient, declining 
after 30 hours, consistent with the notion that T7 polymerase does not 
enter the nucleus and the transcription takes place in the cytoplasm of the 
transfected cells. 
The previous workers used Lipofection to achieve this transfection, but 
bearing in mind the difficulties experienced using this system with our cells 
both Lipofection and Calcium Phosphate precipitation were used in these 
experiments. A Luciferase gene under the control of the T7 promoter 
(pPOLY(A)-luc(T7), Promega Technical Bull. 1 26) was cotransfected along 
with the pSV series of constructs and purified T7 polymerase to act as a 
reporter gene. The Promega Luciferase assay system (Promega technical 
bulletin no.101) was used to monitor luciferase activity according to the 
manufacturers instructions. A general outline of the technique is given 
below. 
The cells were transfected according to the usual protocol, including lpg 
of the luciferase and test constructs along with 100units of purified T7 
polymerase (Promega). 
The cells were incubated for 30 hours at 37°C in 6% CO2. 
The cells were washed x2 with PBS. 
Cells were overlaid with 1 501 of lx Promega cell lysis buffer (25mM Tris-
phosphate pH 7.8, 2mM DTT, 2mM 1,2-diaminocyclohexane-N,N,N',N'-
tetraacetic acid, 10% glycerol, 1% Triton X-100) and left at RT for 10-20 
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mm. 
5) Cells were scraped off into an Eppendorf and pulsed in a microfuge to 
bring down the cell debris. 
6)100pl of Luciferase assay reagent (20mM Tricine, 1.07 mM 
[MgCO3I4Mg[OH12.5H20, 2.67mM MgSO4 0.1mM EDTA, 33.3mM DTT,, 
2701il coenzyme A, 4701i1 luciferin, 5301il ATP) was added to 20p1 aliquots 
of each sample and immediately read in a scintillation counter for 10-20 
counts of 10 sec. 
Co-transfection of RNA polymerase results 
The reaction catalysed by firefly luciferase is the oxidation of beetle luciferin 
with concomitant production of a photon. When luciferase activity is present 
the light intensity of the reaction is constant for about 20 sec., then decays 
slowly, with a half-life of about 5 mm. When no luciferase activity is present 
the background counts do not decay and remain fairly constant over the 
time period of the assay. In repeatable experiments, mock-transfected cells 
gave such a signal, with the number of counts remaining about the same 
over the 3-4 min of the assay. 
Cells that had been cotransfected with the luciferase constructs and either 
the wild-type or mutant PrP pSV construct (pSVPr251 and pSVPr241 
respectively) had much higher initial counts and these declined steadily over 
the course of the assay. This implies that the luciferase gene was being 
successfully transcribed from the T7 promoter by the action of the co-
transfected T7 polymerase. It was hoped that this would mean that the 
recombinant PrP genes would also be transcribed from the upstream T7 
promoter and that as in the cell-free system, this RNA would remain stable 
and be translated in the cell into protein. Therefore, aliquots of cell lysates 
and methanol precipitated aliquots of cell supernatants were examined for 
the presence of PrP protein by SIDS-page and immunoblotting as previously 
described. Fig.40 shows that neither the wild-type or mutant cells or 
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supernatants contained any immunoreactive proteins that were not seen in 
the negative control. Time constraints prevented investigations as to 
whether stable specific PrP mRNA was produced and as no proteins were 
being produced this technique was not persued further. 
Figure 40. 	Expression of pSV constructs from the T7 
promoter in tissue culture by cotransfection of 
T7 polymerase. 
CELLS 	SUPS 





100 units of purified T7 polymerase was cotransfected into Cvi 
cells along with the constructs pSVPr251 and pSVPr241, both of 
which contain a PrP ORF behind a T7 promoter. A luciferase 
reporter plasmid containing a T7 promoter was also 
cotransfected. The cells were lysed and part used in a 
luciferase activity assay whilst the remaining cell lysate was 
examined for the presence or absence of PrP protein. 
Supernatants were methanol precipitated 	and cells and 
supernatants blotted with 1A8. Mock-transfected cells (Lanes 
A,D), pSVPr251 (Lanes B,E), pSVPr241 (Lanes C,F). 
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Conclusions 
During the course of these experiments it was discovered that the 
transfection efficiency for these cells varied greatly from one technique to 
another. The lipofection technique initially gave very good results, with high 
levels of CAT activity being achieved, but these levels quickly deteriorated. 
The exact cause of this decline in transfection efficiency was never 
pinpointed as replacing the media, cells, reagents and DNA with new stocks 
and altering the conditions of the transfection reaction did not consistently 
give rise to better results. The conditions used mimic d those used by 
previous workers with these cells (Feigner et al.,. 1987) but it was 
concluded that the low levels of transfection generally observed would 
preclude detecting low levels of recombinant protein. Electroporation of 
these cells proved to be equally difficult, with all combinations of conditions 
leading to cell death. The cells were regularly checked for mycoplasma 
infection and appeared morphologically healthy, so the reason for their 
sensitivity in this system remains unknown. 
A number of changes in the general maintenance of the cells were adopted 
when the switch to calcium phosphate precipitation transfection was made. 
Firstly, the media was changed from MEEM to DMEM, this having no effect 
on the growth of the cells but the latter was suggested to be a better media 
for transfections (K.Chapman pers.commun.). Secondly, the ratios at which 
cells were divided were altered from 1/10 to 1/4 when cells were to be 
transfected, and fresh media was applied to the cells 2-3 hours before the 
transfection. These measures were designed to avoid stressing the cells as 
much as possible and to allow them to recover after the transfection. Even 
so, some cell death did occur whilst the Calcium Phosphate solution was 
on the cells and the timing of this step was crucial as, if left on too long it 
was highly toxic to the cells. This method was very reproducible once the 
optimum parameters had been established. It is not known why one set of 
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constructs based on the pSVK3 vector (Fig. 10) led to much higher levels of 
CAT activity than another based on the pEE 14 vector, (Fig. 28), (Bebbington, 
1991), whilst the amounts of recombinant protein obtained from the former 
were so much lower than from the latter. The pEE14 vector contains the 
major immediate-early gene promoter-enhancer of human cytomegalovirus 
(hCMV) as well as the 5' untranslated region and the leader intron and a 
polyadenylation signal from SV40 . This is followed by a multi-cloning site 
into which the PrP wild-type and mutated ORFs have been cloned (Fig. 1). 
It also contains a glutamine synthetase selectable marker under the control 
of the SV40 early promoter to enable the establishment of stable cell lines. 
From these experiments it would appear that these constructs give rise to 
a high level of expression of the recombinant proteins in these cells. The 
reason for the degradation of the pSV construct RNA is not understood, as 
these constructs gave rise to abundant recombinant protein in the cell free 
system (Chp. 4) from their T7 promoters. As all stocks of DNA were 
prepared in the same manner, the same CAT vector being used in each case 
and the fact that making of fresh stocks did not alter this pattern of CAT 
activity led to the conclusion that some intrinsic difference in the nature of 
the vectors was governing these properties. 
When high levels of transfection were achieved PrP immunoreactive protein 
was observed in the detergent phase of TX1 14-extracted cells transfected 
with the wild-type construct pSVPr251, whilst none was visible in cells 
transfected with the mutant construct pSVPr241 . No PrP was precipitated 
by methanol from the supernatants of the wild-type transfected cells at any 
time whilst trace amounts were seen in those of the mutant-transfected 
cells, although this was not always reproducible (Fig. 32) The finding of the 
wild-type protein in the detergent phase of the cells (Fig.29, Lane J) is 
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indic,tive of its being a GPI-anchored protein, whilst, as we would expect, 
little protein is found in the mutant-transfected cells. Most of the mutant 
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protein would be expected to be found in the supernatant, if indeed it has 
no GPI-anchor attached. 	The results of the Northern hybridization 
experiments suggest that the RNA is being degraded. If this happened only 
on some occasions or at a slow rate , then some protein could be translated 
before the RNA was degraded and this could account for the presence of 
immunoreactive protein in some experiments and its very low levels or 
absence in others. 
The pSVK3 vector contains an SV40 small T antigen splice site and SV40 
early polyadenylation site and is designed to be an expression vector , so 
the RNA should be capped and have a poly A tail and would be expected to 
be stable in vitro. The constructs also retain the original six bases 5' to the 
start codon, ATG , as these contain the Kozac consensus sequence for the 
correct initiation of translation (Kozac, 1983), so initiation of protein 
synthesis should proceed efficiently from the correct start codon. 
From experiments using the constructs IAH2 and IAH4a we can see that the 
wild-type (IAH2) is contained mostly in the cells (Fig.31), although very 
small traces of it are found in the supernatant (Fig.32). Some endogenous 
PrP is shed from the surface of N2a cells in tissue culture in a soluble form 
(Caughey et al., 1989; Borchelt et al., 1993), but this is a small proportion 
of the total. The mutant (IAH4a), however, is found predominantly in the 
supernatant (Fig.32), with some protein still found in the cells (Fig.31). 
In the mutant protein from the stably transfected cell line CHOL761 h protein 
found in the cells partitioned into the aqueous phase, whilst the vast 
majority of the protein was found in the supernatant (Fig.34). This implies 
that the mutant protein does not have a GPI-anchor. The pattern of banding 
of this protein implied that it is properly glycosylated and only differs from 
the wild-type by the absence of the GPI (Fig.33) 
These results have outlined the difficulties of working with transient 
expression, when even 	using a strong promoter like that of the 
cytomegalovirus the recombinant protein is not always abundant or easily 
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detectable (IAH2). Even when using a cell line that has frequently been used 
previously the difficulties of achieving efficient transfection are evident. 
The presence of the mutant protein in the cells and supernatant does not 
have an obvious pathogenic effect on the cells, which appear 
morphologically normal. 
From these results it can be concluded that the removal of the hydrophobic 
amino acids from the extreme C-terminus of the PrP protein removes the 
signal for GPI-addition, and these proteins are then subsequently secreted 
into the media of tissue culture cells. 
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CHAPTER SIX: 	Discussion 
Introduction 
This project was designed to investigate whether disruption of the post-
translational addition of a GPI-anchor to PrP could account for the observed 
differences between the normal and disease specific forms of the protein 
and also to investigate whether GPI addition has any significance for the 
normal function of the protein. This was investigated by engineering a 
murine PrP protein in in vitro systems from which the signal sequence for 
GPI-addition has been deleted. A full length protein has been produced in 
the same systems so that direct comparisons between the normal and 
mutated forms can be made. These in vitro studies have allowed detailed 
biochemical study of the mutated protein and have shown that GPI addition 
to PrP follows the same general rules that apply to other glypiated proteins. 
Removal of the C-terminal amino acids leads to the failure of GPI-addition 
and the subsequent secretion of the majority of the protein from the cell. 
The mutated protein appears to be glycosylated in a similar manner to the 
wild type protein, although the molecular weight of these glycosylated forms 
is lower than that observed for PrP extracted from mouse brain. This result 
is analagousother observations with recombinant PrP in cell free systems 
and tissue culture and is thought to result from the inability of these 
systems to add complex glycans (Caughey et al, 1 989) Overexpression of 
the mutated PrP in Monkey Kidney cells (CV1) was not toxic for the cells 
and did not lead to any obvious morpholjcc\ changes. The possible 
significance of these mutations for the disease process will be examined in 
vivo by the production of transgenic (Tg) mice carrying these mutations. 
The replacement of normal PrP gene with the mutated forms is being carried 
out using homologous recombination in embryonic stem cells in this 
laboratory (J.Manson). 
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Conversion of PrPC  to  PrPS0 
Anchorless forms of PrP. 
Scrapie and other related transmissible encephalopathies lead to the 
accumulation in the brain and spleen of a disease specific form of a 
membrane protein, PrP. 	The disease specific form (PrPSI  differs in its 
physic 	chemical properties from the normal form (PrPC)  although no 
covalent changes between the two have yet been discovered (Stahl et 
al., 1990). These differences are believed to be governed by a post-
translational change. Both PrP' and PrPsc have been shown to contain GPI 
anchors (Stahl et al.,1987). During the course of this work it became 
possible to purify larger quantities of the normal PrP protein and 
consequently a more detailed chemical analysis of it has been carried out 
(Stahl et al., 1993). These analyses have up until now been unable to 
detect any differences in the GPI-anchors of PrPC  and PrP. This, however, 
does not preclude the possibility that a small amount of an anchorless form 
of the protein could act as either a seed for amyloidogenesis or a catalyst 
for the conformational conversion of the normal protein to the disease 
specific form (Come et al., 1993) As the ratio of PrPSC  molecules to 
infectivity is 1 : 105 the abberant molecule may escape detection (McKinley 
et al., 1983). Disease specific PrP extracted from hamster brains contains 
a significant fraction (-V 15%) that is truncated at its C-terminus and does not 
contain a GPI-anchor (Stahl et al., 1 990) It is not known if this truncated 
protein has any significance in the formation of PrPSC.  Also, at least three 
cases of CJD have been associated with a mutation in the PrP gene that 
would lead to a protein truncated at its C-terminus (Kitamoto et al., 1993). 
However, it has also been shown recently that a C-terminally truncated form 
of PrP is shed from the surface of primary cultures of uninfected hamster 
brains and also in homogenates of uninfected hamster brains, accounting for 
about 10% of the total PrP (Borchelt et al., 1993). Recombinant hamster 
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PrP overexpressed in CHO cells also gave rise to a shed form of PrP, again 
constituting approximately 10% of the total, indicating that it is not a 
shortage of GPI-precursor that gives rise to the shed form of PrP, but rather 
a cleavage event. Endogenous PIPLC activity has been ruled out as these 
shed forms do not react with anti-CAD antibodies. A truncated form of PrP 
which does not contain a CRD epitope has also been detected in the CSF 
of normal patients (Tagliavini et al., 1992) These results suggest that a 
non-anchored form of PrP may normally be produced in vivo. 
Subcellular location of PrPSC  synthesis 
As the precise molecular nature of the changes between PrPcand PrPSC are 
not known discovering where in the biosynthetic pathway this conversion 
takes place may give clues as to what happens. Evidence from work in 
tissue culture cells has shown that PrP" is synthesised from a protease 
sensitive precursor that is almost certainly PrPC  (Caughey and Raymond, 
1991) PrPsc synthesis does not occur if the cells are treated with Brefeldin 
A, an anti-fungal drug that causes the dissolution of the Golgi stacks 
(Taraboulos 1992). Thus, the endoplasmic reticulum alone is not sufficient 
for synthesis. Also, removal of PrPC  from the cell surface with PIPLC or 
Dipase prevents PrPSC  synthesis (Caughey and Raymond, 1991, Borchelt et 
al., 1992) PrPSC has been found to accumulate in cytoplasmic vesicles 
identified as secondary lysosomes, but treatment with lysosomotropic 
amines does not prevent its synthesis (McKinley et al 1991, Caughey and 
Raymond,1991, Taraboulos et al., 1992). From these lines of evidence it 
has been concluded that transit of the precursor to the cell surface is 
necessary and PrPSC  probably occurs in an endosomal compartment before 
reaching the lyzosome. PrPC  is rapidly degraded in the lysosome, whereas 
PrPSC undergoes only some N-terminal trimming and shows no further 
degradation, thus leading to its fatal accumulation. 
The possibility does exist that the conversion might take place at the surface 
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of the cell, or that PIPLC or other enzymes enter the cell prior to digestion. 
The mechanisms whereby PrPC  or PrPSC  are taken up by the cell are not 
known. PrP has been associated with non-clathrin coated invaginations 
called caveolae, as are other GPI-anchored proteins, and may be internalized 
through these patches. Alternatively, free flow endocytosis may be 
responsible. Recent work with the avian homologue of PrP, chPrP, has 
shown that this protein undergoes multiple rounds of recycling from the cell 
surface to an early endosomal compartment (Shyng et al.,1993) About 5% 
of the protein is cleaved near the N-terminus before it is returned to the cell 
surface and these truncated forms appear to have greater stability at the cell 
surface than the intact molecule and may be endocytosed less efficiently. 
From the above an endosomal location for the PrPC  to  PrPSC  conversion is 
envisaged. 
Non-glycosylated PrP 
Two different methods have been used to produce PrP molecules that are 
not glycosylated in in vitro systems. Firstly, treatment with tunicamycin, a 
drug which prevents Winked glycosylation, and secondly, site dircted 
mutagenesis of the consensus sites for addition of Winked oligosaccharides 
(Taraboulos et al 1990, Caughey et al., 1989, Rogers et al., 1990). One 
group reported that none of the mutant protein was transported to the cell 
surface and another that the unglycosylated protein did reach the cell 
surface, but at a much slower rate than the fully glycosylated protein 
(Rogers et al., 1990, Taraboulos et al., 1990 Caughey et al., 1989) The 
first group found that despite this, in scrapie infected cells, a 1 9kD protease 
resistant form of PrP was produced. This raises the possibility of an 
alternative pathway for the cellular processing of the unglycosylated protein 
(Olden K. et al., 1982). The unglycosylated protein was also converted to 
PrPSC more rapidly than the fully glycosylated protein, leading to the 
speculation that it may be intrinsically less stable than the fully glycosylated 
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one (Taraboulos 1990). 
C-terminally truncated PrP in Scrapie infected N2a cells 
Recently workers in another laboratory have produced C-terminally 
truncated PrP in scrapie infected N2a cells (Rogers et al., 1993) They have 
shown that this truncation (from codon 231) gives rise to a protein in the 
cells that is approx. 2kD smaller than wild-type when both are treated with 
tunicamycin. This protein was not sensitive to degradation with 50% 
hydrofluoric acid (HF), which hydrolyzes phosphodiester bonds and should 
result in the removal of a GPI-anchor, whereas the wild-type exhibited a 
reduction of approximately 2kD. Even in the absence of tunicamycin the 
truncated protein was very poorly glycosylated compared to the wild-type. 
After Proteinase K treatment a small amount of protease resistant PrP was 
seen in these cells, suggesting that the protein without the GPI-anchor is still 
a substrate for conversion to PrP. These proteins have been engineered to 
contain an epitope recognised by anti-hamster PrP antibodies in order to 
recognise them against the endogenous mouse PrP of the cells in which they 
are expressed. This work does not refer to a secreted protein and whether 
such a protein was protease resistant or not. 
Our results with similar mutants in CV1 cells do not give identical results to 
the above experiments. The bulk of the PrP synthesized in these cells is 
secreted ( Fig.s 32,33,34,35) and appears as a broad band or doublet of 
approx.31 -33kD. Exact sizing in this system has proved difficult as the PrP 
poyclonal antibody 1A8 used in these immunoblots tends to stain the 
markers also. The molecular weight of the observed proteins and the fact 
that they are secreted suggests that these proteins follow the normal 
biosynthetic pathway for PrPC  and are glycosylated during their transit to 
the cell surface (Caughey et al., 1989). The protein found in the 
supernatant of the stably transfected cell line CHOL761h lends particular 
support to this theory as the pattern of bands observed resembles that seen 
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for the wild-type as seen in cell free systems (Fig.14, Lanes A and C). This 
result needs to be confirmed by the treatment of these proteins with a 
deglycosylase, such as PNGase F and will be carried out on mutant protein 
isolated from transgenic mice. TX114 was carried out on these proteins 
(Fig.34) but the protein in the supernatant was not completely extracted 
into the aqueous phase as would be expected for a non-anchored protein, 
but this may prove to be simply a technical question of repeating the 
extraction more than once, as the quantity of protein in the supernatant 
fraction is large. Immunoreactive PrP was also found in the cells of both 
cells transiently transfected with the truncated protein (Fig.31 ,Lane A) and 
also in the stably transfected cells (Fig.34). In the transiently transfected 
cells this protein exactly resembles that seen in whole cell extracts from 
cells transfected with the wild-type construct (Fig.31). In the stable cell 
line CHOL761 h, the PrP in the cell is found exclusively in the aqueous phase 
on TX1 14 extraction, suggesting that it indeed does not contain a GPI-
anchor. 
From the above results it can be concluded that in this system most of the 
mutated PrP follows the normal pathway of intracellular trafficking and is 
transported to the cell surface where it is not anchored due to its lack of a 
GPI anchor. Some PrP, which also does not contain a GPI anchor, is seen 
to remain in the cell. Whether this protein is glycosylated or not is not 
certain. This may represent protein that has not yet been secreted or 
indeed, may represent a minor alternative pathway of intracellular 
trafficking. If this is a minor pathway and the bulk of the mutant protein is 
secreted this may explain why Rogers et al. were only able to see very small 
amounts of PrP.with their mutants in scrapie infected cells. Thus PrPSC 
can still be produced from an anchorless precursor, but such a mutant may 
be very inefficient at its production. This may be additional support for the 
idea that most PrP is produced from PrP' after it has been endocytosed 
(Caughey et al.1991a,1991b, Borchelt 1990) from the cell surface. 
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These results also imply that for the majority of PrP the absence of the GPI 
anchor does not effect its intracellular targetting. GPI anchors have been 
established as markers for apical targetting in certain epithelial cell lines 
(Lisanti et al, 1991), but their role in targetting in neural cells may be much 
more complex (Dotti et al1991,   Faivre-Sarrailh 1993). The possibility exists 
that sub-populations of PrP exist that behave in diffrerent ways and it is 
one of these that gives rise to an alternative pathway of intracellular 
trafficking. The possibility that these possible sub-populations may be 
defined by differences in their GPI anchors is illustrated , for instance, by the 
existence of heterogeneity of release of GPI anchored proteins from 
different cell lines with PIPLC derived from either Bacillus thuringiensis or 
S.aureus (Low et al 1988). PrP GPI has been shown to have at least six 
different gylcoforms (Stahl 1992) , the significance of which is not yet 
known. 
PrP topography in cell-free systems 
Cell-free translation of recombinant PrP in two different systems has given 
rise to two different topographies for the protein (Hay et al., 1987a, 1 987b). 
When the wheat germ extract (WG) system was used a predominantly 
transmembrane form was produced (Hay et al ., 1987b), whilst the RRL 
system gave rise to a fully translocated protein (Hay et al., 1987a). These 
studies gave rise to the discovery of a stop transfer effector sequence in PrP 
and interaction with a cytosolic factor was implicated in effecting these 
differences (Lopez et al., 1990). Membrane interactions may have some 
significance for PrP and scrapie as infectivity has long been associated with 
membrane fractions. 
In the cell free work undertaken here with the RRL system and C-terminally 
truncated PrP an extra band of -28kD was identified (Fig.s 14 and 15) in 
both the mutants pSVPr241 and pSVPr228, but not in the wild-type 
pSVPr251. This does not appear to be a glycosylation intermediate as it is 
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unaffected by treatment with the deglycosylase PNGase F, whereas the 
larger 33kD band is completely degraded by this enzyme (Fig.22). Neither 
does it appear to be an integral membrane form of the protein, as it is fully 
protected from proteinase K digestion in the absence of detergent (Fig.1 1-
20), implying that it is a fully translocated form. This band does not appear 
to be present in the truncation mutant IAH4a when expressed in CV1 cells 
(Fig.31), nor is it present in PrP extracted from the stable cell line 
CHOL761h (Fig.33 and 34). The pSV series of mutants did not produce 
enough protein in tissue culture to ascertain whether or not this band was 
present. Therefore it is not possible to state whether it is produced as a 
product of cell free translation or as a product of these particular 
constructs. 
Conformational changes in PrP-the "protein only" hypothesis 
Theories have arisen to explain the replication of the infectious agent in the 
absence of a nucleic acid which suggest that an incoming molecule of PrPSC 
is able to interact with existing PiPC  and change its conformation such that 
it acquires the properties of PrPSC  (Prusiner,S., 1992,McKinley et al., 
1991,Pan et al., 1993). Proteins that form amyloid have been shown to 
contain a high proportion of fl-sheet conformation as opposed to a-helix 
(Kisilevsky 1987). Recent work with synthetic peptides corresponding to 
parts of the PrP protein has shown that some peptides predicted to have a-
helix conformation actually adopt a fl-sheet conformation in vitro (Gasset et 
al., 1992). As shown by electron microscopy and Congo Red staining these 
peptides spontaneously form amyloid and this leads to the suggestion that 
the conversion of PrPC  to PrPSC involves the changing of PrP a-helices to fl-
sheets (Pan et al., 1993). 
The existence of scrapie strains are accounted forthis model by the 
proposal that the incoming PrPSC  molecule converts existing PrPC 	into an 
exact replica of itself and that these molecules differ from each other in 
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some way other than primary sequence, for instance differential 
glycosylation (Endo et al., 1989, Prusiner,S., 1993) . Such variations might 
govern the interactions of the incoming PrPSC  with only subsets of existing 
PrP' molecules, thus explaining the influence of primary PrP sequence on 
incubation periods (Westaway et at., 1987) or target it to specific sets of 
neurons, thus explaining the diverse and reproducible patterns of pathology 
observed with different strains of scrapie (Bruce et at 1991). 
It has been found that the expression of certain GPI anchored proteins is 
regulated between different types of neuron (Rosen et al 1992) . These 
workers found variations in the relative abundance and degree of 
glycosylation of GPI-anchored proteins including Thy-1, F3/F1 1 and the 
120kD form of N-CAM on superior cervical ganglion neurons, dorsal root 
ganglion neurons and granule cell neurons. Whether GPI-anchored proteins 
are axonalty or dendritically targetted also seems to be subject to regulation 
(Faivre-Sarriliah et at., 1992) Thus the possibility exists that differential 
expression or glycosylation of PrP on neuronal cell surfaces may give rise to 
subsets of cells that are more susceptible to infection, or to infection with 
a particular strain of scrapie. The finding that PrP from different sources has 
different solubilities with respect to extraction with the detergent TX1 14 is 
also interesting in this respect (see "Float" experiments Chp.5). In this case 
I was unable to detect any PrP in the insoluble pellet formed when CV1 cells 
were extracted with TX1 14, but in this laboratory other workers routinely 
find that up to 50% of the PrP from infected and uninfected mouse brain is 
found in this fraction (J.Hope, pers.commun.). This again suggests the 
existence of different forms of PrP in different cell types that may exhibit 
very different behaviours. 
It is also possible that the infectious agent replicates by interfering with the 
folding process of normal PrP and interacts with the foldases and 
chaperones that control the correct configuration of the molecule, rather 
than having a direct interaction with PrP itself (Wills,P., 1992). Forms of 
149 
these diseases exist in humans (Will,R., 1993, Tateishsi 1993, Gambetti 
1993) and thirteen different mutations in the PrP gene have been found to 
segregate with human TE type diseases (CJD, GSS, FF1) . It is thought that 
at least some of these act by lowering the activation energy required to 
convert PrPC  to PrPSC (Weissmann 1993). Association of PrPC  with  PrPSC  is 
seen to lower this necessary activation energy even further, whilst the 
spontaneous conversion of PrPC  to  PrPSC  -a very rare event- has the highest 
activation energy of all (Gadjusek 1988). The occurrance of spontaneous 
neuorodegenerative disease in Tg mice bearing the codon 101 (equivalent 
to the human codon 102 leucine-proline substitution associated with GSS) 
has been put forward as evidence supporting the supposition that the 
abnormal PrP protein alone is sufficient to cause the disease (Hsiao et al., 
1989). 
Inhibitors of PrPSC  formation 
A number of different substances have been shown to inhibit the production 
of PrPSC  both in cells and in vivo and also to prolong incubation periods in 
mice and hamsters (Caughey and Race, 1992, Caughey et at., 1993, 
Caughey and Raymond, 1993, Ladogana et al., 1992,Xi et al., 1992, 
Diringer et at. 1991, Farquhar , 1986). These prominently include the 
sulphate polyanions and the dye Congo Red, which has long been used to 
stain amyloid. The mechanism of inhibition is not fully understood but seems 
to work by preventing the formation of PrPSC,  having no effect on preexisting 
PrPS. A comparison of the inhibitory activities on PrPsc formation of these 
compounds in tissue culture correlated well with their prophylactic qualities 
in vivo (Caughey 1993), suggesting that it is indeed this abilty to prevent 
PrPSC formation that gives them their anti-scrapie qualities. It is proposed 
that these substances are analogues of cellular sulfated glycosaminoglycans 
(GAGs) which may be involved in the formation of amyloid deposits and act 
by preventing PrP-GAG interactions (Caughey 1993). 
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The mechanism of action of Amphotericin B, which was shown to delay the 
accumulation of PrPsc without altering scrapie replication (Xi et al., 1992) is 
likely to have a different mechanism of action as it is not polyanionic in 
nature. 
Application of such inhibitors to prevent amyloidogenesis and thus reduce 
clinical symptoms is being further investigated. 
Normal function of PrP 
The normal function of PrP is unknown, but the high level of conservation 
at both RNA and protein levels amongst mammalian species argues that it 
may be an important one. 
The cell surface location and GPI anchor of PrP suggest a number of possible 
functions. It may act as a receptor and could be involved in receptor-
mediated internalization of ligands. The finding that the avian homologue 
of PrP, chPrP,is constitutively recycled from the cell surface to an early 
endosomal compartment would support such a role (Shyng et al 1993). 
PrP's association with caveolae, along with other GPI anchored proteins 
might suggest a ligand internalizing role. 
Due to its homology with chPrP, which was first isolated as a factor 
inducing acetlycholine receptors in chicken motorneurons, a similar role was 
proposed for mammalian PrP (Harris et al., 1992). However, this proposal 
has been negated by the fact that the regulation of cholinergic receptor 
expression in Tg mice, in which the PrP gene has been ablated (null mice, 
PrP°'°) and no PrP protein is produced, is completely normal (Brenner et al., 
1992) 
Its cell surface location, GPI anchor and embryonic expression (Manson et 
al., 1992) also suggest a possible function as a cell-cell adhesion factor, 
similar to N-CAM and the cadhedrins. The transmembrane and GPI-
anchored forms of N-CAM are generated by differential splicing of mRNA 
and it is not known how they differ in function. Such molecules are involved 
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in the development of the cellular architecture of the CNS. 
PrP mRNA is expressed in many different cell and tissues. In situ 
hybridization (Manson et al 1992, Brown et al, 1990) and oligonucleotide 
primer extension and Si mapping (Westaway et al 1987) have been used 
to show mRNA expression in neurons in the CNS, in the lungs, where it is 
associated with the alveolar lining and septal interstital cells, muscle cells in 
heart, and to a lesser extent in the spleen, liver and kidney (Brown et al, 
1990). It is possible that in these different cell and tissue types PrP adopts 
different functions. It has been suggested that PrP on the surface of 
normal human lymphocytes may act as an activation-released soluble signal 
for the activation of other subsets of lymphoid cells (Cashman et al., 1990). 
The presence of a GPI-anchor could facilitate such a release, although 
soluble forms of PrP found to date are not released by endogenous PIPLCs 
(Borchelt et al., 1993) 
Experiments with PrP°'°  mice 
Results with Tg null mice show that no phenotype is observed and the mice 
appear physically and behaviourially normal and are fully fertile (Bueler et 
al., 1992). This suggests that either the function of PrP is a non-essential 
one or else that this function can be taken over by another protein in the null 
mice. A third possibility is that PrP only becomes important under certain 
circumstances, for instance stress, and therefore this function has not yet 
been observed in the null mice. 
Null mice (PrP°'°) have been shown to be resistant to infection with scrapie 
when inoculated with infected mouse brain intracerebrally, where normal Tg 
littermates were susceptible to the disease within the expected incubation 
period (Bueler et al., 1993). 
Hetreozygotes (PrP° ) were shown to have incubation times much longer 
than would be expected for the model used. The introduction of Tg hamster 
genes into these mice rendered them susceptible to infected hamster 
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inoculum but not to mouse infected inoculum. These results implicate that 
the scrapie agent cannot replicate in the absence of the PrP gene product 
and that, as shown by the results with the heterozygotes, that the rate at 
which the disease progresses is proportional to the amount of PrPC  that is 
present. This conclusion is supported by the finding with conventional 
transgenic animals that with higher numbers of copies of the PrP transgene 
shorter incubation periods result (Prusiner 1990). The fact that the null mice 
do not contract scrapie and appear perfectly normal in the absence of the 
PrP protein implies that it is the accumulation of the abnormal protein rather 
than the disruption of the normal function of PrP that is the cause of 
pathogenicity. 
Anchor-less PrP and its function 
Expression of constructs coding for a truncated PrP protein in CV1 cells led 
to most of the protein being secreted from the cell instead of being attached 
to the cell membrane. This alteration ought to severely affect the normal 
function of the protein. However, no pathological effects were seen in tissue 
culture. This is consistent with the results described above with mice who 
produce no PrP protein which appear functionally normal. Experiments with 
Tg mice expressing these truncation mutations are underway. These mice 
will presumably secrete their PrP from the cell surface . These experiments 
should tell us if the secreted protein aggregates in the uninfected brain, and 
whether these aggregates, should they arise , cause disease . The fate of 
normally GPI-membrane anchored proteins in patients suffering from 
paroxysmal nocturnal hemoglobinuria (PNH), in which a specific defecta 
gene coding for a GPI-biosynthetic precursor has been implicated (Takeda 
et al 1993), has not been examined in detail. Increased serum levels of a 
soluble form of PrP may render the individual more susceptible to the risk 
of developing a transmissible degenerative encephalopathy. The production 
of Tg animals carrying mutations in their PrP gene should answer many of 
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the remaining questions regarding the molecular mechanisms involved in the 
conversion of p1pC  to PrP. 
154 
References 
Alper, T. (1985). Scrapie agent unlike viruses in size and susceptibility to 
inactivation by ionizing or ultraviolet-radiation. Nature 317, 750. 
Amthauer, R., Kodukula, K., and Udenfriend, S. (1992). Placental alkaline-
phosphatase - a model for studying cooh-terminal processing of 
phosphatidylinositol-glycan-anchored membrane-proteins. ClinicalChemistry 
38, 2510-2516. 
Amthauer, R., Kodukula, K., Gerber, L., and Udenfriend, S. (1993). Evidence 
that the putative COOH-terminal signal transamidase involved in 
glycosylphosphatidylinositol protein is present in the endoplasmic reticulum. 
Proceedings of the National Academy of Sciences of the United States of 
America 90, 3973-3977. 
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., and Lacey, S. W. 
(1992). Potocytosis:Sequestration and transport of small molecules by 
caveolae. Science 255, 410-411. 
Anderson, R.G.W., (1 992a). Potocytosis. Biochemical Society Transactions, 
Glasgow Meeting, June 1992. 
Bailey, J., Howard, A. D., Brink, L., and Udenfriend, S. (1989). Processing 
at the carboxyl-terminus of nascent placental alkaline phosphatase in a cell 
free system. Proceedings of the National Academy of Sciences of the United 
States of America 86, 22-26. 
Bangs, J. D., Hereld, D., Krakow, J. L., Hart, G. W., and Englund, P. T. 
(1985). Rapid processing of the carboxyl terminus of a trypanosome variant 
surface gylcoprotein. Proceedings of the National Academy of Sciences of 
the United States of America 82, 3201-3211. 
Basler, K., Oesch, B., Scott, M., Westaway, D., Walchli, M., Groth, D. F., 
McKinley, M. P., Prusiner, S. B., and Weissmann, C. (1986). Scrapie and 
cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 
417-428. 
Bebbington, C. R. (1991). Expression of antibody genes in nonlymphoid 
mammalian cells. Methods 2, 136-145. 
Berger, J., Howard, A. D., Brink, L., Gerber, L., Hauber, J., Cullen, B. R., 
and Udenfriend, S. (1988). COOH-terminal requirements for the correct 
processing of a phosphatidylinositol-glycanaflChOred membrane protein. 
155 
Journal of Biological Chemistry 263, 10016-10021. 
Birnholm, H., and Dolby, A. (1979). A rapid alkaline extraction procedure for 
screening recombinant plasmid DNA. Nucleic Acids Research 7, 1513. 
Borchelt, D. R., Scott, M., Taraboulos, A., Stahl, N., and Prusiner, S. B. 
(1990). Scrapie and cellular prion proteins differ in their kinetics of synthesis 
and topology in cultured-cells. Journal of Cell Biology 110, 743-752. 
Borchelt, D. R., Taraboulos, A., and Prusiner, S. B. (1992). Evidence for 
synthesis of scrapie prion proteins in the endocytic pathway. Journal of 
Biological Chemistry 267, 16188-16199. 
Borchelt, D. R., Rogers, M., Stahl, N., Telling, G., and Prusiner, S. B. 
(1993). Release of the cellular prion protein from cultured-cells after loss of 
its glycoinositol phospholipid anchor. Glycobiology 3, 319-329. 
Bordier, C. (1981). Phase separation of integral membrane proteins in Triton 
X-114. Journal of Biological Chemistry 256, 1604-1607. 
Brenner, H. R., Herczeg, A., and Oesch, B. (1992). Normal development of 
nerve muscle synapses in mice lacking the prion protein gene. Proceedings 
of the Royal Society of London Series B-Biological Sciences 250, 151-155. 
Brodsky, F. M. (1988). Living with clathrin-its role in intracellular traffic. 
Science 242, 1396-1402. 
Brown, D. (1993). The tyrosine kinase connection - how GPI-anchored 
proteins activate t-cells. Current Opinion in Immunology 5, 349-354. 
Brown, D. A., and Rose, J. K. (1992). Sorting of GPI-anchored proteins to 
glycol ipid-enriched membrane subdomains during transport to the apical cell-
surface. Cell 68, 533-544. 
Brown, D., Crise, B., and Rose, J. (1989). Mechanism of membrane 
anchoring affects polarized expression of 2 proteins in MDCK cells . Science 
245, 1499-1501. 
Brown, M. S., Anderson, R. G. W., and Goldstein, J. L. (1983). Recycling 
receptors-the round trip itinery of migrant membrane proteins. Cell 32, 663-
667. 
Bruce, M. E., McConnell, I., Fraser, H., and Dickinson, A. G. (1991). The 
disease characteristics of different strains of scrapie in sinc congenic mouse 
lines - implications for the nature of the agent and host control of 
156 
pathogenesis. Journal of General Virology 72, 595-603. 
Bueler,H. ,Ag uzzi,A. , Sailer,. A.,G reiner,R.A. . , Auten red, P., Aguet,M. ,and 
Weissmann,C, (1993). Me devoid of PrP are resistant to scrapie. Cell 73, 
1339-1347. 
Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., Dearmond, S. 
J., Prusiner, S. B., Aguet, M., and Weissmann, C. (1992). Normal 
development and behavior of mice lacking the neuronal cell-surface prp 
protein. Nature 356, 577-582. 
Caras, I., and Weddell, G. N. (1989). Signal peptide for protein secretion 
directing glycophospholipid membrane anchor attachment. Science 243, 
1196-1198. 
Cashman, N. R., Loertscher, R., Nalbantoglu, J., Shaw, I., Kascsak, R. J., 
Bolton, D. C., and Bendheim, P. E. (1990). Cellular isoform of the scrapie 
agent protein participates in lymphocyte-activation. Cell 61, 185-192. 
Caughey, B., Ernst, D., and Race, R. E. (1993a). Congo red inhibition of 
scrapie agent replication. Journal of Virology 67, 6270-6272. 
Caughey, B., and Raymond, G. J. (1993b). Sulfated polyanion inhibition of 
scrapie-associated prp accumulation in cultured-cells. Journal of Virology 67, 
643-650. 
Caughey, B., and Race, R. E. (1992). Potent inhibition of scrapie-associated 
prp accumulation by congo red. Journal of Neurochemistry 59, 768-771. 
Caughey, B., Raymond, G.W., Ernst, D. 	and Race,R. (1991). N-terminal 
truncation of the scrapie-associated form of PrP by lysosomal proteases-
implications regarding the site of conversion of PrP to the protease resistant 
state. Journal of Virology 65(12), 6597-6603. 
Caughey, B., Race, R. E., Vogel, M., Buchmeier, M. J., and Chesebro, B. 
(1988). Invitro expression in eukaryotic cells of a prion protein gene cloned 
from scrapie-infected mouse-brain. Proceedings of the National Academy of 
Sciences of the United States of America 85, 4657-4661. 
Caughey, B., Raymond, G. J., Ernst, D., and Race, R. E. (1991). N-terminal 
truncation of the scrapie-associated form of prp by lysosomal protease(s) - 
implications regarding the site of conversion of PrP to the protease-resistant 
state. Journal of Virology 65, 6597-6603. 
157 
Caughey, B., and Raymond, G. J. (1991). The scrapie-associated form of 
PrP is made from a cell-surface precursor that is both protease-sensitive and 
phospholipase-sensitive. Journalof Biological Chemistry 266,118217-18223. 
Caughey, B., Race, R. E., Ernst, D., Buchmeier, M. J., and Chesebro, B. 
(11989). Prion protein-biosynthesis in scrapie-infected and uninfected neuro-
blastoma cells. Journal of Virology 63, 175-181. 
Chesebro, B., Race, R., Wehrly, K., Nishio, J., Bloom, M., Lechner, D., 
Bergstrom, S., Robbins, K., Mayer, L., Keith, J. M., Garon, C., and Haase, 
A. (1985). Identification of scrapie prion protein-specific messenger-RNA in 
scrapie-infected and uninfected brain. Nature 315, 331-333. 
Chu, G., Hayakawa, H., and Berg, P. (1987). Electroporation for the efficient 
transfection of mammalian cells with DNA. Nucleic Acids Research 15, 
1311-1326. 
Cohen, S., Chang, A., and Hau, L. (1972). Nonchromasosmal antibiotic 
resistance in bacteria: Genetic transformation of E.coli by R-factor DNA.. 
Proceedings of the National Academy of Sciences of the United States of 
America 69, 2110. 
Collinge, J., Palmer, M. S., and Dryden, A. J. (1991). Genetic predisposition 
to iatrogenic creutzfeldt-jakob disease. Lancet 337, 1441-1442. 
Come, J. H., Fraser, P. E., and Lansbury, P. T. (1993). A kinetic-model for 
amyloid formation in the prion diseases - importance of seeding. Proceedings 
of the National Academy of Sciences of the United States of America 90, 
5959-5963. 
Cross, G. A. (1990). Glycolipid anchoring of plasma membrane proteins. 
Annual Review of Cell Biology 1, 2-39. 
Diringer, H., Blode, H., and Oberdieck, U. (1991). Virus-induced amyloidosis 
in scrapie involves a change in covalent linkages in the preamyloid. Archives 
of Virology 118, 127-131. 
Doering, T. L., Masterson, W. J., Englund, P. T., and Hart, G. W. (1989). 
Biosynthesis of the glycosyl phosphatidylinositol membrane anchor of the 
trypanosome variant surface glycoprotein - origin of the non-acetylated 
glucosamine. Journal of Biological Chemistry 264, 11168-11173. 
Doering, T. L., Masterson, W. J., Hart, G. W., and Englund, P. T. (1990). 
Biosynthesis of glycosyl phosphatidylinositol membrane anchors. Journal of 
158 
Biological Chemistry 265, 611-614. 
Doncheva,J., Georgiev,O.,Milchev,G., and Tsoneva,I. (1991). Stable transfer 
of plasmid pSV3 neo inCVl cells by electroporation. Bioelectrochemistry and 
Bioenergetics 26, 339-343. 
Dotti, T., Parton, R., and Simons, K. (1991). Polarized sorting of glypiated 
proteins in hippocampal neurons. Nature 349, 158-161. 
Dretzen, G., Bellard, M., Sassone-Corsi, P., and Chambon, P. (1981) . Anal. 
Biochem. 112, 295. 
Dupree, P., Parton, R. G., Raposo, G., Kurzchalia, H., and Simons, K. 
(1993). Caveolae and sorting in the trans-Golgi network of epithelial cells. 
EM(SC)Journal 12, 1597-1605. 
Eardley, D. D., and Koshland, M. (1991). Glycosylphosphatidylinositol- a 
candidate system for interleukin-2 signal transduction. Science 251, 78-80. 
Elleman, C. J. (1984). Attempts to establish the scrapie agent in cell-lines. 
Veterinary Research Communications 8, 309-316. 
Endo, T., Groth, D., Prusiner, S. B., and Kobata, A. (1989). Diversity of 
otigosaccharide structures linked to asparagines of the scrapie prion protein. 
Biochemistry 28, 8380-8388. 
Englund, P. T. (1993). The structure and biosynthesis of 
glycosylphosphatidylinositol protein anchors. Annu. Rev. Biochem. 62, 1 21-
138. 
Faivre-Sarrailh, C., and Rougon, G. (1993). Are the glypiated adhesion 
molecules preferentially targeted to the axonal compartment. Molecular 
Neurobiology 7, 49-60. 
Farquhar, C. F., and Dickinson, A. G. (1986). Prolongation of scrapie 
incubation period by an injection of dextran sulfate 500 within the month 
before or after infection. Journal of General Virology 67, 463-473. 
Farquhar, C. F., Somerville, R. A., and Ritchie, L. A. (1989). Post-mortem 
immunodiagnosis of scrapie and bovine spongiform encephalopathy. Journal 
of Virological Methods 24, 215-221. 
Fasel, N., Rousseaux, M., Schaerer, E., Medof, M. E., Tykocinski, M. L., and 
Bron, C. (1989). In vitro attachment of glycosly-phosphatidylinositol anchor 
structures to mouse Thy-1 antigen and human decay accelerating factor. 
159 
Proceedings of the National Academy of Sciences of the United States of 
America 86, 6858-6862. 
Feigner, P., Gadek, T., Holm, M., Roman, P., Chan, H., Wenz, M., Northorp, 
J., Ringoid, G., and Danielsen, M. (1987). Lipofection: a highly efficient,lipid 
mediated DNA-transfection procedure. Proceedings of the National Academy 
of Sciences of the United States of America 84, 7412-7417. 
Ferguson, M. (1992). Site of palmitoylation of a phospholipase C-resistant 
glycosyl-phosphatidylinositol membrane anchor. Biochemical Journal 284, 
297-300. 
Ferguson, M., and Williams, A. F. (1988). Cell surface anchoring of proteins 
via glycosyl-phosphatidylinositol structures. Annu. Rev. Biochem. 57, 285-
320. 
Ferguson, M. A. J., Duszenko, M., Lamont, M. Variant surface 
glycoproteins N-glycosylation and addition of a phosphatidylinositol 
membrane anchor. Journal of Biological Chemistry 261, 356-362. 
Fukuoka, S. I., Freedman, S. D., Heron, Y., and Sukhatme, V. (1992). GP-
2/THP gene family encodes self-binding glycosylphosphatidylinositol-
anchored proteins in apical secretory compartments of pancreas and kidney. 
Proceedings of the National Academy of Sciences of the United States of 
America 89, 1189-1193. 
Gambetti,P., Petersen, R., Monari,L. ,Tabaton, M. 	and Autilio-Gambetti,L. 
(1993). Fatal familail insomnia and the widening spectrum of prion diseases. 
British Medical Bulletin 49(4), 980-994. 
Gajdusek,C. (1988). Journal of Neuroimmunology 120, 95-100. 
Garcia,M., Mirre,C.,Quaroni,A., Reggio, H. and Lebivic,a. (1993). GPI-
anchored proteins associate to form microdomains during their intracellular 
transport in caco-2 cells. Journal of Cell Science 104, 1281-1290. 
Gasset, M., Baldwin, M. A., Lloyd, D. H., Gabriel, J. M., Holtzman, D. M., 
Cohen, F., Fletterick, R., and Prusiner, S. B. (1992). Predicted alpha-helical 
regions of the prion protein when synthesized as peptides form amyloid. 
Proceedings of the National Academy of Sciences of the United States of 
America 89, 10940-10944. 
Goldfarb, L. G., Brown, P., Haltia, M., Cathala, F., McCombie, W. R., 
Kovanen, J., Cervenakova, L., Goldin, L., Nieto, A., Godec, M. S., Asher, 
D. M., and Gajdusek, D. C. (1992a). Creutzfeldt-jakob disease cosegregates 
160 
with the codon-1 78 Asn PrnP mutation in families of european origin. Annals 
of Neurology 31, 274-281. 
Goldfarb, L. G., Brown, P., Vrbovska, A., Baron, H., McCombie, W. R., 
Cathala, F., Gibbs, C. J., and Gajdusek, D. C. (1992b). An insert mutation 
in the chromosome 20 amyloid precursor gene in a Gerstmann-Straussler-
Scheinker family. Journal of the Neurological Sciences 111, 189-194. 
Goldmann, W., Hunter, N., Foster, J. D., Salbaum, J. M., Beyreuther, K., 
and Hope, J. (1990). 2 alleles of a neural protein gene linked to scrapie in 
sheep. Proceedings of the National Academy of Sciences of the United 
States of America 87, 2476-2480. 
Greenfield, S. (1984). Acetylcholinesterase may have novel functions in the 
brain. Trends in Neurosciences 7, 364-368. 
Hammelburger, J. W., Palfree, R. G. E., Sirling, S., and Hammerling, U. 
(1987). Demonstration of phosphatidylinositol anchors on LY-6 molecules 
by specific phospholipase-C digestion and gel electrophoresis in 
octyiglucoside. Biochemical and Biophysical Research Communications 148, 
1304-1311. 
Hannan, L. A., Lisanti, M. P., Rodriguezboulan, E., and Edidin, M. (1993). 
Correctly sorted molecules of a GPI-anchored protein are clustered and 
immobile when they arrive at the apical surface of mdck cells. Journal of 
Cell Biology 120, 353-358. 
Harris, D. A., Falls, D. L., Johnson, F. A., and Fischbach, G. D. (1991). A 
prion-like protein from chicken brain copurifies with an acetylcholine 
receptor-inducing activity. Proceedings of the National Academy of Sciences 
of the United States of America 88, 7664-7668. 
Hay, B., Barry, R. A., Lieberburg, I., Prusiner, S. B., and Lingappa, V. R. 
(1987a). Biogenesis and transmembrane orientation of the cellular isoform 
of the scrapie prion protein. Molecular and Cellular Biology 7, 914-920. 
Hay, B., Prusiner, S. B., and Lingappa, V. R. (1987b). Evidence for a 
secretory form of the cellular prion protein. Biochemistry 26, 8110-8115. 
Higuchi, R., Krummel, B., and Saiki, R. (1988). A general method of in vitro 
preparation and specific mutagenesis of DNA fragments: study of protein 
and DNA interaction. Nucleic Acids Research 16, 7351-7367. 
Ho, S., Hunt, H., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989). Site-
directed mutagenesis by overlap extension using the polymerase chain 
161 
reaction. gene 77, 51-59. 
Hooper, N., and Bashir, A. (1991). Glycosyl-phosphatidylinositol-anchored 
membrane proteins can be distinguished from transmembrane polypeptide-
anchored proteins by differential solubilization and temperature-induced 
phase separation in Triton X-1 14. Biochemical Journal 280, 745-751. 
Hooper, N. M., and Turner, A. J. (1988). Ecto enzymes of the kidney 
microvillar membrane-differential solubilization by detergents an predict a 
glycosyl-phosphatidylinositol membrane anchor. Biochemical Journal 250, 
8865-8869. 
Hope, J., and Manson, J. (1991). The scrapie fibril protein and its cellular 
isoform. Curr.Top. Micro. Immun. 172, 57-74. 
Hope, J., Morton, L. J. D., Farquhar, C. F., Multhaup, G., Beyreuther, K., 
and Kimberlin, R. H. (1986). The major polypeptide of scrapie-associated 
fibrils (SAF) has the same size, charge-distribution and n-terminal protein-
sequence as predicted for the normal brain protein (PrP). Embo Journal 5, 
2591-2597. 
Horton, R. M., Hunt, H. D., Ho, S., Pullen, J., and Pease, L. R. (1989). 
Engineering hybrid genes without the use of restriction enzymes:gene 
splicing by overlap extension. gene 77, 61-68. 
Howarth, A., Gardner, R., Messing, J., and Sheperd, R. (1981). . Virology 
112, 678. 
Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. 
D., Westaway, D., Ott, J., and Prusiner, S. B. (1989). Linkage of a prion 
protein missense variant to Gerstmann-Straussler Syndrome. Nature 338, 
342-345. 
Hunter, N., Hope, J., McConnell, I., and Dickinson, A. G. (1987). Linkage 
of the scrapie-associated fibril protein (prp) gene and sinc using congenic 
mice and restriction fragment length polymorphism analysis. Journal of 
General Virology 68, 2711-2716. 
Hutchinson, C. A., Phillips, S., Edgell, M., Gillam, S., Janke, P., and Smith, 
M. (1978). Mutagenesis at a specific position in a DNA sequence. Journal 
of Biological Chemistry 253, 6551-6560. 
Ishihara, A., Hou, V., and Jacobson, K. (1987). The Thy-1 antigen exhibits 
rapid lateral diffusion in the plasma membrane of rodent lymphoid cells and 
fibroblasts. Proceedings of the National Academy of Sciences of the United 
162 
States of America 84, 1290-1293. 
Keller, G. A., Siegal, M. W., and Caras, I. (1992). Endocytosis of 
glycophospholipid-anchored and transmembrane forms of CD4 by different 
endocytic pathways. Embo Journal 11, 863-874. 
Kisilevsky,R. (1987). From arthritis to Altzheimer's disease-current concepts 
on the pathogenesis of amyloidosis. Canadian Journal of Physiology and 
Pharmocology 65, 1805-1815. 
Kitamoto, T., Ohta, M., Dohura, K., Hitoshi, S., Terao, Y., and Tateishi, J. 
(1993). Novel missense variants of prion protein in Creutzfeldt-Jakob 
disease or Gerstmann-Straussler Syndrome. Biochemical and Biophysical 
Research Communications 191, 709-714. 
Klip, A., Ramlal, T., Douen, A. G., Burdett, E., Young, D., Cartee, G. D., and 
Holloszy, J. 0. (1988). Insulin induced decrease in 5'-nucleotidase activity 
in skeletal muscle membranes. FEBS Letts 238, 419-423. 
Kodukula, K., Micanovic, R., Gerber, L., Tamburrini, M., Brink, L., and 
Udenfriend, S. (1991a). Biosynthesis of phosphatidylinositol glycan-
anchored membrane-proteins - design of a simple protein substrate to 
characterize the enzyme that cleaves the COOH-terminal signal peptide. 
Journal of Biological Chemistry 266, 4464-4470. 
Kodukula, K., Micanovic, R., Gerber, L., Tamburrini, M., Brink, L., and 
Undenfriend, S. (1991b). Biosynthesis of phosphatidylinositol glycan-
anchored membrane proteins. Journal of Biological Chemistry 266, 4464-
4470. 
Kodukula,K., Cines,D.,Amthauer,R., Gerber, L. and Udenfriend,S. (1992). 
Biosynthesis of PI-G anchored membrane proteins in cell-free systems. 
Proc.Nat.Acad.Sci.USA 89, 1350-1353. 
Kodukula, K., Gerber, L. D., Amthauer, R., Brink, L., and Udenfriend, S. 
(1993). Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored 
membrane-proteins in intact-cells - specific amino-acid-requirements adjacent 
to the site of cleavage and gpi attachment. Journal of Cell Biology 120, 
657-664. 
Kozac, M. (1983). Comparison of initiation of protein synthesis in 
prokaryotes, eukaryotes and organelles. Microbiological reviews 47, 1-45. 
Kreig, P. A., and Melton, D. A. (1987). In vitro RNA synthesis with SP6 
RNA polymerase. Methods 155, chp25. 
163 
Ladoga na,A.Casaccia,P.,Ingrosso,L.,Cibati,M., Salvatore, M.,Xi,YG.,MasuIl 
o,C. and Pocchiari M. (1992). Sulphate polyanions prolong the incubation 
period of scrapie-infected hamsters. Journal of General Virology 73, 661-
665. 
Laemmli, U. (1970). Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4 . Nature 227, 680. 
Lingappa, V. R. (1991a). Control of protein topology at the endoplasmic - 
reticulum. Cell Biophysics 19, 1-15. 
Lingappa, V. R. (1991b). More than just a channel - provocative new 
features of protein traffic across the ER membrane. Cell 65, 527-530. 
Lisanti, M. P., Caras, I., Davitz, M., and Rodriguez-Boulan, E. (1989a). A 
glycophospholipid membrane anchoracts as an apical targetting signal in 
polarized epithelial cells. Journal of Cell Biology 109, 2145-2156. 
Lisanti, M. P., Darnell, J. C., Chan, B. L., Rodriguez-Boulan, E., and Saltiel, 
A. (1989b). The distribution of glycosyl-phosphatidylinositol anchored 
proteins is differentially regulated by serum and insulin. Biochemical and 
Biophysical Research Communications 164, 824-832. 
Lisanti, M. P., Lebivic, A., Saltiel, A. R., and Rodriguezboulan, E. (1990a). 
Preferred apical distribution of glycosyl-phosphatidylinositol (GPI) anchored 
proteins - a highly conserved feature of the polarized epithelial-cell 
phenotype. Journal of Membrane Biology 113, 155-167. 
Lisanti, M. P., Rodriguez-Boulan, E., and Saltiel, A. R. (1990b). Emerging 
functional roles for the glycosyl-phosphatidylinositol membrane protein 
anchor. Journal of Membrane Biology 117, 1-10. 
Lisanti, M. P., Field, M. C., Caras, I. W., Menon, A. K., and 
Rodriguezboulan, E. (1991). Mannosamine, a novel inhibitor of glycosyl-
phosphatidylinositol incorporation into proteins. EMBO Journal 10, 1969-
1977. 
Lisanti,M.P., Rod rigeuz-Boulan,E. (1991). Polarized sorting of gpi-linked 
proteins in epithelia and membrane microdomains. Cell Biology lnternatioal 
Reports 15(11), 1023-1049. 
Locht, C., Chesebro, B., Race, R., and Keith, J. M. (1986). Molecular-
cloning and complete sequence of prion protein cdna from mouse-brain 
infected with the scrapie agent. Proceedings of the National Academy of 
Sciences of the United States of America 83, 6372-6376. 
164 
Lopez, C.D.,Yost,C.S.,Prusiner,S., Myers, R.M. and Lingappa,V. (1990). 
Unusual topogenic sequence directs prion protein biogenesis. Science248, 
226-229. 
Low, M. (1987). Biochemistry of the glycosyl-phosphatidylinositol 
membrane protein anchors. Biochemical Journal 244, 1-13. 
Low,M.G.,Stiernberg,J., Waneck,G.,Flavell,R. and Kincade W. (1988). Cell-
specific heterogeneity in sensitivity of P1-anchored membrane antigens to 
release by phosphlipase C. Journal of Immunological Methods 113, 101- 
Low, M., and Saltiel, A. (1988). Structural and functional roles of glycosyl-
phosphatidylinositol membrane protein anchors. Biochemical Journal 244, 
1-13. 
Manson, J., McBride, P., and Hope, J. (1992a). Expression of the PrP gene 
in the brain of Sinc congenic mice and its relationship to the development 
of scrapie. Neurodegen 1, 45-52. 
Manson, J., West, J. D., Thomson, V., McBride, P., Kaufman, M. H., and 
Hope, J. (1992b). The prion protein gene - a role in mouse embryogenesis. 
Development 115, 117-122. 
/ Masterson, W., and Ferguson, M. (1990). PMSF inhibits GPI anchor 
( 	
biosynthesis in the African trypanosome. EMBO Journal 10, 2041-2045. 
Masterson, W. J., and Ferguson, M. A. J. (1991). Phenylmethanesulphonyl 
fluoride inhibits gpi anchor biosynthesis in the African trypanosome. EMBO 
Journal 10, 2041-2045. 
Masterson, W., Doering, T., Hart, G., and Eglund, P. (1989). Anovel 
pathway for glycan assembly: Biosynthesis of the glycosyl-
phosphatidylinositol anchor of the trypanosome varient surface glycoprotein. 
Cell 56, 793-800. 
Mayor, S., Menon, A., and Cross,G. (1991). Transfer of glycosyl-
phosphatidylinositol membrane anchors to polypeptide acceptors in a cell 
free system. Journal of Cell Biology 114, 61-71. 
McKinley, M. P., Bolton, D. C., and Prusiner, S. B. (1983). A protease-
resistant protein is a structural component of the scrapie prion. Cell 35, 57-
62. 
McKinley, M. P., Meyer, R. K., Kenaga, L., Rahbar, F., Cotter, R., Serban, 
165 
A., and Prusiner, S. B. (1991). Scrapie prion rod formation invitro requires 
both detergent extraction and limited proteolysis. Journal of Virology 65, 
1340-1351. 
Menon, A., Schwarz, R., Mayor,S and Cross, G. (1990). Cell-free of 
glycosyl-phosphatidylinositol precursors for the glycolipid membrane anchor 
of Trypanosoma brucei variant surface glycoproteins. Journal of Biological 
Chemistry 265, 9033-9042. 
Merz, P. A., Somerville, R. A., Wisniewski, H. M., and lqbal, K. (1981). 
Abnormal fibrils from scrapie-infected brain. Acta Neuropathologica 54, 63-
74. 
Micanovic, R., Gerber, L., Kodukula, K., and Udenfriend, S. (1990). 
Phosphatidylinositol-glycan anchored membrane proteins determined by site-
specific mutagenesis at ASP-484 of placental alkaline phosphatase. PNAS 
87, 157-161. 
Miyata, T., Takeda, J., lida, V., Yamada, N., Inoue, N., Takahashi, M., 
Maeda, K., Kitani, T., and Kinoshita, T. (1993). The cloning of PIG-a, a 
component in the early step of gpi-anchor biosynthesis. Science 259, 1318-
1321. 
Mongkolsuk, S. (1988). A series of mammalian expression vectors and 
characterization of their expression and of a reporter gene in stably and 
transfected cells. Nucleic Acids Research 18, 1068. 
Moran, P., and Caras, I. (1991). A nonfunctional sequence converted to a 
signal for glycophosphatidylinositol membrane anchor attachment. Journal 
of Cell Biology 115, 1595-1600. 
Morris, R., Beech, J., Barber, P., and Raisman, G. (1985). Early stage of 
Purkinje cell maturation demonstrated by Thy-1 immunohistochemistry on 
post-natal rat cerebellum. Journal of Neurocytology 14, 427-452. 
Mullis, K., and Faloona, F. (1987). Specific synthesis of DNA in vitro via a 
polymerase catalysed chain reaction . Methods 155, 335-350. 
Noda, M., Yoon, K., Rodan, G. A., and Koppel, D. E. (1987). High lateral 
mobility of endogenous and transfected alkaline phosphatase: a 
phosphatidylinositol-anchored membrane protein. Journal of Cell Biology 
105, 1671-1677. 
Oesch, B., Westaway, D., Walchli, M., McKinley, M. P., Kent, S. B. H., 
Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., Prusiner, 
166 
S. B., and Weissmann, C. (1985). A cellular gene encodes scrapie PrP 27-30 
protein. Cell 40, 735-746. 
Olden, K.,Parent,J.B. and White,S.L. (1982) Carbohydrate moieties of 
glycoproteins- a re-evaluation of their functions. Biochem.Biophys.Acta. 
650, 209-232. 
Paifree, R. G. E., and Hammerling, U. (1986). Biochemical characterization 
of the murine activated lymphocyte alloantigen LY-6E.1 controlled by the 
LY-6 locus. Journal of Immunology 136, 594-600. 
Pan,K.M.,Baldwin, M. ,Nguyen,J .,Gasset, M . ,Serban,D. ,Groth,D. ,Mehlhorn,l 
.,Huang,ZW.,Fletterick,R.J., Cohen, F.E. and Prusiner. (1993). Conversion of 
alpha-helices into beta sheets features in the formation of the scrapie prion 
proteins. PNAS 90(23), 10962-10966. 
Pelham, H., and JacksonR (1976). An efficient mRNA dependant system for 
reticulocyte lysates. European Journal of Biochemistry 67, 247-256. 
Perara, E., and Lingappa, V. (1985). A former amino terminal sequence 
engineered to an internal location directs translocation of both flanking 
protein domains. Journal of Cell Biology 101, 2292-2301. 
Phelps, B. M., Primakoff, P., Koppel, D. E., Low, M. G., and Myles, D. G. 
(1988). Restricted lateral diffusion of PH-20, aPI-anchored sperm membrane 
protein. Science 240, 1780-1782. 
Plough, M., Plesner, T., Ronne, E., Ellis, V., Hoyer-Hansen, G., Hansen, N., 
and Dano, K. (1992). The receptor for Urokinase-type plasminogen activator 
is deficient on peripheral blood leukocytes in patients with paroxysmal 
nocturnal hemoglobinuria. Blood 79, 1447-1455. 
Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause 
scrapie. Science 216, 136-144. 
Prusiner, S. B. (1991). Molecular-biology of prion diseases. Science 252, 
1515-1522. 
Prusiner, S. B. (1992). Chemistry and biology of prions. Biochemistry 31, 
12277-12288. 
Roberts, wI, Myher, J. J., Kuksis, A., Low, M., and Rosenberry, T. L. 
(1988). Lipid analysis of the glycoinositol phospholipid membrane anchor of 
human erythrocyte acetyicholinesterase. Journal of Biological Chemistry 
263, 18766-18775. 
167 
Robinson, P. J., Millrain, M., Antoniou, J., Simpson, E., and Mellor, A. L. 
(1989). A glycophospholipid anchor is required for Qa-2-mediated T-cell 
activation. Nature 1986, 85-87. 
Rogers, M., Taraboulos, A., Scott, M., Groth, D., and Prusiner, S. B. (1990). 
Intracellular accumulation of the cellular prion protein after mutagenesis of 
its Asn-linked glycosylation sites. Glycobiology 1, 101-109. 
Rogers, M., Yehiely, F., Scott, M., and Prusiner, S. B. (1993). Conversion 
of truncated and elongated prion proteins into the scrapie isoform in 
cultured-cells. Proceedings of the National Academy of Sciences of the 
United States of America 90, 3182-3186. 
Romero, G., Lutterell, L., Rogol, A., Zeller, K., Hewlett, E., and Lamer, J. 
(1988). Phosphatidylinositol-glycan anchors of membrane proteins: potential 
precursors of insulin mediators. Science 240, 509-511. 
Rosse, W. F. (1190). Phosphatidylinositol-linked proteins and paroxysmal 
nocturnal hemoglobinuria. Blood 75, 1595-1601. 
Rothberg, K. D., Ying, Y., Kolhouse, J. F., Kamen, B. A., and Anderson, R. 
G. W. (1992). The glycophospholipid-linked folate receptor internalizes folate 
without entering the clathrin-coated pit endocytic pathway. Journal of Cell 
Biology 110, 637-649. 
Saiki, R., Scharf, S., Faloona, F., Mullis, K., Horn, G., Elrich, H., and 
Amnheim, N. (1985). Enzymatic amplification of Beta-globin genomic 
sequences and restriction site analysis for diagnosis of sickle cell anemia. 
Science 37, 170-72. 
Saltiel, A., Fox, J., Sherline, P., and Cuatrecasas, P. (1986). Insulin 
stimulated hydrolysis of a novel glycolipid generates modulators of CAMP 
phosphodiesterase. 233, 967-972. 
Sambrook, J., Fritsch, E. F., and Maniatis, T., eds. (1989). Molecular 
cloning: a laboratory manual. (New York: Cold Spring Harbour Laboratory). 
Sanger, F., Nicklen, S., and Coulson, A. (1977). . Proceedings of the 
National Academy of Sciences of the United States of America 74, 5463-
5476. 
Schell, M. J., Maurice, M., Steiger, B., and Hubbard, A. L. (1992). 5' 
nucleotidase is sorted to the apical domain of hepatocytes via an indirect 
route. Journal of Cell Biology 119, 1173-1182. 
im 
Seed, B. (1982). . In Genetic engineering: principles and methods, vol. 4, J. 
Setlow, and A. Hollaender, eds. (New York: Plenum Publishing), pp. 91-. 
Shyng, S. L., Huber, M. T., and Harris, D. A. (1993). A prion protein cycles 
between the cell-surface and an endocytic compartment in cultured 
neuroblastoma-cells. Journal of Biological Chemistry 268, 15922-15928. 
Simons, K., and van Meer, G. (1988). Lipid sorting in epithelial cells. 
Biochemistry 27, 6197-6202. 
Soloski, M. J., Vernachio, J., Einhorn, G., and Lattimore, A. (1986). Ga 
gene expression-biosynthesis and secretion of Qa-2 molecules in activated 
T-cells. Proceedings of the National Academy of Sciences of the United 
States of America 83, 2949-2953. 
Somerville, R. A., and Ritchie, L. A. (1990). Differential glycosylation of the 
protein (prp) forming scrapie-associated fibrils. Journal of General Virology 
71, 833-839. 
Southern, E. (1975). Detection of specific sequences among DNA fragments 
separated by gel electrophoresis. Journal of Molecular Biology 98, 503. 
Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. (1987). Scrapie 
prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240. 
Stahl, N., Baldwin, M., Burlingame, A. L., and Prusiner, S. (1990a). 
Identification of glycoinositol phospfolipid linked and truncated forms of the 
scrapie prion protein. Biochemistry 29, 8879-8884. 
Stahl, N., Borchelt, D. R., and Prusiner, S. B. (1990b). Differential release 
of cellular and scrapie prion proteins from cellular membranes by 
phosphatidylinositol-specific phospholipase-C. Biochemistry 29,5405-5412. 
Stahl, N., Baldwin, M. A., and Prusiner, S. B. (1991). Electrospray mass-
spectrometry of the glycosylinositol phospholipid of the scrapie prion 
protein. Cell Biology International Reports 15, 853-862. 
Stahl, N., Baldwin, M. A., Hecker, A., Pan, K. M., Burlingame, A. L., and 
Prusiner, S. B. (1992). Glycosylinositol phospholipid anchors of the scrapie 
and cellular prion proteins contain sialic-acid. Biochemistry 31, 5043-5053. 
Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., 
Burlingame, A. L., and Prusiner, S. B. (1993). Structural studies of the 
scrapie prion protein using mass-spectrometry and amino-acid sequencing. 
Biochemistry 32, 1991-2002. 
169 
Stefanova, I., Horejsi, V., Ansotegui, I. J., Knapp, W., and Stockinger, H. 
(1991). Gpi-anchored cell-surface molecules complexed to protein tyrosine 
kinases. Science 254, 1016-1019. 
Suggs, S., Hirose, T., Miyake, T., Kawashina, E., Johnson, M., ItakuraK, 
and Wallace, R. (1981). . In Developmental biology using purified genes, D. 
Brown, ed. (New York: Academic Press). 
Tagliavini, F., Prelli, F., Porro, M., Salmona, M., Bugiani, 0., and Frangione, 
B. (1992a). A soluble form of prion protein in human cerebrospinal-fluid - 
implications for prion-related encephalopathies. Biochemical and Biophysical 
Research Communications 184, 1398-1404. 
Tagliavini, F., Prelli, F., Porro, M., Salmona, M., Bugiani, 0., and Frangione, 
B. (1 992b). A soluble form of prion protein in the cerebrospinal-fluid. Journal 
of Neuropathology and Experimental Neurology 51, 352. 
Takeda, J., Miyata, T., Kawagoe, K., lida, Y., Endo, Y., Fujita, T., 
Takahashi, M., Kitani, T., and Kinoshita, T. (1993). Deficiency of the GPI 
anchor caused by a somatic mutation of the pig-a gene in paroxysmal-
nocturnal hemoglobinuria. Cell 73, 703-711. 
Taraboulos, A., Serban, D., and Prusiner, S. B. (1990). Scrapie prion 
proteins accumulate in the cytoplasm of persistently infected cultured-cells. 
Journal of Cell Biology 110, 2117-2132. 
Taraboulos, A., Raeber, A. J., Borchelt, D. R., Serban, D., and Prusiner, S. 
B. (1992). Synthesis and trafficking of prion proteins in cultured-cells. 
Molecular Biology of the Cell 3, 851-863. 
Tartakoff, A., and Singh, N. (1992). How to make a glycoinositol anchor. 
TIBS 17, 470-473. 
Tateishi,J. and Kitamoto T. (1993). Developments in dianosis for prion 
diseases. British Medical Bulletin 49(4), 971-979. 
Tausk.F, Fey, M., and Gigli, I. (1989). Endocytosis and shedding of the 
decay accelerating factor on human polymorphonuclear cells. Journal of 
Immunology 143, 3295-3302. 
Thomas, J., Webb, W., Davitz, M. A., and Nussenzweig, V. (1987). Decay 
accelerating factor diffuses rapidly on HeLa cell surfaces. Biophysical Journal 
51, 522a. 
Thomas, P., and Samelson, L. E. (1992). The glycophosphatidylinositol- 
170 
anchored Thy-1 molecule interacts with the P68FYN protein tyrosine kinase 
in T-cells. Journal of Biological Chemistry 267, 12317-12322. 
Toutant, J. P., Roberts, W. L., Murray, N. R., and Rosenberry, T. L. (1989). 
Conversion of human erythrocytE acetylcholinesterase from an amphiphillic 
to a hydrophillic form by phosphatidylinositol specific phospholipase C and 
serum phosphlipase D. European Journal of Biochemistry 180, 503-508. 
Turk, E.,Teplow, D. B., Hood, L. E., and Prusiner, S. B. (1988). Purification 
and properties of the cellular and scrapie hamster prion proteins. European 
Journal of Biochemistry 176, 21-30. 
Urkaze,M., Kamitani,T., DeGasperi,R.,Sugiyama,E.,and Chang, H.M. (1992). 
Identification of a missing link in GPI-anchor biosynthesis in mammalian 
cells. Journal of Biological Chemistry 267, 6459-6462. 
Van den Bosch, R. A., Dumaline, A. P., Geuze, H. J., Van der Ende, A., and 
Strous, G. J. (1988). Recycling of 5' nucleotidase in a rat hepatoma-cell 
line. EMBO Journal 7, 3345-3351. 
Vieira, J., and Messing, J. (1987). Production of single-stranded DNA. 
Methods in enzymology 153, 3-. 
Von Heijne, G. (1990). The signal peptide. Journal of Membrane Biology 
115, 195-201. 
Wallace, R., Johnson, P., Tanaka, S., Schold, M., Itakura, K., and Abelson, 
J. (1980). . Science 209, 1396-1400. 
Walter,, E, Roberts, W. L., Rosenberry, T. L., Ratnoff, W. D., and Medof, M. 
E. (1990). Structural basis for variations in the sensitivity of human decay-
accelerating factor to phosphatidylinositol-specific phopholipase C cleavage. 
Journal oflmmunology 144, 1030-1036. 
Waneck, G., Stein, M., and Flavell, R. (1988).Conversion of a GPI-anhored 
protein to a n integral membrane protein by a single amino acid mutation 
Science 241, 697-699. 
Weichenhan, D. (1991). Fast recovery of DNA from agarose gels by 
centrifugation through blotting paper. TIGS 7, 109. 
Weissmann, C.,Bueler,H., Sailer, A., Fischer, M.,Aguet,M. and Aguzzi A. (1993) 
Role of PrP in prion diseases. British Medical Bulletin 49(4), 995-1011. 
Wells, G. A. H., Scott, A. C., Johnson, C. T., Gunning, R. F., Hancock, R. 
171 
D., Jeffrey, M., Dawson, M., and Bradley, R. (1987). A novel progressive 
spongiform encephalopathy in cattle. Veterinary Record 121, 419-420. 
Westaway, D., Goodman, P. A., Mirenda, C. A., McKinley, M. P., Carlson, 
G. A., and Prusiner, S. B. (1987). Distinct prion proteins in short and long 
scrapie incubation period mice. Cell 51, 651-662. 
Wieslander, L. (1979). A simple method to recover intact high molecular 
weight RNA and DNA after electrophoretic separation in low gelling 
temperature Agarose gels. Anal. Biochem. 98, 305. 
Wills, P. R. (1992). Potential pseudoknots in the PrP-encoding messenger-
RNA. Journal of Theoretical Biology 159, 523-527. 
Wills, R.G. (1993). Epidemiology of Creutzfeldt-Jacob disease. British 
Medical Bulletin 49(4), 960-970. 
Xi, Y. G., Ingrosso, L., Ladogana, A., Masullo, C., and Pocchiari, M. (1992). 
Amphotericin-b treatment dissociates invivo replication of the scrapie agent 
from PrP accumulation. Nature 356, 598-601. 
Xue, G. P., Calvert, R. A., and Morris, R. J. (1990). Expression of the 
neuronal cell surface glycoprotein Thy-1 is under post-transcriptional control 
and is spatially regulated in the developing olefactory system. Development 
109, 851-864. 
Yost, C. S., Lopez, C. D., Prusiner, S. B., Myers, R. M., and Lingappa, V. R. 
(1990). Nonhydrophobic extracytoplasmic determinant of stop transfer in 
the prion protein. Nature 343, 669-672. 
172 
Supplementary references. 
Conzelmann,A., Reizman, H., Desponds, C.,Bron, C. (1988). Amajor 
125kd membrane glycoprotein of Saccharorayces cerevisiae is 
attached to the lipid bilayer through an inositol-containing 
phospholipid. EMBO J. 7, 2233-2240. 
Puoti, A., Conzelmann, A. (1993). Characterization of abnormal 
free glycophosphatidylinositols accumulating in mutant lymphoma- 
cells of class-B, class-E, class-F and class-H. 	Journal of 
Biological Chemistry 268, 7215-7224. 
Zamze,S., Ferguson,M.A.J., Collins, R., Dwek, R.A. and 
Rademacher, T.W. (1988). Characterization of the cross-reacting 
determinant (CRD) of the glycosyl-phosphatidylinositOl membrane 
anchor of Trypanasoma brucei variant surface gylcoprotein. 
European Journal of Biochemistry 176, 527-534. 
Appendix l.  
Antibiotics 
Name 	 Stock 	 working conc. 	 storage 
Ampiciiiin 	1 00mg/mI 	1 OOpg/ml 	 -20°C 
Streptomycin 	10mg/mi lOOpg/mI -20°C 
Kanamycin 25mg/mi 	 70pg/ml 	 -20°C 
Alkaline aei loadinci buffer 
NaOH 	 300mN 
EDTA 6mM 
Ficoli 	 18% 
Bromophenol green 	 0.15% 
XCFF 	 0.25% 
1 x Alkaline gel running buffer 
5OmN NaOH 
1mM EDTA 
Aaarose ciel loadinci buffer 
Ficoll 	 ig 
1xTAE 8m1 
0.5M EDTA 	 2m1 
Bromophenol blue 	 0.025% 
Xylene cyanol 	 0.05% 
Bind-Silane 
Ethanol 	 5ml 
10% Acetic acid 	 170p1 
Bind-Siiane 	 1 7pl 
Chromic acid 
Add 200m1 70% Nitrous acid to 1 litre H20. 
To this add 1 50g of pottasium dichromate and make up to 1.5 litres. 
50 X Denharts solution 
Ficoli 	 0.5g 
Polyvinyl pyrrolidine 	 0.5g 
Bovine serum albumin(BSA) 	 0.5g 
H20 to 50 ml 
Store as 1 ml aliquots at -20°C 
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DEPC treatment 
Dietylpyrocarbonate (DEPC) was added to H20 at a final concentration of 
0.1%, left overnight in a fume hood and autoclaved before use. 
Dialysis tubing 
Cut tubing into suitable lengths. 
Boil for 10 min in 1 litre 10% sodium carbonate. 
Discard the buffer and boil x 3 in 1 litre H20. 
Pour off H20 and store in TE at 4°C. 
Rinse with distilled H20 before use. 
EDTA 
Weigh out enough EDTA to make 500m1 of a 0.5M solution. Dissolve in 
approx. 200m1 and pH to 8.0 with NaOH and make up to 500m1 with H20. 
Equilibrating phenol 
Phenol was obtained from Gibco-BRL and stored at -20°C prior to 
equilibration. 
It was defrosted by placing in a 65°C waterbath overnight. 
The next day 0.1% 8-hydroxyquinalone was added, ie., 0.1g was added to 
75m1 of neat phenol and the volume made up to lOOmI with 1M Tris.Hcl 
pH9. This was mixed and the phases allowed to separate. The aqueous 
layer was removed and the extraction with 1 M iTris repeated x 2. Then the 
buffer was change to 0.1M Tris and repeated x 2. The pH of the aqueous 
layer should be 8.0. 
Phenol was stored at 4°C. All manipulations were carried out in a fume 
hood. 
Ficoll-dve EDTA (FDE 
0.2M EDTA 	 500p1 
Ficoll type 400 	 0.3g 
trace Bromophenol blue 
H20 to imI. 
Formamide sample buffer 
lOx MOPS 	 lOOpl 
Formamide(99%) 	 200pl 
Formaldehyde (40%w/v) 	1 20p1 
Final samole buffer (FSB 
Glycerol 1 .Oml 
10% SDS 2.Oml 
Bromophenol blue 2.0mg 
Stacking gel buffer 1 .25m1 
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H20 to lOmi 
Just prior to use add lpI $-mercaptoethanol per 201il of sample buffer. 
Minimal agar 
Add 6g Difco agar to 300ml H20 , autoclave. 
Cool to 60°C, add: 	Spitzen salts 	 80m1 
20% glucose 4ml 
Vitamen Bi (2mg/mi) 	0.1ml 
H20 to 400m1 
OLB Buffer 
Mix solutions A, B and C in the ratios 100:250:150, aliquot and store at 
-20°C. 
Solution A:- 	Solution 0 








12.5pI store -20°C 




pH to 8 with HCI 
H20 to lOmi 
Solution B:- Hepes 	 6.51g 
pH to 6.6 with NaOH 
H20 to 12.5m1 
Solution C:- 	pN6 
PBST 
lOOx Phosphate buffered saline tablets 
Tween 20 
Polvacrvlamide ciels for seciuencinci 
For an 8% gel: 
40% Acrylamide solution 
9M Urea 
10% Ammonium persulphate 
Temed 
Pharmacia 	stote -20°C 
5 
0.5g 







Rubidium chloride 12g 1 00m 
Mangenese chloride 9.9g 50mM 
1M Pottassium acetate 30m1 30mM 
Calcium chloride 1.5g 10mM 
Glycerol 15.15ml 15% 
H20 to lOOmI 
Sterilize through a 0.22pm filter 
RF2 
0.5M MOPS 	 20m1 	 10mM 
Rubidium chloride 	 1.2g 10mM 
Calcium chloride 11 g 	 75mM 
Glycerol 	 15.15ml 	 15% 
H20 to 1 00M 
Sterilize through a 0.22pm filter 
SIDS-PAGE stackinq buffer 
Tris 	 6.06g 
10% SIDS 	 4 ml 
pH to 6.8 with HCl 
H20 to 1 00M 
SIDS-PAGE seoaratinci buffer 
Tris 	 18.2g 
10% SIDS 	 4ml 
pH to 8.8 with HCI 
H20 to 1 00M 
SX SDS-oaae runninu buffer 
Tris 	 15g 
Glycine 	 72g 
SIDS 5g 
H20 to 1 litre 	 store at 4°C 
Semi-dry blottinu buffer 
Glycine 	 2.93g 
Tris 	 5.81g 
SIDS 0.38g 
20% Methanol 	 200ml 
H20 to 1 litre, 	 store at 4°C 
10  SSC 
NaCitrate 	 88.3g 
NaCl 	 175.3g 
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H20 to 1 litre. 
20 x SSCP 
NaCl 140.3g  
NaCitrate 	 88.4g
62.4g NaH2PO42H20 	
NaOH to pH 7.4 
H20 to 1 litre. 
20 x SSPE 
NaCl 	 448g 
H2PO4H20 	 55.2g 
EDTA 	 14.8g 
4N NaOH 	 90ml 
H20 to 2 litres. 
5OXTAE 
Tris 	 242g 
Glacial acetic acid 	 57ml 
0.5M EDTA 	 1 00m 
H20 to 1 litre 
lox TBE 
Tris 	 108g 
Boric acid 	 55g 
0.5 M EDTA 20m1 
H20 to 1 litre 
TBST 
1M Tris.Hcl pH 8.0 	 1001u1 
1M NaCl 	 1.5ml 
Tween-20 5pl 
H20 to lOmI 
TE 
1M Tris.Hcl pH 8.0 lOmi 
0.5M EDTA 2ml 
H20 to 1 litre 
Top agar 
Tryptone lOg 
Yeast extract 5g 
NaCl 5g 
Difco agar 7g 
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